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Background: Daily, approximately one million people become infected with one 
of four sexually transmitted infections (STIs) – C. trachomatis (CT), N. gonorrhea 
(NG), syphilis and trichomoniasis (TV). Accurate and timely STI diagnosis is 
critical to prevent disease spread. This dissertation focused on STI treatment 
seeking behavior and self-collected samples (SCS) for STI testing as means to 
improve and expand STI diagnosis in low-resource settings. 
Methods: This research was conducted in Rakai, Uganda as a part of the STI 
Prevalence Study (STIPS), nested within the Rakai Community Cohort Study. 
From a population-based sample of all consenting participants aged 18-49 in two 
communities, we presented descriptive data to characterize treatment seeking 
behavior among 962 participants who reported STI-related symptoms. We then 
used modified Poisson regression to identify factors associated with clinic 
treatment. We also conducted interviews with 36 adults who self-collected a 
sample for STI testing, as well as nine key informants, to assess the acceptability 
of SCS and explore service delivery preferences for a SCS for STI testing 
program. 
Results: Fifty-seven percent of adults with STI-related symptoms reported 
seeking any treatment for their symptoms; seeking treatment at a clinic was 47% 
among men and 48% among women. For men, being from an inland community 
(PRR: 1.43, 95%CI: 1.12-1.83) and having more than one STI-related symptom 
(PRR: 1.73, 95%CI: 1.36-2.21) increased the likelihood of seeking clinic 
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treatment. For women, having more than one STI-related symptom (PRR: 1.41, 
95%CI: 1.12-1.78) increased the likelihood of seeking clinic treatment. SCS were 
acceptable among participants with and without symptoms, though healthcare 
worker (HCW)-collection was often preferred. While we did not find a single most 
preferred approach for SCS/STI testing service delivery; common themes of 
confidentiality/privacy and HCW interaction explained participant’s high 
acceptance of, and preference for, home- and facility-based approaches.   
Conclusions: Our findings indicate that up to half of individuals with STI-related 
symptoms may not be seeking clinical care. SCS may be an acceptable, 
additional means to expand STI diagnostic testing in our setting, and a patient-
centered approach for service delivery may be needed to in order to make the 
service acceptable to the larger population.   
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Chapter 1. Introduction 
1.1 Specific Aims  
Non-HIV sexually transmitted infections (STIs) are an issue of growing concern; 
in settings with a widespread availability of combination HIV interventions, STI 
incidence is rising.1–3 With the recent success of HIV control programs, low-
resource settings like Uganda may follow a similar trajectory. Data from the 2016 
Demographic and Health Survey (DHS) show that the self-reported prevalence of 
previous STIs and/or STI symptoms for Ugandans aged 15-49 was 24.4% 
among women and 13.6% among men, with over a quarter of these persons 
stating that they did not seek any advice or treatment for their symptoms.4 Timely 
and accurate diagnosis of infection is critical to STI control, including prevention 
of sequelae, and will be essential in curbing any rise in STIs the country may 
experience in the near future. 
 
Treatment seeking behavior can be a limiting factor to timely and appropriate STI 
diagnosis. Delayed or inappropriate treatment seeking can result in an improper 
diagnosis, ineffective treatment and the continued spread of disease.5,6 Various 
factors can influence the decision to seek treatment, including individual-level 
and contextual factors.5 These factors not only influence when and where an 
individual seeks treatment, but also if they seek any treatment at all.5 However, 
with the exception of DHS data, current, population-based data on treatment 




Etiologic testing is also critical for accurate STI diagnosis. Like most other low-
resource settings, Uganda currently uses the syndromic approach to manage 
STIs.7 This involves an examination by a healthcare worker and subsequent 
antibiotic administration for individuals who report symptoms common to 
prevalent STIs in the region. While practical, the approach is limited due to low 
sensitivity and specificity and the high proportion of asymptomatic infections or 
failure to recognize symptoms.8 Given these limitations, the World Health 
Organization (WHO) has recommended a global shift away from syndromic case 
management in favor of etiologic testing where feasible and cost-effective.9 With 
an improved infrastructure and laboratory capacity due to the scale-up of HIV 
programs, Uganda stands ready for such a shift. Self-collected samples (SCS) 
for etiologic genital testing may be a way to expand STI case management. By 
allowing the patient to collect a sample themselves, studies suggest that SCS for 
STI testing (SCS/STI testing) can circumvent barriers to clinic- and/or clinician-
based STI case management, like inaccessibility, stigma or privacy concerns.10–
12 Despite its potential, SCS/STI testing programs are expensive and thus 
uncommon in low-resource settings, and their acceptability is not well 
documented. 
 
This dissertation focused on improving and expanding STI diagnosis in Uganda 
and similar low-resource settings, and assessed treatment seeking behavior as 
well as the acceptability of SCS/STI testing among adults in Rakai, Uganda. This 
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research was nested within a larger study examining population-level STI 
prevalence through the Rakai Community Cohort Study (RCCS), and had the 
following aims: 
1. Describe current treatment seeking behavior among adults with STI-
related symptoms and identify factors associated with seeking clinic 
treatment.  
2. Explore the acceptability of SCS/STI testing. 
3. Explore service delivery preferences for a SCS/STI testing service. 
 
1.2 Organization of the dissertation  
This dissertation is organized in six chapters. The first chapter introduces the 
research aims. Chapter 2 provides context for the dissertation; it includes a 
literature review and describes the theoretical grounding and conceptual 
framework that guides the research. The second chapter also describes the 
study setting and the parent study under which this research was conducted. 
Chapter 3 presents a summary of the study design and analysis methods. 
Chapters 4 through 6 present the main dissertation findings. Chapter 4 describes 
current treatment seeking behavior among adults with STI-related symptoms in 
Rakai, Uganda and presents descriptive data on treatment seeking as well as 
factors associated with clinic treatment seeking (Aim 1). Chapter 5 explores the 
acceptability of SCS among adults (Aim 2). Chapter 6 explores service delivery 
preferences for a SCS/STI testing service among adults (Aim 3). Finally, Chapter 
7 summarizes the key findings and conclusions, study strengths and limitations. 
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A discussion of program implications, as well as recommendations for future 
research, is also included in chapter seven.  
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Chapter 2. Background and Significance 
2.1 Literature review 
2.1.1 The need for a renewed focus on STI control in Uganda 
Sexually transmitted infections (STIs) are a global issue of growing concern. 
Every year, there are an estimated 357 million new infections with one of the four 
curable STIs – C. trachomatis (CT), N. gonorrhea (NG), syphilis and 
trichomoniasis (TV) – across the world, with about one million STIs acquired 
every day.13 STI infections have deleterious effects on both reproductive health 
and quality of life and can increase the risk of HIV acquisition three-fold.13–15 Sub-
Saharan Africa (SSA) – where over two-thirds of new HIV cases and AIDS-
related deaths occur – accounts for approximately 40% of the global STI 
burden16 and the largest per-capita rates of syphilis, NG, TV, and herpes simplex 
virus-2 (HSV-2) globally, with the majority of African cases occurring among 
heterosexual individuals.17,18 In 2016, the World Health Organization (WHO) 
identified the health sector response to the STI epidemic as critical to achieving 
the 2030 United Nations Sustainable Development Goals (SDGs).16  
 
While HIV incidence in SSA is generally declining, incidence trajectories among 
non-HIV STIs are unclear. SSA has historically seen the world’s highest burden 
of HIV.19 However, data suggest that HIV incidence is declining with the scale up 
of combination HIV prevention interventions in many African settings.20–22 This 
includes Rakai, Uganda where a 42% decline in HIV incidence was observed 
following scale-up of antiretroviral therapy and voluntary medical male 
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circumcision programs, and delay of adolescent sexual debut.21 Recent data on 
STI trends in the U.S. and Europe suggest increasing STI incidence 
simultaneous with the rollout of combination HIV prevention strategies, possibly 
due to behavioral disinhibition with perceived HIV protection, the use of HIV pre-
exposure prophylaxis (PrEP), and a decline in the perceived need for condom 
use.1–3 While limited, Uganda DHS data also show an increase in self-reported 
STIs and STI symptoms in both men and women since 1995 (Table 1). If Uganda 
– with its reduction of incident HIV following combination HIV interventions – 
follows a similar trajectory to the U.S. and Europe, STI rates in the country may 
be expected to rise further in the coming years.  
 
Table 1. Percentage of persons 15-49 years who ever had sexual 
intercourse who reported having an STI or STI symptoms 
in the past 12 months (Uganda DHS data) 
 
DHS 
Females who reported 
having STI/genital 
discharge/ 
sore or ulcer 
Males who reported 
having STI/genital 
discharge/ 
sore or ulcer 
199523 247 of 7,070 (3.4%)† 120 of 1,996 (6.0%)‡ 
2000-0124 1,062 of 6,398 (16.6%)  90 of 1,643 (5.5%) 
200625 1,602 of 7,281 (22.1%) 248 of 2,056 (12.8%) 
201126 1,956 of 7,383 (26.5%) 249 of 1,777 (14.0%) 
20164 3,855 of 15,799 (24.4%)  565 of 4,155 (13.6%)†§ 
Data are presented as n (%). 
† Reported having syphilis, NG, genital warts or other STD (non-HIV). 
‡ Reported having syphilis, NG, discharge from penis, sore/ulcer on penis or 
other STD (non-HIV). 
§ Reported having abnormal discharge from penis/sore or ulcer. 
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2.1.2 The importance of timely and accurate STI diagnosis for STI 
control 
STI control programs can be guided by the standard epidemiological model for 
STIs, which describes the basic reproductive rate of an STI in a population to be 
influenced by: (a) the average probability of transmitting infection from an 
infected to non-infected person, (b) the average rate of acquisition of new sexual 
partners, and (c) the average duration of infectiousness.5,6,27 Control programs 
can target their interventions on one or more of these variables in order to reduce 
an STI’s reproductive rate. Appropriate and timely STI diagnosis and effective 
treatment can reduce the duration of infectiousness in an infected person and is 
one approach to slow disease spread in a population.  
 
Uganda currently uses the syndromic approach to manage STIs.7 This involves a 
clinic-based exam and subsequent antibiotic administration for those who report 
symptoms common to prevalent STIs in the region. While practical and 
inexpensive, the syndromic approach for STI case management can result in 
inappropriate and/or overtreatment of STIs and the development of antimicrobial 
resistance. Syndromic management of STIs also lacks the specificity of a 
diagnostic test and does not detect asymptomatic cases – the majority of STI 
cases.10,28 Even among those with symptoms, the syndromic approach is limited; 
it relies upon the patient to: a) recognize their symptoms, b) ascribe those 
symptoms to a health-related cause and then c) seek appropriate care in order to 
receive effective treatment.8 These steps may not always occur, resulting in 
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untreated, or ineffectively treated, individuals.8 If left untreated, STIs can have 
deleterious effects on individual health and can also further the spread of STIs 
within the community. Given these limitations, the WHO has recently 
recommended a global shift away from syndromic case management in favor of 
etiologic testing where feasible and cost-effective.9 
2.1.3 Improving STI diagnosis by focusing on STI treatment seeking  
In this dissertation, ‘treatment seeking behavior’ is defined as any activity 
undertaken by an individual who perceives themselves to be ill or have a health 
problem, for the purpose of finding an appropriate remedy. This borrows from 
Kasl and Cobb’s definition of ‘illness behavior’29 and is analogous to the term 
‘health seeking behavior’ used in other studies.8 A review by Ward et al. 
identified various factors that influence health seeking behavior for STIs in low-
resource settings: symptom recognition; individual preexisting beliefs and 
meanings of symptoms; perceived efficacy of different treatment approaches 
(traditional, spiritual, western medical, or none at all); availability, quality and 
accessibility of services (including convenience, privacy and affordability); and 
social stigma.8 These factors influence not only whether or not an individual 
seeks care, but also when and where they go for care.  
 
Other studies conducted in SSA on adult treatment seeking behavior confirm 
Ward’s findings.30,31,40,32–39 For instance, in a study on delayed healthcare 
seeking among patients with STI-related symptoms in South Africa, Meyer-Weitz 
et al. found that individuals who delayed to seek care were more likely to be 
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those who treated themselves prior to seeking health care, who were female, 
whose friends waited before seeking treatment, who held misconceptions 
regarding the cause of STIs, who perceived STIs not to be serious, who valued 
personal autonomy in sexual behaviors and who had less positive outcome 
expectations of refusing sex.36 A population-based study in Kenya, Nairobi found 
a gender difference in care seeking, with 20% of men versus 35% of women not 
seeking care, mainly because symptoms were not considered serious, symptoms 
had disappeared, or as a result of lack of money.39 The study also found that 
because women were mostly monogamous, they did not relate their symptoms to 
sexual intercourse, which prevented them from promptly seeking care. 
Additionally, the study found that young women sought care less often, but 
promptly, whereas older women sought care more often but waited longer. Fonck 
et al. also found a major gender difference in treatment seeking for STIs among 
patients in Nairobi, Kenya (with females waiting almost three times as long as 
men to seek care),38 as did Moses et al., who found that Kenyan women waited 
longer than men to attend study clinics and were more likely to continue to have 
sex while symptomatic.41  
 
Qualitative studies have also illustrated a variety of contextual factors that 
influence treatment seeking. A study among individuals in Zambia found that a 
person's perception, how the diagnosis was determined, type and cost of 
treatment, the demand by the professional sector to bring sexual partners for 
care, as well as the attitudes of health workers, parents, and the church affected 
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an individual’s treatment decisions.35 A qualitative study among men in 
Zimbabwe found that prevailing gender norms of resilience and self‐reliance, in 
addition to shyness and embarrassment, could delay a man’s treatment seeking 
behavior in general, and HIV‐related stigma could hinder a man's treatment 
seeking behavior for sexual‐health concerns (especially for STIs).34 Finally, we 
found one qualitative study that was conducted in 1999 among lay persons in 
Uganda that explored STI treatment seeking behavior.31 The study found that 
STIs were perceived as naturalistic diseases caused by a tiny insect and female 
infertility (a complication of STIs) was perceived as a supernatural ailment. The 
study also found that stigma towards people with STIs other than HIV was high. 
As identified by the participants, sources of health care for STI patients included: 
public health institutions, private practitioners, traditional healers and self-
treatment, with self-treatment being very common. For those with STI-related 
symptoms, deterrents to care at public health institutions included: long waiting 
times, lack of drugs, user charges, corruption and bribes by health workers, 
health workers abusing STI patients, lack of privacy, long distances, fear of being 
tested for AIDS, not being examined in the laboratory, and being given tablets 
instead of injections (which were preferred). The study also found a gender 
difference in disease perception and behavior: women were less likely to agree 
that their diseases were STIs, more likely to say that STI prevention depended 
on their partner, more likely to report that partner referral was difficult and more 
likely to have sex while symptomatic in comparison to men.  
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Data from the 2016 Uganda DHS show that over a quarter of persons who 
reported an STI or STI symptoms in the past twelve months did not seek any 
advice or treatment at all.4 Despite this and the above information, data on STI 
treatment seeking behavior in Uganda are limited: first, with the exception of one 
study among female sex workers and truckers,42 previous studies on STI 
treatment seeking behavior in Uganda were conducted before 2006 and may not 
accurately reflect behaviors in the current context – that is, after the rollout of HIV 
combination prevention services. Second, existing studies drew their samples 
from clinics and thereby do not include individuals who never sought treatment. 
Calls have been made for a broader research perspective in order to better 
understand sexual healthcare seeking behavior.43 This includes a focus on non-
attendance at services as well as research that uses population-based studies 
including non-patient samples recruited from non-medical settings. In Aim 1, we 
assessed population-based data collected in 2019 to better understand STI 
treatment seeking behavior in the general population. 
2.1.4 Expanding STI diagnosis through SCS/STI testing 
As aforementioned, the syndromic approach for STI case management is limited.  
With a global shift toward etiologic testing, SCS may be one way to expand STI 
case management beyond the syndromic approach. SCS/STI testing occurs 
when individuals take a swab or fluid sample themselves, either within or outside 
the clinic, and send the specimen to a laboratory for testing.44 Research in high-
resource settings shows that self-collected STI samples are as accurate as 
clinician-based tests,45 and that SCS/STI testing interventions are feasible and 
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acceptable in a variety of populations.46–55 Previous studies in Rakai have also 
demonstrated that self-administered vaginal swabs are valid and acceptable 
methods to screen for STIs among females and urine samples are acceptable to 
both females and males.56–59  
 
While not a replacement for clinic-based examination and clinician counseling, 
SCS may be a way to expand STI case management beyond the clinician- and 
clinic-dependent syndromic approach.60–62 For instance, SCS/STI testing can 
provide opportunities for testing outside of the clinic, such as within schools or 
homes.60 Home-based STI testing programs implemented in high-resource 
settings allow individuals to request STI self-testing ‘kits’ online or in-person and 
receive them via post or at a prespecified pick-up location. Individuals are then 
able to self-collect their samples and return them to the designated laboratory 
through postal mail or by dropping them off in a clinic, pharmacy or other 
location. Testing results are then returned to the user by various means (either 
through the clinician, phone call or text message, etc.). A recent meta-analysis 
assessing the programmatic value of SCS/STI testing found that SCS increased 
overall uptake of STI testing services and case finding, suggesting that self-
collection of STI samples could be an effective additional strategy to increase STI 
case management.62 
 
Despite their potential, SCS/STI testing services are not common in low-resource 
settings. The greatest weakness in individual case management of STIs in low-
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resource settings is the lack of cheap and accurate diagnostic tests.63 Syndromic 
management of STIs is inexpensive and does not require a laboratory for 
diagnosis.10 However, in settings like Uganda, intensive scale-up of HIV care and 
treatment over the past 15 years has resulted in strengthened supply chains, 
infrastructure and laboratory capacity. In such a context, the potential for using 
cheaper technologies to facilitate STI etiologic testing is becoming a more viable 
reality.61 With an improved infrastructure and laboratory capacity due to the 
scale-up of HIV programs, Uganda and similar low-resource settings stand ready 
to shift toward etiologic testing. 
 
At present, data on the acceptability of SCS for etiologic STI testing in a general 
population in Uganda are not common. This information is critical for successful 
intervention uptake and will be needed for future program development. In Aim 2, 
we used qualitative methods to provide data on the acceptability of self-collected 
genital swabs among adult males and females.   
 
Beyond acceptability, questions also exist around how a prospective SCS/STI 
testing service should be delivered and what users most prefer. SCS/STI testing 
involves a variety of user-dependent activities, including requesting and receiving 
sampling materials, returning samples to the lab for testing, receiving test results 
and receiving treatment, if necessary. In order to be successful, SCS/STI testing 
programs must consider user values and preferences for service delivery in 
relation to these activities. In Aim 3, we used qualitative methods to explore user 
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acceptability of and preferences for various approaches for service delivery for a 
SCS/STI testing service.  
 
2.2 Theoretical grounding 
A review of the literature identifies two dominant approaches to understanding 
health seeking behavior and the utilization of health services: (1) ‘pathways 
models’ – which use an anthropological approach to describe the series of steps 
an individual takes to use a health service – and (2) ‘determinants models’ – 
which use a biomedical approach to outline a set of explanatory variables that 
affect that journey.64 In his review of health-seeking behavior in developing 
countries, Kroeger identified three main classifications of explanatory variables 
that govern the use of care in a determinants framework: those related to the 
subject, those that relate to the disorder and those related to the service (Figure 
1).65 Kroeger’s determinants model was used to inform this dissertation’s 
analysis approach. 
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The conceptual framework that guided this dissertation research is presented in 
Figure 2. This framework was based upon Kroeger’s framework as well as other 
literature exploring factors associated with STI treatment seeking behavior. Our 
framework also drew upon McLeroy et al.’s socioecological framework, which 
explicitly acknowledges the influence of the larger social and structural ecology 
on individual behavior.66 Rather than a descriptive or predictive model of 
behavior change, the socioecological framework emphasizes the different levels 
of causal influence on behavior; this approach is useful for program-makers, as it 
compels them to consider the multiple, interacting levels that affect a behavior of 
interest. We used our framework to guide our analysis in Aim 1; in Figure 2, the 
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sociodemographic variables that are assessed in Aim 1 can be found at the 
individual level, and are underlined.  
 





2.3 Study setting 
2.3.1 STI case management in Uganda 
Data from the 2016 Uganda DHS showed that the self-reported prevalence of 
previous STIs and/or STI symptoms for those ages 15-49 years was 24.4% 
among women and 13.6% among men.4 Of those who reported having an STI or 
STI symptoms, 71% of women and 64% of men reported seeking advice or 
treatment from a clinic, hospital, or private doctor or other health professional, 
while 26% of women and 34% of men reported not seeking any advice or 
treatment at all. As per the Ugandan Ministry of Health, risk factors for prevalent 
STIs in Uganda include multiple sexual partners, lack of/inconsistent condom 
use, lack of circumcision in men, alcohol/drug use and early sexual debut.7 The 
Uganda Clinical Guidelines recommend general STI prevention measures, 
including: (1) health education about STIs; (2) specific education on the need for 
early reporting and compliance with treatment; (3) notification and treatment of 
sexual partners; (4) patient counseling patient on risk reduction (e.g. “practice of 
safe sex by using condoms, remaining faithful to one sexual partner, personal 
hygiene”); (5) condom provision; and (6) schedule return visits, “if necessary and 
possible.”7 
 
Since 1995, has Uganda mandated the syndromic management of STIs in all 
health care delivery levels in the country: in primary health care settings, 
syndromic management is recommended; in referral centers and hospitals where 
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laboratories are available, it is recommended that the syndromic approach be 
supplemented by lab-based case management.7 Referral is recommended when 
there is evidence of ineffective treatment and/or if a clinician is not able to make 
a syndromic diagnosis. Laboratories are used in STI surveillance (and estimating 
antibiotic sensitivity), syndrome etiology and definitions, and research. As such, 
testing for STIs does not occur on a routine basis in Uganda; clinical 
management of disease is only initiated in the general population following 
patient complaint, and is based on health care provider experience to make a 
diagnosis and prescribe drugs of his/her choice. Disadvantages of the treatment 
algorithms include: inadequate care for asymptomatic persons (oftentimes 
women), drug wastage and poor predictive power of symptoms for some STIs 
(e.g. vaginal discharge for gonococcal and chlamydial infections among women).  
 
According to Ugandan national guidelines, clinical assessment of STI patients 
involves: a) taking an appropriate history, b) performing a clinical examination 
and c) conducting a laboratory investigation, if necessary.7 Should a patient 
report symptoms for one STI, he/she should be examined for other STIs, too. 
Syphilis testing is recommended for all pregnant women at the first antenatal 
visit. Components of case management in Uganda include: history taking 
(including probes on symptom duration and recent sexual partners), clinical 
examination (including a general physical exam and then a genital exam), correct 
diagnosis, early and effective treatment, advice on sexual behavior, promotion 
and/or provision of condoms, partner notification and treatment, case reporting 
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and clinical follow-up, as necessary. The provision of HIV testing is also 
recommended. Increased attention to history taking and risk counseling for 
adolescents is specifically recommended.  
 
With respect to individuals living with HIV, the 2018 Consolidated Guidelines for 
Prevention and Treatment of HIV in Uganda recommends that all HIV-infected, 
sexually active adults and adolescents should be screened for STIs at every 
clinic visit. 67 Screening is recommended regardless of the individual’s ART 
status; treatment of STIs for HIV-infected individuals also follows national 
treatment algorithms.  
2.3.2 The Rakai region of Uganda 
This research was conducted in the Rakai region of South-central Uganda 
(Figure 3), a rural area where the first AIDS cases in East Africa were identified.68 
Presently, Rakai has among the highest HIV prevalence levels in Uganda.69 The 
majority of Rakai’s population resides in small agrarian villages; however, the 
district also contains several mid-sized trading towns along international 
highways and fishing communities along Lake Victoria. The Rakai HIV epidemic 
is both geographically heterogeneous and virologically diverse with circulation of 
HIV-1 subtypes A, D, C, and multiple recombinant forms.70,71 In 2016, HIV 
prevalence was documented at 43% in fishing communities, 17% in trading 
communities, and 14% in agrarian communities.69 
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2.3.3 The Rakai Health Sciences Program (RHSP) and the Rakai 
Community Cohort Study (RCCS) 
Established in 1987, RHSP has a mission to conduct health research and 
provide health-related services in Rakai and neighboring districts.72 In addition to 
providing HIV services to the area, RHSP also conducts the RCCS, one of the 
oldest population-based studies of HIV. The RCCS is an open, population-based 
cohort that was established by RHSP in 1994. Agrarian and trading community 
boundaries were established in 1994 as part of a community-randomized trial on 
STI treatment for HIV prevention. In 2011, the four largest Lake Victoria fishing 
communities in the Rakai region were added to the RCCS on the basis of their 
proximity to Rakai District’s inland community populations and their growth in 
population associated with commercial fishing in Lake Victoria and the 
establishment of a fish processing/freezing plant for export to Europe.  
 
The RCCS surveys persons aged 15-49 years in 40 communities.69 To identify 
eligible cohort participants in these study communities, the RCCS first holds an 
informational community mobilization event. Afterward, a census is conducted: all 
households within the communities are systematically approached, household 
global positioning system (GPS) coordinates are recorded, and all resident 
household members are enumerated by gender, age, and duration of residence, 
regardless of whether they are present or absent at the time of the census. 
People must be resident for at least six months in agrarian and trading 
communities and one month with an intention to stay longer in fishing 
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communities for inclusion in the RCCS. The census identifies persons eligible for 
RCCS participation. After the census, the RCCS enrolls consenting eligible 
participants at central community locations (“hubs”). Eligible persons who are not 
identified at the hubs are approached at their household to request their 
participation. Up to two return visits to the household are made to enroll eligible 
participants, if necessary.  
 
The RCCS survey, conducted after the census, includes all consenting residents 
aged 15-49 years (70-80% participation of censused population). Interviewers 
use structured questionnaires programmed on laptop computers to collect 
sociodemographic, behavioral, and health information. Venous blood is collected 
for HIV testing using a three rapid test algorithm with post-test results and 
counseling provided at the hub. Individuals who participate in the RCCS consent 
to HIV testing and the use of samples for future testing. Participants also consent 
to be re-contacted for future studies. The RCCS achieves high rates of 
community acceptance: approximately 94% of RCCS community residents agree 
to be interviewed, of whom more than 98% provide biologic samples. While 
behavioral outcomes are based on self-report, they have been strongly 
associated with anticipated biological outcomes, suggesting relatively limited self-
reporting bias. 
2.3.4 The STI Prevalence Study (STIPS) 
The nineteenth round of the RCCS included the STIPS, a population-based study 
estimating the prevalence of STIs in two RCCS study communities comprising 
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four villages (one fishing community along Lake Victoria and one larger inland 
community inclusive of agrarian and semi-urban trading villages). To this end, the 
STIPS interviewed all eligible individuals – 1,825 sexually active men and women 
aged 18-49 – in four villages: Ddimo (fishing) and Bitabago, Lumbugu, and 
Nsozibbiri (inland), from May to October 2019. STIPS study communities were 
selected to represent the diversity of communities in Rakai; the study design 
allowed for population-based prevalence estimates for the study communities, 
although the estimates are not necessarily representative of all communities in 
the region or country overall. 
 
In addition to the standard RCCS questionnaire, STIPS participants were 
administered an STI module that assessed their previous and recent symptoms 
as well as treatment seeking behavior. This module was an abbreviated version 
of the original module, which was used to estimate STI prevalence in the RCCS 
in the mid-1990s.73,74  
 
To assess for symptoms, participants were prompted on whether they 
experienced any of the following conditions in the past six months (previous 
symptoms), and also in the past week (recent symptoms):  
• For females: genital ulcer; genital discharge; thick/colored vaginal 
discharge; itching of the vagina or vulva; unpleasant vaginal odor; 
frequent urination; painful urination; pain during intercourse; bleeding 
during intercourse; lower abdominal pain; or none of the above. 
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• For males: genital ulcer; urethral discharge; frequent urination; painful 
urination; pain during intercourse; bleeding during intercourse; lower 
abdominal pain; genital warts; or none of the above. 
Those participants who indicated any symptom in the past six months (including 
recent symptoms) were also asked if they sought treatment for those symptoms, 
and if so, where. Participants were allowed to specify up to three locations from 
the following options, in no particular order: a pharmacy/drug store, market/shop, 
government doctor/nurse/clinic, private doctor/nurse/clinic, the RHSP clinic, 
traditional healer or some other location. This information provided the data for 
Aim 1 of this dissertation.   
 
In addition to the routine HIV testing offered through the RCCS, STIPs also 
evaluated participants for syphilis, NG, CT, TV and HSV-2. For this, genital 
swabs were obtained from consenting participants for STI testing: three self-
administered vaginal swabs were obtained from women and three clinician-
collected penile urethral meatus swabs were obtained from men. Self-
administered penile urethral meatus swabs were obtained from a small sub-
sample of men (n=40). The first swab was used for CT/NG testing, the second for 
TV testing, and the third was stored for future research. Serum was used for 
syphilis and HSV-2 serology. All individuals who tested positive for any STI 
(syphilis, TV, NG, CT, or HSV-2 with current ulcer) were provided treatment by 
RHSP per the Ugandan National Clinical Treatment Guidelines for Sexually 
Transmitted Infections. A select number of women and men who self-collected a 
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sample for STI testing (n=36) were invited for participation in Aims 2 and 3 of this 
dissertation. 
2.3.5 STIs in Rakai: findings from the STD Control for HIV Prevention 
Trial (1994-98) 
 
The STIPS STI module and STI testing protocols were first included in the 
original STD Control for HIV Prevention cluster randomized trial (1994-98).75 
Findings from the trial showed that the STI burden in Rakai communities was 
high: prevalence of active syphilis was ~10%, TV prevalence was 20%, and NG 
and CT prevalence estimates were ~4% and ~2%, respectively.  
 
The trial also observed that approximately 30% of women and 10% of men 
experienced genital tract symptoms during the ten-month follow-up period.74 
Symptoms among women included vaginal itching (15.4%), pelvic pain (14.7%), 
vaginal discharge (9.4%) and genital ulcer (5.5%). Men reported genital ulcer 
(4.3%), dysuria (4.2%) and urethral discharge (1.7%). All in all, approximately 
20% of the population was found to be symptomatic, and of those, 56% sought 
care for their symptoms (59.1% of symptomatic men and 55.4% of symptomatic 
women).  
 
Finally, with regard to treatment seeking, the trial found that approximately 67% 
were treated at a government or private clinic, while the rest used traditional 
healers or treated themselves. Women used traditional healers more than men 
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(14.7% versus 5.1%), while men chose to treat themselves more than women 
(27.5% versus 11.3%).74   
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Chapter 3. Methods 
 
We used both quantitative and qualitative research methods to address the aims 
of this dissertation: we used quantitative methods to for Aim 1 and qualitative 
methods for Aims 2 and 3. While we did use multiple methods, we do not 
consider this dissertation to be a mixed methods study because each of our aims 
addressed separate research questions, and we did not integrate or combine the 
methods to address them.76 We do note, however, that the individuals who were 
included in our qualitative aims were sampled from the study population used in 
our quantitative aim. Methods for each aim are described in detail, below.  
3.1 Quantitative Methods (Aim 1) 
3.1.1 Aim 1 research questions 
The first aim of this dissertation was to describe current treatment seeking 
behavior among adults with STI-related symptoms and identify factors associated 
with seeking clinic treatment, with the following research questions: 
1. What is the prevalence of treatment seeking among adults with STI-related 
symptoms? 
2. What is the prevalence of treatment seeking at a government or private 
clinic?  
3. Which factors are independently associated with treatment seeking at a 
government or private clinic?  
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3.1.2 Methodology 
To address Aim 1, we conducted a secondary analysis of STIPS data, which 
included 1,825 men and women, aged 18-49 years, from two RCCS communities 
of different types (fishing and inland), including a total of four villages. Data used 
in the analysis included sociodemographic characteristics and sexual behaviors, 
as well as STI symptomatology and treatment seeking behavior. Participants’ STI 
diagnostic test results were also linked to their survey data and included in our 
analysis. To assess treatment seeking behavior among those with symptoms, we 
restricted our sample to only those participants who reported any STI-related 
symptoms in the past six months (n=962). 
 
3.1.3 Analysis 
For Aim 1, we estimated the overall prevalence of STI symptoms in the entire 
STIPS sample. We then restricted our analysis to only those who reported any 
STI-related symptoms in the past six months (n=962). First, we presented 
descriptive data for this sample as well as the prevalence of various symptoms. 
Second, we estimated the prevalence of seeking treatment from any location for 
the sample, as well as each gender and community type. We used univariable 
modified Poisson regressions with robust variance to compare the prevalence of 
any treatment seeking between genders and between community types, as well 
as between gender-specific community strata. Third, we estimated the 
prevalence of treatment seeking at each specific treatment location (e.g. 
government clinic, private clinic, pharmacy/drug store, market/shop, traditional 
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healer, other) and used univariable modified Poisson regressions with robust 
variance to compare the prevalence of private versus government clinic 
treatment seeking between genders, community types, and gender-specific 
community strata. Fourth, we estimated the prevalence of seeking treatment at a 
clinic for the full sample, as well as each gender and community type. Clinic 
treatment seeking was defined as seeking treatment for any STI-related 
symptoms in the past six months, at a private or government clinic. Those who 
were coded as negative for the outcome (i.e. did not seek treatment at a clinic) 
included individuals who sought treatment at a non-clinic location (e.g. 
pharmacy/drug store, market/shop, traditional healer, etc.), as well as those who 
sought no treatment at all. Once again, we used univariable modified Poisson 
regressions with robust variance to compare the prevalence clinic treatment 
seeking between genders, community types, and gender-specific community 
strata. Fifth, we used multivariable modified Poisson regressions with robust 
variance to determine sociodemographic and symptom-related factors 
independently associated with seeking clinic treatment, for each gender. We 
used our conceptual framework (Figure 2) to critically evaluate and select 
variables for inclusion in the final multivariable model. Finally, for each gender, 
we estimated the prevalence of any curable STI (NG, CT, TV or active syphilis) 
at the time of the survey comparing those who did and did not previously seek 
clinic treatment. We used modified Poisson regressions with robust variance to 
compare these estimates and explore the univariable association between 
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previous clinic treatment seeking and current prevalence of curable STIs, for 
each gender. We conducted all data analyses in STATA version 15.77 
 
3.2 Qualitative Methods (Aims 2 and 3) 
3.2.1 Aim 2 research questions 
The second aim was to explore the acceptability of SCS/STI testing, and had the 
following research questions: 
1. What motivates adults to provide a self-collected sample for STI testing? 
2. What is their overall experience during the self-collection process? 
3. How acceptable is SCS in comparison to healthcare worker (HCW)-
collection? 
3.2.2 Aim 3 research questions  
The third aim was to explore service delivery preferences for an STI testing 
program that uses SCS, and had the following research questions: 
1. How acceptable are various SCS/STI testing service delivery approaches? 
2. Which approach is most preferred and why? 
3.2.3 Methodology 
To address the second and third aims, we conducted a qualitative study involving 
STIPS participants from the inland community who self-collected a sample for 
STI testing. To this end, we invited 36 STIPS participants, both with and without 
STI-related symptoms, from our Aim 1 study population to participate in a semi-
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structured interview; all selected participants self-collected a sample for STI 
testing in the STIPS. The interview explored their experience self-collecting a 
sample and their sample collection preferences (SCS versus HCW-collection) 
(Aim 2). The interview also evaluated their acceptability of and preferences for 
various SCS/STI testing service delivery approaches (Aim 3). In addition to 
participants, we also conducted nine interviews with key informants (KI) to 
contextualize participant findings. KIs included relevant stakeholders from 
various levels of the health system, with experience in the field of STI control. KIs 
included: a community mobilizer, a village health worker, a community health 
worker, a traditional healer, a STIPS team leader, a STIPS clinical officer, two 
local hospital-based clinicians and a district health officer. 
3.2.4 Analysis 
Interviewers trained in behavioral science and qualitative research methods 
conducted semi-structured interviews in Luganda. Interviews lasted 
approximately one hour and were recorded. After each interview, interviewers 
reviewed their field notes and composed a one-page reflexive memo that 
reflected on their experience and highlighted any insights that could inform future 
data collection. YPO and the interviewers reviewed the field notes and memos 
after the completion each interview. Following the completion of all interviews, we 
translated and transcribed the recorded data. We imported the data into 
MAXQDA 2018 (VERBI Software, 2018)78 for organization and initial coding. We 
conducted further analysis and coding using an adapted version of the 
Framework Method:79 first, interviewers transcribed and translated the interviews 
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that they conducted. Next, we reviewed each transcript in part (by aim) and in 
full, to familiarize ourselves with the data. Similar to the Framework Method, we 
developed an analytic framework based on the research objectives and interview 
guides. We then used this framework to index our transcripts. After indexing all of 
our transcripts, we charted the data into a framework matrix by copying and 
pasting relevant data into their respective categories in an Excel spreadsheet, 
with one sheet for users and another for KIs. At this stage, we conducted 
iterative, open-ended coding, followed by focused coding,80 on data within each 
category to generate prominent themes. We identified any prominent themes 
emerging from the data, as defined by: the depth of discussion any one 
participant provided on the topic, prevalence across participants and ‘keyness’ in 
relation to study research questions.81 As described in the Framework Method, 
we constructed analytic memos and tables to help us interpret the findings. For 
both Aims 2 and 3, we compared themes between men and women and between 
those with and without symptoms. Finally, we discussed our preliminary findings 
within the wider research group, comprised of interviewers and Principal 
Investigators, to ensure that they were coherent, cohesive and comprehensive.   
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Chapter 4. Treatment Seeking Behavior Among 
Adults with STI-related Symptoms in Rakai, Uganda 
4.1 Abstract 
Background: Understanding treatment seeking behavior is critical to the control 
of sexually transmitted infections (STIs), yet current data on STI treatment 
seeking in low-resource settings is scarce. In such settings, where syndromic 
management is used to diagnose infection, seeking clinical care is the best way 
to ensure effective treatment. This study aims to describe STI treatment seeking 
behavior and identify factors associated with seeking treatment at a clinic among 
adults with STI-related symptoms in rural Uganda. 
Methods: We conducted a population-based survey and STI testing among all 
consenting adults aged 18-49 in two communities (fishing and inland) in Rakai, 
Uganda. Out of 1,825 participants, 962 individuals self-reported STI symptoms in 
the past six months. We present descriptive data on treatment-seeking and STI 
prevalence among these 962 individuals. We also use multivariable Poisson 
regressions with robust variance to determine the sociodemographic and 
symptom-related factors independently associated with seeking STI treatment at 
a clinic, as well as explore the association with previous clinic treatment seeking 
and current STI prevalence. 
Results: Forty-three percent of adults who reported STI-related symptoms in the 
past six months reported not seeking any treatment for their symptoms. For 
those who did seek treatment, 58% sought treatment at a private clinic, 28% at a 
government clinic, 9% at a pharmacy/drug store, 3% at a traditional healer, 2% at 
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a market/shop, and 5% at some other location. Overall, 47% of men and 48% of 
women sought treatment at a government or private clinic. Among men and 
women, we found no significant difference in the prevalence of clinic treatment 
seeking between genders or community types. When stratified by gender, 
independent factors positively associated with clinic treatment seeking for men 
included being from the inland community (PRR: 1.43, 95%CI: 1.12-1.83) and 
having more than one STI-related symptom (PRR: 1.73, 95%CI: 1.36-2.21). For 
women, the only significant factor was having more than one STI-related 
symptom (PRR: 1.41, 95%CI: 1.12-1.78). Approximately one-third of men and 
women who reported previously seeking clinic treatment for their symptoms were 
diagnosed with a curable STI at the time of the survey; we found no significant 
association between previous clinic treatment seeking and current STI 
prevalence for curable STIs.  
Conclusions: Half of adults with STI-related symptoms in our population are not 
seeking appropriate care at a clinic. There is also a high proportion of STIs 
among those who have reported previously seeking clinic care, suggesting poor 
management of STI symptoms, high reinfection rates, or both, in this population. 
Timely and appropriate treatment is critical to control the spread of infection; we 
recommend that researchers further explore barriers to care and urge decision-
makers to focus their resources on methods to increase STI treatment seeking in 
this, and similar, settings. 
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4.2 Introduction 
Understanding STI treatment seeking behavior is critical to STI control; timely 
and appropriate STI treatment can reduce the duration of infectiousness and limit 
the spread of infection.5,6  Treatment seeking behavior can be defined as any 
activity undertaken by an individual who perceives themselves to be ill or have a 
health problem, in order to find a remedy. Various factors can influence the 
decision to seek treatment, including individual-level factors such as symptom 
recognition, preexisting beliefs and meanings of symptoms, as well as perceived 
efficacy of different treatment methods.5,6 Contextual factors such as the 
availability, quality and accessibility of treatment, as well as social stigma, also 
play a role.5,6 These factors influence not only the timing and location of 
treatment seeking, but also whether an individual seeks treatment at all.5,6  
 
Despite its importance, population-based data on treatment seeking in low-
resource settings, such as Uganda, is scarce. In such settings, syndromic 
management by a healthcare worker is used to diagnose presumptive 
infection,7,82 and so seeking clinical care is the best way to receive effective 
treatment. Data from the 2016 Uganda DHS show that, of those who reported 
having an STI or STI symptoms, 71% of women and 64% of men sought advice 
or treatment from a clinic, hospital, private doctor or other health professional, 
while 26% of women and 34% of men did not seek any advice or treatment.4 
Previous studies on STI treatment seeking behavior in Uganda report a variety of 
treatment approaches, including public health facilities, private practitioners, 
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traditional healers and self-treatment.31,83 A qualitative study from 1999 on STI 
treatment seeking behaviors among Ugandan adults found that treatment in the 
informal sector, including self-treatment and traditional healers, was especially 
common (over 60% of participants). The study also found that for participants 
with STI-related symptoms, deterrents to seeking care at public health facilities 
included long waiting times, lack of drugs, user fees, corruption and bribes by 
health workers, health workers abusing STI patients, lack of privacy, long 
distances, fear of being tested for AIDS, specimens not being examined in the 
laboratory and being given tablets instead of injections (which were preferred).31  
 
Other studies in SSA have identified a gender difference in treatment seeking: 
three studies in Kenya found women to be less likely to seek care than men 
mainly because symptoms were not considered severe, symptoms had 
disappeared, or as a result of lack of money.38,39,84 One study found that because 
women were mostly monogamous, they did not relate their symptoms to sexual 
intercourse, which prevented them from promptly seeking care.39 Age was also 
found to affect the timing of treatment seeking among women in the study, with 
younger women seeking less care than older women. A recent qualitative study 
on health care among women in rural Uganda found that the biggest concern for 
women was STI infection and barriers to seeking care included inaccessibility to 
facilities, lack of time and money, and dependence on men for permission to 
leave the home.85 As a result, women coped by either ignoring their problem, 
using self-care or self-medication, using herbal or traditional medicine, or using 
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services in secret. Finally, a qualitative study assessing the pathway to cervical 
cancer diagnosis among Ugandan women reported that lay consultations with 
husbands, relatives and friends were common and influenced treatment seeking 
decisions and timing among women.86  Prompt treatment seeking was triggered 
by symptoms that were perceived to be more severe or life threatening (e.g. 
heavy vaginal bleeding or lower abdominal pain), if the symptoms affected their 
routine work or if symptoms persisted even after home-remedies. Authors 
reported that late treatment seeking was due to symptoms being perceived as 
mild or normal, and attributed to a common illness that they could self-manage.  
 
While useful in providing context, previous studies from low-resource settings, 
including those mentioned above, are limited in that many of them sampled 
participants at treatment facilities only after they presented for care; most studies 
do not capture individuals who delay seeking treatment or who do not seek 
treatment at all. This population-based study uses a population-based sample to 
describe treatment seeking behavior among adults with STI-related symptoms in 
rural Uganda and identify factors associated with seeking treatment at a clinic. 
The research questions are as follows: 
1. What is the prevalence of treatment seeking among adults with STI-
related symptoms? 
2. What is the prevalence of treatment seeking at a government or private 
clinic?  
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3. Which sociodemographic and symptom-related factors are independently 
associated with treatment seeking at a government or private clinic?  
4.3 Methods 
Study Setting 
This study was conducted as part of the STI prevalence study (STIPS), a 
population-based survey conducted in the Rakai region of South-central Uganda 
that aimed to estimate the STI burden in the area. The STIPS was conducted as 
a part of the Rakai Community Cohort Study (RCCS), one of the oldest 
population-based studies of HIV in SSA. Conducted by the Rakai Health 
Sciences Program (RHSP), the RCCS is an ongoing, open community-based 
cohort of residents aged 15-49 years in agrarian communities, semi-urban 
trading centers and Lake Victoria fishing communities in the Rakai region. The 
RCCS includes the administration of a demographic and health questionnaire, as 
well as HIV testing for all consenting participants. Details of the RCCS study 
design can be found elsewhere.73  
 
The last estimation of STI burden in Rakai was conducted in the STD Control for 
HIV Prevention cluster randomized trial (1994-98).75 The trial found that 
approximately 20% of the population were symptomatic.74 Common STI 
symptoms among women included vaginal itching (15.4%), pelvic pain (14.7%), 
vaginal discharge (9.4%) and genital ulcer (5.5%); men reported genital ulcer 
(4.3%), dysuria (4.2%) and urethral discharge (1.7%). With regard to treatment 
seeking, the trial found that 56% of those with symptoms sought care (59.1% of 
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symptomatic men and 55.4% of symptomatic women).74 More specifically, 67% 
sought treatment at a government or private clinic, while the rest used traditional 
healers or treated themselves. Women used traditional healers more than men 
(14.7% versus 5.1%), while men chose to treat themselves more than women 
(27.5% versus 11.3%).74  
 
Data Collection 
The STIPS was a population-based survey that recruited all individuals aged 18-
49 years from two RCCS communities – one inland and one fishing – from May 
to October 2019. Three villages (Bitabago, Lumbugu, and Nsozibbiri) comprised 
the inland community and one (Ddimo) comprised the fishing community. In 
addition to the standard RCCS questionnaire, participants were administered an 
STI module that assessed their symptom status and treatment seeking behavior. 
To ascertain symptom status, each participant was prompted on a list of 
symptoms and asked to identify each symptom that they had experienced in the 
past six months (previous symptoms) and also in the past 7 days (recent 
symptoms). Symptoms included: genital ulcer, genital discharge, frequent 
urination, painful urination, pain during intercourse, bleeding during intercourse, 
lower abdominal pain and genital warts, as well as thick and/or colored vaginal 
discharge, itching of the vagina and unpleasant vaginal odor for women. If 
participants indicated ever experiencing symptoms, treatment seeking behavior 
was assessed. Participants were asked if they did anything to help cure those 
symptoms or to prevent passing on infection to their spouse or partner(s), and if 
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so, what action(s) did they take: used condoms, abstinence, sought treatment for 
self, sought treatment for partner or some other action. Those who reported 
seeking treatment for themselves were finally asked to specify where they went 
for treatment; the interviewer probed on the following items: pharmacy/drug 
store, market/shop, Rakai Program Clinic (RHSP clinic), government 
doctor/nurse/clinic, private doctor/nurse/clinic, traditional healer or other. Up to 
three locations were recorded, per participant. 
 
In addition to the routine HIV screening conducted in the RCCS, STIPS 
participants were also evaluated for Chlamydia trachomatis (CT), Neisseria 
gonorrhoeae (NG), Trichomonas vaginalis (TV), syphilis and herpes simplex 
virus type 2 (HSV-2). All consenting participants provided genital swabs at the 
time of interview for testing (clinician-collected penile urethral meatus swabs for 
men and self-administered vaginal swabs for women). CT/NG testing was 
performed using the Abbott RealTime CT/NG assay using the Abbott m2000 
RealTime System for PCR testing at the RHSP central laboratory. TV testing was 
performed using the OSOM Trichomonas Rapid Test (Sekisui) at the time of the 
survey. Syphilis screening was performed using the SD Bioline 3.0, a solid phase 
immunochromatographic assay for the qualitative detection of antibodies of all 
isotypes (IgG, IgM, IgA) against T. pallidum. Syphilis screening was performed 
with HIV testing at time of survey; the rapid plasma reagin test (RPR) was then 
performed within 24 hours at the RHSP central laboratory for all participants with 
positive screening results to determine syphilis titers. HSV-2 testing was 
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performed using routinely collected sera the after collection of all STIPS samples. 
Testing was performed at the RHSP central laboratory using the Kalon HSV-2 
gG2 ELISA (Kalon Biologicals Ltd. Guildford, UK). The assay was performed 
manually; optical densities (OD) were read using a Bio-Tek ELx 800 microplate 
reader. All assays were conducted according to the manufacturers’ protocol. All 
individuals who tested positive for any STI were provided treatment by RHSP per 
the Ugandan National Clinical Treatment Guidelines for STIs.   
 
Data Analysis  
To begin, we estimated the overall prevalence of STI-related symptoms among 
all STIPS participants. For the rest of the analysis, we restricted our sample to 
only those who reported any STI-related symptoms in the past six months 
(n=962). First, we presented descriptive data for the sample, including the 
prevalence of various symptoms. Second, we estimated the prevalence of any 
treatment seeking (defined as self-reported treatment seeking from any location 
for STI-related symptoms in the past six months) for the sample, as well as each 
gender and community type. Modified Poisson regression with robust variance 
allow for direct estimation of prevalence ratios in cross-sectional data;87 we used 
univariable modified Poisson regressions with robust variance to compare the 
prevalence of any treatment seeking between genders and between community 
types, as well as between gender-specific community strata. Third, we estimated 
the prevalence of treatment seeking at each treatment location (e.g. government 
clinic, private clinic, pharmacy/drug store, etc.) and used univariable modified 
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Poisson regressions with robust variance to compare the prevalence of private 
versus government clinic treatment seeking between genders, community types, 
and gender-specific community strata. Fourth, we estimated the prevalence of 
seeking treatment at a clinic for the full sample, as well as each gender and 
community type. For this, we compared participants who sought treatment at a 
government or private clinic (clinic) to those who did not (no clinic). Included 
among those who did not seek clinic treatment were those who sought treatment 
at a non-clinic location (e.g. pharmacy/drug store, market/shop, traditional healer, 
etc.), as well as those who sought no treatment at all. Again, we used univariable 
modified Poisson regressions with robust variance to compare the prevalence 
clinic treatment seeking between genders, community types, and gender-specific 
community strata. Fifth, we used multivariable modified Poisson regressions with 
robust variance to determine sociodemographic and symptom-related factors 
independently associated with seeking clinic treatment, for each gender. Finally, 
for each gender, we estimated the prevalence of any curable STI (NG, CT, TV or 
active syphilis) at the time of the survey among those who did, and did not, 
previously seek clinic treatment. We used modified Poisson regressions with 
robust variance to compare these estimates and explore the univariable 
association between previous clinic treatment seeking and current prevalence of 
curable STIs, for each gender. 
 
Complete treatment seeking information (i.e. any treatment seeking [yes or no] 
and specific treatment location) was collected for 99.4% of the sample, with only 
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6 participants dropped from the analysis because of missing treatment data. 
Considering the different social and economic contexts of men and women, we 
conducted analyses for the sample as a whole, as well as for each gender 
separately. We also stratified data for each gender by community type to assess 
for differences between same-gender participants in fishing and inland 
communities. Age in years was analyzed in five year age groupings. We also 
calculated the number of symptoms in the past week, and in the past six months, 
as a sum of a participant’s self-reported symptoms in the respective time period. 
For all analyses, the RHSP clinic was classified as a private clinic. We assessed 
positive STI diagnoses with the STIPS test result, with syphilis RPR titers 8 
considered indicative of active syphilis infection and an index value of 1.5 
indicative of a positive HSV-2 test.88  
 
We used prior information from the literature to critically evaluate and select 
variables for inclusion in the final multivariable models. Based on a conceptual 
framework of treatment seeking behavior,5 we included in our model the number 
of STI-related symptoms experienced in the past six months, as well as select 
sociodemographic characteristics (age, community type, marital status, HIV 
status) that could theoretically affect treatment seeking behavior. All data 
analysis was carried out in STATA version 15.77 
4.4 Results  
Sociodemographic characteristics, sexual behavior and STI symptomatology 
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Fifty-three percent (962/1,825) of adults reported any STI symptoms in the six 
months prior to the STIPS interview date (34% [290/860] of males; 70% 
[672/964] of females). Sixty-three percent (605/962) of those with symptoms 
reported at least one symptom in the past seven days (51% [149/290] of males; 
68% [456/672] of females). Table 2 summarizes the demographic characteristics 
of the study group. Most men were aged 30-39 years, in a monogamous 
marriage, from the fishing community, Christian, educated at some level and 
working in the fishing industry. Most women were aged 20-29 years, in a 
monogamous marriage, from the fishing community, Christian, having some 
education and working in agricultural or housework. Approximately one-third of 
the study sample were people living with HIV. With respect to sexual behaviors, 
approximately half of the men in the sample had 2-4 sexual partners in the past 
year (148 [51%]) with the majority reporting 5-10 sexual partners in their lifetime 
(205 [71%]). Over three-quarters of women in the sample reported having one 
sexual partner in the past year (529 [79%]) and just over half of women reported 
2-4 lifetime sexual partners (408 [61%]). For unmarried men, the majority 
reported inconsistent condom use in the past year (48/87 [55%]) while the 
majority of unmarried women reported never using a condom (90/158 [57%]).  
 
Table 2. Sociodemographic characteristics and symptomatology 
of STIPS participants who reported STI symptoms in the 
past 6 months (N=962), by gender. Data are presented as 
n (%). 
 
 Total Male Female 
 N=962 N=290 N=672 
Age    
   15-19 years 69 (7%) 14 (5%) 55 (8%) 
   20-29 years 371 (39%) 98 (34%) 273 (41%) 
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   30-39 years 356 (37%) 115 (40%) 241 (36%) 
   40-49 years 166 (17%) 63 (22%) 103 (15%) 
Marital status    
   Never Married 75 (8%) 33 (11%) 42 (6%) 
   Married, Monogamous 560 (58%) 174 (60%) 386 (57%) 
   Married, Polygamous 128 (13%) 23 (8%) 105 (16%) 
   Previously Married 199 (21%) 60 (21%) 139 (21%) 
Community type    
   Inland 420 (44%) 96 (33%) 324 (48%) 
   Fishing 542 (56%) 194 (67%) 348 (52%) 
Religion (N=935)    
   Christian 806 (86%) 244 (84%) 562 (87%) 
   Muslim 123 (13%) 45 (16%) 78 (12%) 
   Other/none 6 (1%) 1 (0%) 5 (1%) 
Education    
   No 62 (6%) 21 (7%) 41 (6%) 
   Yes 900 (94%) 269 (93%) 631 (94%) 
Occupation    
   Agricultural or housework 342 (36%) 50 (17%) 292 (43%) 
   Bar or restaurant work 71 (7%) 1 (0%) 70 (10%) 
   Boda boda driving or trucking 20 (2%) 20 (7%) 0 (0%) 
   Fishing 128 (13%) 128 (44%) 0 (0%) 
   Student 12 (1%) 4 (1%) 8 (1%) 
   Trader or shopkeeper 220 (23%) 36 (12%) 184 (27%) 
   Other 169 (18%) 51 (18%) 118 (18%) 
HIV status (N=960)    
   Negative 649 (68%) 200 (69%) 449 (67%) 
   Positive 311 (32%) 90 (31%) 221 (33%) 
Sex in the past year    
   No 55 (6%) 9 (3%) 46 (7%) 
   Yes 907 (94%) 281 (97%) 626 (93%) 
Sexual partners in the past year    
   None 55 (6%) 9 (3%) 46 (7%) 
   1 631 (66%) 102 (35%) 529 (79%) 
   2-4 243 (25%) 148 (51%) 95 (14%) 
   5-10 25 (3%) 24 (8%) 1 (0%) 
   >10 8 (1%) 7 (2%) 1 (0%) 
Sex with partner from outside the community    
   No 711 (74%) 162 (56%) 549 (82%) 
   Yes 251 (26%) 128 (44%) 123 (18%) 
Lifetime sexual partners    
   None 10 (1%) 2 (1%) 8 (1%) 
   1 77 (8%) 1 (0%) 76 (11%) 
   2-4 460 (48%) 52 (18%) 408 (61%) 
   5-10 376 (39%) 205 (71%) 171 (25%) 
   >10 39 (4%) 30 (10%) 9 (1%) 
Condom use in past 12 months by marital 
status    
   Married 688 (72%) 197 (68%) 491 (73%) 
   Not married, never used condoms 120 (12%) 30 (10%) 90 (13%) 
   Not married, sometimes/inconsistent use 103 (11%) 48 (17%) 55 (8%) 
   Not married, always used condoms 22 (2%) 9 (3%) 13 (2%) 
   NA, no sex 29 (3%) 6 (2%) 23 (3%) 
Symptoms in the past 7 days    
   No 357 (37%) 141 (49%) 216 (32%) 
   Yes 605 (63%) 149 (51%) 456 (68%) 
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Number of STI symptoms in past 6 months    
   1 313 (33%) 161 (56%) 152 (23%) 
   2-4 462 (48%) 120 (41%) 342 (51%) 
   >=5 187 (19%) 9 (3%) 178 (26%) 
Number of STI symptoms in past 7 days    
   0 357 (37%) 141 (49%) 216 (32%) 
   1 261 (27%) 101 (35%) 160 (24%) 
   2-4 250 (26%) 42 (14%) 208 (31%) 
   >=5 94 (10%) 6 (2%) 88 (13%) 
 
In terms of symptoms, the majority of men reported only one symptom (161 
[56%]) in the past six months, with painful urination being the most common 
(42%). The majority of women reported 2-4 symptoms (342 [51%]) in the past six 
months, with vaginal itching being the most common (62%) (Figure 4). Half (149 
[51%]) of men reported experiencing symptoms in the seven days before the 
interview as compared to 68% (456) of women. Of those who reported symptoms 
in the past seven days, most men reported one symptom in the past week (101 
of 149 [68%]) and most women reported 2-4 symptoms in the past week 
(208/456 [46%]). 
 
Figure 4. Symptomatology of STIPS participants who reported STI-








B – Females 
 
Treatment seeking for STI symptoms  
Overall, 545 participants (57%) reported seeking any treatment for their 
symptoms, while the remaining 43% reported seeking no treatment at all. The 
likelihood of seeking any treatment was similar between men and women 
(160/290 [55%] males; 385/671 [57%] females; PRR: 1.04, 95% CI: 0.92-1.18). 
The prevalence of seeking any treatment also did not differ by community type 
(PRR: 1.04, 95% CI: 0.93-1.16). No significant differences were observed when 
further stratifying by gender and community type. 
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Figure 5 shows where participants sought treatment for their symptoms. Nearly 
all participants (95%, 515/541) who sought treatment did so at only one location, 
while 5% (26/541) reported seeking treatment at two locations. Of those who 
sought treatment, 58% sought treatment at a private clinic, 28% at a government 
clinic, 9% at a pharmacy/drug store, 3% at a traditional healer, 2% at a 
market/shop, and 5% at some other location. Private clinics were the most 
common treatment location among both genders (71% among males; 53% 
among females). RHSP clinics comprised 7% of all private clinic visits. 
Comparing private and government clinics, women were less likely to seek 
treatment at private clinics (more likely to seek government clinics) than men 
(PRR: 0.76, 95% CI: 0.68-0.85). This trend was seen in both the fishing (PRR: 
0.86, 95% CI: 0.76-0.96) and inland (PRR: 0.65, 95% CI: 0.51-0.83) 
communities. When comparing men across communities, men in fishing 
communities were significantly more likely to seek treatment at a private clinic 
than men in inland communities (PRR: 1.25, 95% CI: 1.04-1.51). Similarly, 
women in the fishing community were significantly more likely to seek treatment 
at private clinics than women in the inland community (PRR: 1.65, 95% CI: 1.36-
2.01). 
 
Figure 5. Treatment locations reported by STIPS participants who 










B – Females   
 
Treatment seeking at a clinic  
A total of 457 participants (48%) reported seeking treatment at a clinic 
(government or private) for their symptoms. There was no difference in the 
prevalence of clinic treatment by gender (47% males; 48% females; PRR: 1.02, 
95% CI: 0.88-1.18) or by community type (48% inland; 47% fishing; PRR: 0.98, 
95% CI: 0.78-0.86) When stratifying each gender by community type, however, 
we found that men in the fishing community were significantly less likely to seek 
clinic treatment than men in the inland community (43% men in inland; 55% men 
in fishing; PRR: 0.78, 95% CI: 0.61-1.00).  
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Full descriptive data of clinic treatment seekers can be found in Table 3. Overall, 
of those men who sought clinic treatment, most were aged 20-39 years; married 
in a monogamous union; and/or working in the fishing industry. Of those women 
who sought clinic treatment, most were aged 20-29 years; married in a 
monogamous union; and/or engaged in agriculture or housework. Thirty-three 
percent of men and 35% of women who sought treatment at a clinic were HIV-
positive. With respect to STI symptomatology, painful urination (52%), genital 
discharge (47%) and genital ulcers (35%) were the most common symptoms 
reported among men who sought treatment at a clinic. Vaginal itching (69%), 
genital discharge (57%) and vaginal discharge (50%) were the most frequently 
reported symptoms among women who sought clinic treatment. About half of 
men who reported seeking treatment at a clinic reported 2-4 STI symptoms in the 
past six months (73/136 [54%]). This was similar for women (157/321 [49%]).  
 
Just over half of men who reported seeking care at a clinic for their symptoms 
reported no symptoms in the past week (73/136 [54%]). In contrast, the majority 
of women who reported seeking care at a clinic for their symptoms reported 
having at least one STI symptom in the past week (66%), with 65/321 [20%] 
reporting one symptom 97/321, [30%] reporting 2-4 symptoms and 49/321 [15%] 
reporting five or more symptoms. When considering only those who reported at 
least one symptom in the past week, we saw that, for both men and women, just 
over half reported that they did not seek treatment at a clinic in the past six 
months for their symptoms (85/148 [57%] and 244/455 [54%], respectively). We 
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found no significant differences in any of these associations when we further 
stratified our gender-stratified analyses by community type.  
 
Table 3 describes the univariable associations between sociodemographic 
characteristics, sexual behaviors, and STI symptomatology with clinic treatment 
for the full sample, as well as for men and women. Women were more likely to 
seek clinic treatment if they were in a polygamous marriage (PRR: 1.64, 95% CI: 
1.01-2.66) and less likely to seek treatment if they had no sexual partners in the 
past year (PRR: 0.59, 95% CI: 0.37-0.94). Condom use, the number of STI 
symptoms reported in the past six months and the number of STI symptoms 
reported in the past week were also associated with clinic treatment seeking for 
both men and women. Certain symptoms also showed univariable associations 
with clinic treatment seeking for each gender. For men, the likelihood of seeking 
treatment in a clinic increased with reporting of painful urination in the past six 
months (PRR: 1.55, 95% CI: 1.22-1.98) and more than doubled with reporting of 
genital discharge (PRR: 2.16, 95% CI: 1.73-2.69). However, the likelihood for 
seeking clinic care decreased with reporting of genital warts (PRR: 0.46, 95% CI: 
0.21-1.01). For women, self-reported genital ulcer (PRR: 1.44, 95% CI: 1.23-
1.68), vaginal itching (PRR: 1.33, 95% CI: 1.11-1.59) frequent urination (PRR: 
1.28, 95% CI: 1.09-1.51), painful urination (PRR: 1.54, 95% CI: 1.32-1.79), pain 
during intercourse (PRR: 1.27, 95% CI: 1.06-1.52) and lower abdominal pain 
(PRR: 1.22, 95% CI: 1.04-1.42) in the past six months were each associated with 
an increased likelihood of seeking care at a clinic. We found no significant 
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differences in any of these associations when we further stratified our gender-
stratified analyses by community type. 
 
Table 3. Crude prevalence of clinic treatment seeking among 
STIPS participants who reported STI symptoms in the 
past 6 months (N=956), for the full sample and by gender. 
Data are presented as n (%). 
 
A – Full Sample 








Gender     
   Male 152/288 (53%) 136/288 (47%) REF 
   Female 347/668 (52%) 321/668 (48%) 1.02 (0.88-1.18) 
Age    
   15-19 years 39/69 (57%) 30/69 (43%) REF 
   20-29 years 182/368 (49%) 186/368 (51%) 1.16 (0.87-1.55) 
   30-39 years 184/355 (52%) 171/355 (48%) 1.11 (0.83-1.48) 
   40-49 years 94/164 (57%) 70/164 (43%) 0.98 (0.71-1.36) 
Marital status    
   Never Married 43/73 (59%) 30/73 (41%) REF 
   Married, Monogamous 296/558 (53%) 262/558 (47%) 1.14 (0.86-1.52) 
   Married, Polygamous 63/127 (50%) 64/127 (50%) 1.23 (0.89-1.70) 
   Previously Married 97/198 (49%) 101/198 (51%) 1.24 (0.91-1.69) 
Community type    
   Inland 216/418 (52%) 202/418 (48%) REF 
   Fishing 283/538 (53%) 255/538 (47%) 0.98 (0.86-1.12) 
Religion    
   Christian 414/802 (52%) 388/802 (48%) REF 
   Muslim 65/122 (53%) 57/122 (47%) 0.97 (0.79-1.18) 
   Other/none 3/6 (50%) 3/6 (50%) 1.03 (0.46-2.31) 
Education    
   No 37/62 (60%) 25/62 (40%) REF 
   Yes 462/894 (52%) 432/894 (48%) 1.20 (0.88-1.63) 
Occupation    
   Agricultural or housework 177/342 (52%) 165/342 (48%) REF 
   Bar or restaurant work 38/70 (54%) 32/70 (46%) 0.95 (0.72-1.25) 
   Boda boda driving or trucking 10/19 (53%) 9/19 (47%) 0.98 (0.60-1.60) 
   Fishing 76/127 (60%) 51/127 (40%) 0.83 (0.66-1.06) 
   Student 7/12 (58%) 5/12 (42%) 0.86 (0.44-1.70) 
   Trader or shopkeeper 113/219 (52%) 106/219 (48%) 1.00 (0.84-1.20) 
   Other 78/167 (47%) 89/167 (53%) 1.10 (0.92-1.32) 
HIV status    
   Negative 347/645 (54%) 298/645 (46%) REF 
   Positive 152/309 (49%) 157/309 (51%) 1.10 (0.96-1.26) 
Sex in the past year    
   No 36/54 (67%) 18/54 (33%) REF 
   Yes 463/902 (51%) 439/902 (49%) 1.46** (1.00-2.14) 
Sexual partners in the past year    
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   None 36/54 (67%) 18/54 (33%) 0.68** (0.47-1.01) 
   1 322/628 (51%) 306/628 (49%) REF 
   2-4 127/242 (52%) 115/242 (48%) 0.98 (0.84-1.14) 
   5-10 11/24 (46%) 13/24 (54%) 1.11 (0.76-1.62) 
   >10 3/8 (38%) 5/8 (62%) 1.28 (0.75-2.21) 
Sex with partner from outside the 
community    
   No 365/708 (52%) 343/708 (48%) REF 
   Yes 134/248 (54%) 114/248 (46%) 0.95 (0.81-1.11) 
Lifetime sexual partners    
   None 9/10 (90%) 1/10 (10%) 0.21* (0.03-1.37) 
   1 45/77 (58%) 32/77 (42%) 0.88 (0.66-1.17) 
   2-4 242/458 (53%) 216/458 (47%) REF 
   5-10 180/372 (48%) 192/372 (52%) 1.09 (0.95-1.26) 
   >10 23/39 (59%) 16/39 (41%) 0.87 (0.59-1.28) 
Condom use in past 12 months 
by marital status    
   Married 359/685 (52%) 326/685 (48%) REF 
   Not married, never 67/119 (56%) 52/119 (44%) 0.92 (0.74-1.14) 
   Not married, 
sometimes/inconsistent 38/101 (38%) 63/101 (62%) 1.31*** (1.10-1.55) 
   Not married, always 12/22 (55%) 10/22 (45%) 0.96 (0.60-1.52) 
   NA, no sex 23/29 (79%) 6/29 (21%) 0.43** (0.21-0.89) 
Symptoms in the past 7 days    
   No 170/353 (48%) 183/353 (52%) REF 
   Yes 329/603 (55%) 274/603 (45%) 0.88** (0.77-1.00) 
Number of STI symptoms in past 
6 months    
   1 200/312 (64%) 112/312 (36%) REF 
   2-4 227/457 (50%) 230/457 (50%) 1.40*** (1.18-1.67) 
   >=5 72/187 (39%) 115/187 (61%) 1.71*** (1.42-2.06) 
Number of STI symptoms in past 
7 days    
   0 170/353 (48%) 183/353 (52%) REF 
   1 160/260 (62%) 100/260 (38%) 0.74*** (0.62-0.89) 
   2-4 128/249 (51%) 121/249 (49%) 0.94 (0.80-1.10) 
   >=5 41/94 (44%) 53/94 (56%) 1.09 (0.89-1.33) 
Genital ulcer    
   No 380/675 (56%) 295/675 (44%) REF 
   Yes 119/281 (42%) 162/281 (58%) 1.32*** (1.16-1.51) 
Genital discharge    
   No 285/495 (58%) 210/495 (42%) REF 
   Yes 214/461 (46%) 247/461 (54%) 1.26*** (1.11-1.44) 
Thick and/or colored vaginal 
discharge    
   No 342/638 (54%) 296/638 (46%) REF 
   Yes 157/318 (49%) 161/318 (51%) 1.09 (0.95-1.25) 
Itching of the vagina    
   No 303/539 (56%) 236/539 (44%) REF 
   Yes 196/417 (47%) 221/417 (53%) 1.21*** (1.06-1.38) 
Unpleasant vaginal odor    
   No 411/774 (53%) 363/774 (47%) REF 
   Yes 88/182 (48%) 94/182 (52%) 1.10 (0.94-1.29) 
Frequent urination    
   No 390/733 (53%) 343/733 (47%) REF 
   Yes 109/223 (49%) 114/223 (51%) 1.09 (0.94-1.27) 
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Painful urination    
   No 400/687 (58%) 287/687 (42%) REF 
   Yes 99/269 (37%) 170/269 (63%) 1.51*** (1.33-1.72) 
Pain during intercourse    
   No 436/806 (54%) 370/806 (46%) REF 
   Yes 63/150 (42%) 87/150 (58%) 1.26*** (1.08-1.48) 
Bleeding during intercourse    
   No 488/941 (52%) 453/941 (48%) REF 
   Yes 11/15 (73%) 4/15 (27%) 0.55 (0.24-1.29) 
Lower abdominal pain    
   No 318/577 (55%) 259/577 (45%) REF 
   Yes 181/379 (48%) 198/379 (52%) 1.16** (1.02-1.33) 
Genital warts    
   No 463/906 (51%) 443/906 (49%) REF 
   Yes 36/50 (72%) 14/50 (28%) 0.57** (0.37-0.90) 
*** p≤0.01, ** p≤0.05, * p≤0.1 
 
 
B – Males  








Age    
   15-19 years 8/14 (57%) 6/14 (43%) REF 
   20-29 years 45/97 (46%) 52/97 (54%) 1.25 (0.66-2.36) 
   30-39 years 62/114 (54%) 52/114 (46%) 1.06 (0.56-2.02) 
   40-49 years 37/63 (59%) 26/63 (41%) 0.96 (0.49-1.89) 
Marital status    
   Never Married 15/32 (47%) 17/32 (53%) REF 
   Married, Monogamous 102/173 (59%) 71/173 (41%) 0.77 (0.53-1.12) 
   Married, Polygamous 13/23 (57%) 10/23 (43%) 0.82 (0.46-1.45) 
   Previously Married 22/60 (37%) 38/60 (63%) 1.19 (0.82-1.74) 
Community type    
   Inland 43/96 (45%) 53/96 (55%) REF 
   Fishing 109/192 (57%) 83/192 (43%) 0.78** (0.61-1.00) 
Religion    
   Christian 123/242 (51%) 119/242 (49%) REF 
   Muslim 29/45 (64%) 16/45 (36%) 0.72 (0.48-1.09) 
   Other/none 0/1 (0%) 1/1 (100%) 2.03*** (1.79-2.31) 
Education    
   No 11/21 (52%) 10/21 (48%) REF 
   Yes 141/267 (53%) 126/267 (47%) 0.99 (0.62-1.58) 
Occupation    
   Agricultural or housework 21/50 (42%) 29/50 (58%) REF 
   Bar or restaurant work 1/1 (100%) 0/1 (0%)  -  
   Boda boda driving or trucking 10/19 (53%) 9/19 (47%) 0.82 (0.48-1.39) 
   Fishing 76/127 (60%) 51/127 (40%) 0.69** (0.50-0.95) 
   Student 2/4 (50%) 2/4 (50%) 0.86 (0.31-2.37) 
   Trader or shopkeeper 19/36 (53%) 17/36 (47%) 0.81 (0.54-1.24) 
   Other 23/51 (45%) 28/51 (55%) 0.95 (0.67-1.33) 
HIV status    
   Negative 108/199 (54%) 91/199 (46%) REF 
   Positive 44/89 (49%) 45/89 (51%) 1.11 (0.86-1.43) 
Sex in the past year    
   No 4/9 (44%) 5/9 (56%) REF 
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   Yes 148/279 (53%) 131/279 (47%) 0.85 (0.46-1.54) 
Sexual partners in the past year    
   None 4/9 (44%) 5/9 (56%) 1.21 (0.65-2.25) 
   1 55/102 (54%) 47/102 (46%) REF 
   2-4 79/147 (54%) 68/147 (46%) 1.00 (0.76-1.32) 
   5-10 11/23 (48%) 12/23 (52%) 1.13 (0.73-1.77) 
   >10 3/7 (43%) 4/7 (57%) 1.24 (0.63-2.44) 
Sex with partner from outside the 
community    
   No 86/162 (53%) 76/162 (47%) REF 
   Yes 66/126 (52%) 60/126 (48%) 1.02 (0.79-1.30) 
Lifetime sexual partners    
   None 2/2 (100%) 0/2 (0%)  -  
   1 0/1 (0%) 1/1 (100%) 2.26*** (1.67-3.07) 
   2-4 29/52 (56%) 23/52 (44%) REF 
   5-10 104/203 (51%) 99/203 (49%) 1.10 (0.79-1.54) 
   >10 17/30 (57%) 13/30 (43%) 0.98 (0.59-1.63) 
Condom use in past 12 months 
by marital status    
   Married 115/196 (59%) 81/196 (41%) REF 
   Not married, never 13/30 (43%) 17/30 (57%) 1.37* (0.96-1.96) 
   Not married, 
sometimes/inconsistent 14/47 (30%) 33/47 (70%) 1.70*** (1.32-2.18) 
   Not married, always 6/9 (67%) 3/9 (33%) 0.81 (0.31-2.07) 
   NA, no sex 4/6 (67%) 2/6 (33%) 0.81 (0.26-2.54) 
Symptoms in the past 7 days    
   No 67/140 (48%) 73/140 (52%) REF 
   Yes 85/148 (57%) 63/148 (43%) 0.82 (0.64-1.04) 
Number of STI symptoms in past 
6 months    
   1 103/161 (64%) 58/161 (36%) REF 
   2-4 45/118 (38%) 73/118 (62%) 1.72 (1.34-2.21) 
   >=5 4/9 (44%) 5/9 (56%) 1.54 (0.83-2.87) 
Number of STI symptoms in past 
7 days    
   0 67/140 (48%) 73/140 (52%) REF 
   1 65/100 (65%) 35/100 (35%) 0.67*** (0.49-0.92) 
   2-4 18/42 (43%) 24/42 (57%) 1.10 (0.81-1.49) 
   >=5 2/6 (33%) 4/6 (67%) 1.28 (0.71-2.30) 
Genital ulcer    
   No 104/192 (54%) 88/192 (46%) REF 
   Yes 48/96 (50%) 48/96 (50%) 1.09 (0.85-1.40) 
Genital discharge    
   No 132/204 (65%) 72/204 (35%) REF 
   Yes 20/84 (24%) 64/84 (76%) 2.16 (1.73-2.69) 
Frequent urination    
   No 107/217 (49%) 110/217 (51%) REF 
   Yes 45/71 (63%) 26/71 (37%) 0.72* (0.52-1.01) 
Painful urination    
   No 104/169 (62%) 65/169 (38%) REF 
   Yes 48/119 (40%) 71/119 (60%) 1.55*** (1.22-1.98) 
Pain during intercourse    
   No 136/251 (54%) 115/251 (46%) REF 
   Yes 16/37 (43%) 21/37 (57%) 1.24 (0.91-1.69) 
Bleeding during intercourse    
   No 149/283 (53%) 134/283 (47%) REF 
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   Yes 3/5 (60%) 2/5 (40%) 0.84 (0.29-2.49) 
Lower abdominal pain    
   No 108/203 (53%) 95/203 (47%) REF 
   Yes 44/85 (52%) 41/85 (48%) 1.03 (0.79-1.34) 
Genital warts    
   No 135/266 (51%) 131/266 (49%) REF 
   Yes 17/22 (77%) 5/22 (23%) 0.46*** (0.21-1.01) 
*** p≤0.01, ** p≤0.05, * p≤0.1 
 
 
C – Females  








Age    
   15-19 years 31/55 (56%) 24/55 (44%) REF 
   20-29 years 137/271 (51%) 134/271 (49%) 1.13 (0.82-1.57) 
   30-39 years 122/241 (51%) 119/241 (49%) 1.13 (0.82-1.57) 
   40-49 years 57/101 (56%) 44/101 (44%) 1.00 (0.69-1.45) 
Marital status    
   Never Married 28/41 (68%) 13/41 (32%) REF 
   Married, Monogamous 194/385 (50%) 191/385 (50%) 1.56* (0.99-2.48) 
   Married, Polygamous 50/104 (48%) 54/104 (52%) 1.64** (1.01-2.66) 
   Previously Married 75/138 (54%) 63/138 (46%) 1.44 (0.89-2.34) 
Community type    
   Inland 173/322 (54%) 149/322 (46%) REF 
   Fishing 174/346 (50%) 172/346 (50%) 1.07 (0.92-1.26) 
Religion    
   Christian 291/560 (52%) 269/560 (48%) REF 
   Muslim 36/77 (47%) 41/77 (53%) 1.11 (0.88-1.39) 
   Other/none 3/5 (60%) 2/5 (40%) 0.83 (0.28-2.45) 
Education    
   No 26/41 (63%) 15/41 (37%) REF 
   Yes 321/627 (51%) 306/627 (49%) 1.33 (0.88-2.01) 
Occupation    
   Agricultural or housework 156/292 (53%) 136/292 (47%) REF 
   Bar or restaurant work 37/69 (54%) 32/69 (46%) 1.00 (0.75-1.32) 
   Boda boda driving or trucking 0/0 (0%) 0/0 (0%)  -   
   Fishing 0/0 (0%) 0/0 (0%)  -  
   Student 5/8 (62%) 3/8 (38%) 0.81 (0.33-1.99) 
   Trader or shopkeeper 94/183 (51%) 89/183 (49%) 1.04 (0.86-1.27) 
   Other 55/116 (47%) 61/116 (53%) 1.13 (0.91-1.40) 
HIV status    
   Negative 239/446 (54%) 207/446 (46%) REF  
   Positive 108/220 (49%) 112/220 (51%) 1.10 (0.93-1.29) 
Sex in the past year    
   No 32/45 (71%) 13/45 (29%) REF 
   Yes 315/623 (51%) 308/623 (49%) 1.71** (1.07-2.73) 
Sexual partners in the past year    
   None 32/45 (71%) 13/45 (29%) 0.59** (0.37-0.94) 
   1 267/526 (51%) 259/526 (49%) REF 
   2-4 48/95 (51%) 47/95 (49%) 1.00 (0.81-1.25) 
   5-10 0/1 (0%) 1/1 (100%) 2.03*** (1.86-2.22) 
   >10 0/1 (0%) 1/1 (100%) 2.03*** (1.86-2.22) 
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Sex with partner from outside the 
community    
   No 279/546 (51%) 267/546 (49%) REF  
   Yes 68/122 (56%) 54/122 (44%) 0.91 (0.73-1.12) 
Lifetime sexual partners     
   None 7/8 (88%) 1/8 (12%) 0.26 (0.04-1.65) 
   1 45/76 (59%) 31/76 (41%) 0.86 (0.64-1.15) 
   2-4 213/406 (52%) 193/406 (48%) REF  
   5-10 76/169 (45%) 93/169 (55%) 1.16* (0.98-1.37) 
   >10 6/9 (67%) 3/9 (33%) 0.70 (0.28-1.78) 
Condom use in past 12 months 
by marital status    
   Married 244/489 (50%) 245/489 (50%) REF 
   Not married, never 54/89 (61%) 35/89 (39%) 0.78* (0.60-1.03) 
   Not married, 
sometimes/inconsistent 24/54 (44%) 30/54 (56%) 1.11 (0.86-1.43) 
   Not married, always 6/13 (46%) 7/13 (54%) 1.07 (0.64-1.79) 
   NA, no sex 19/23 (83%) 4/23 (17%) 0.35** (0.14-0.85) 
Symptoms in the past 7 days    
   No 103/213 (48%) 110/213 (52%) REF 
   Yes 244/455 (54%) 211/455 (46%) 0.90 (0.76-1.06) 
Number of STI symptoms in past 
6 months    
   1 97/151 (64%) 54/151 (36%) REF 
   2-4 182/339 (54%) 157/339 (46%) 1.30** (1.02-1.65) 
   >=5 68/178 (38%) 110/178 (62%) 1.73*** (1.36-2.20) 
Number of STI symptoms in past 
7 days     
   0 103/213 (48%) 110/213 (52%) REF  
   1 95/160 (59%) 65/160 (41%) 0.79** (0.63-0.99) 
   2-4 110/207 (53%) 97/207 (47%) 0.91 (0.75-1.10) 
   >=5 39/88 (44%) 49/88 (56%) 1.08 (0.86-1.35) 
Genital ulcer     
   No 276/483 (57%) 207/483 (43%) REF 
   Yes 71/185 (38%) 114/185 (62%) 1.44*** (1.23-1.68) 
Genital discharge    
   No 153/291 (53%) 138/291 (47%) REF 
   Yes 194/377 (51%) 183/377 (49%) 1.02 (0.87-1.20) 
Thick and/or colored vaginal 
discharge    
   No 190/350 (54%) 160/350 (46%) REF 
   Yes 157/318 (49%) 161/318 (51%) 1.11 (0.95-1.30) 
Itching of the vagina    
   No 151/251 (60%) 100/251 (40%) REF 
   Yes 196/417 (47%) 221/417 (53%) 1.33*** (1.11-1.59) 
Unpleasant vaginal odor    
   No 259/486 (53%) 227/486 (47%) REF 
   Yes 88/182 (48%) 94/182 (52%) 1.11 (0.93-1.31) 
Frequent urination    
   No 283/516 (55%) 233/516 (45%) REF 
   Yes 64/152 (42%) 88/152 (58%) 1.28*** (1.09-1.51) 
Painful urination    
   No 296/518 (57%) 222/518 (43%) REF 
   Yes 51/150 (34%) 99/150 (66%) 1.54*** (1.32-1.79) 
Pain during intercourse     
   No 300/555 (54%) 255/555 (46%) REF  
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   Yes 47/113 (42%) 66/113 (58%) 1.27*** (1.06-1.52) 
Bleeding during intercourse    
   No 339/658 (52%) 319/658 (48%) REF 
   Yes 8/10 (80%) 2/10 (20%) 0.41 (0.12-1.43) 
Lower abdominal pain     
   No 210/374 (56%) 164/374 (44%) REF  
   Yes 137/294 (47%) 157/294 (53%) 1.22*** (1.04-1.42) 
Genital warts    
   No 328/640 (51%) 312/640 (49%) REF  
   Yes 19/28 (68%) 9/28 (32%) 0.66 (0.38-1.14) 
*** p≤0.01, ** p≤0.05, * p≤0.1 
 
 
In multivariable analyses, significant factors associated with seeking treatment at 
a clinic for men included being from the inland community and having multiple 
STI-related symptoms in the past six months. For women, the only significant 
factor associated with seeking STI treatment at a clinic included having multiple 
STI-related symptoms in the past six months (Table 4).  
 
Table 4. Predictors of clinic treatment seeking among STIPS 
participants who reported STI symptoms in the past 6 
months (N=956), by gender 
 
 MALES  FEMALES 




Age   
   15-19 years REF REF 
   20-29 years 1.10 (0.61-2.00) 0.97 (0.70-1.33) 
   30-39 years 1.01 (0.54-1.90) 0.96 (0.69-1.33) 
   40-49 years 0.85 (0.44-1.64) 0.89 (0.61-1.31) 
Community type   
   Inland REF REF 
   Fishing 0.70*** (0.55-0.89) 0.97 (0.82-1.15) 
Marital status   
   Never Married REF REF 
   Married, Monogamous 0.92 (0.61-1.37) 1.57* (0.96-2.58) 
   Married, Polygamous 0.91 (0.52-1.59) 1.67* (0.99-2.81) 
   Previously Married 1.44* (0.97-2.14) 1.46 (0.86-2.47) 
HIV status   
   Negative REF REF 
   Positive 1.27* (0.98-1.67) 1.08 (0.90-1.30) 
Number of STI symptoms in past 6 months   
   1 REF REF 
   >1 1.73*** (1.36-2.21) 1.41*** (1.12-1.78) 
*** p≤0.01, ** p≤0.05, * p≤0.1 
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Previous treatment seeking and current STI prevalence 
Among those who reported STI-related symptoms, CT prevalence was 11%, NG 
was 10%, TV was 13%, active syphilis was 7% and HSV-2 was 61%. The most 
common diagnosis for men and women who reported seeking treatment at a 
clinic in the past six months for their symptoms, was HSV-2 (53% and 67%, 
respectively). When we restricted our analysis to only those individuals who 
reported previously seeking clinic treatment for their symptoms, we found that 
approximately one-third tested positive for any curable STI (CT, NG, TV or active 
syphilis) at the time of the survey (45/136 [33%] males; 98/321 [31%] females) 
(Table 5). We found no significant difference in the current prevalence of curable 
STIs between those who did and did not previously seek clinic treatment, for 
either gender (for men: 33% with curable STI who previously sought treatment 
versus 27% with curable STI who previously did not seek treatment; PRR: 1.23, 
95% CI: 0.86-1.75); for women, 31% with curable STI who previously sought 
treatment versus 33% with curable STI who previously did not seek treatment; 
PRR: 0.92, 95% CI: 0.74-1.15).  
  
Table 5. Prevalence of any curable STI (CT, NG, TV or active 
syphilis) at the time of the survey among STIPS 
participants who reported STI symptoms in the past 6 
months (N=956), by gender 
 
    Any curable STI 
Crude PRR 






No clinic  111/152 (73%) 41/152 (27%) REF 
Clinic  91/136 (67%) 45/136 (33%) 1.23 (0.86-1.75) 
Females (N=668) 
No clinic  232/347 (67%) 115/347 (33%) REF 
Clinic  223/321 (69%) 98/321 (31%) 0.92 (0.74-1.15) 
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*** p≤0.01, ** p≤0.05, * p≤0.1 
 
4.5 Discussion 
Prevalence of clinic treatment seeking 
This study provides the first population-based assessment of STI-related 
symptoms and treatment seeking in two communities in rural Uganda since the 
mid-nineteen nineties and assesses factors associated with seeking treatment at 
a government or private clinic. Just over half (57%) of adults who reported STI-
related symptoms in the past six months reported seeking any treatment for their 
symptoms, with similar rates in men and women. Seeking treatment at a clinic 
was 48% overall (47% among men; 48% among women). While our estimates 
were based on a population-based sampling approach of all eligible adults in our 
study communities, our estimations of clinic treatment seeking are lower than 
those found in previous studies, including the 2016 Ugandan DHS (70% for the 
country) and the first round of the RCCS in the 1990s (67% for the region).4,74  
 
Our estimations of clinic treatment seeking may be lower than national estimates 
because of the communities included in our sample. The communities that we 
included are considered rural and treatment seeking tends to be lower in rural 
settings.5,89–93 Because national-level estimates (e.g. DHS estimates) of 
treatment seeking include both rural and urban communities (and are not 
disaggregated by community type), we cannot compare the two. Because our 
study communities are not the same as the ones included in the first round of the 
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RCCS, and because of the difference in time, our overall estimates may not be 
comparable to the data drawn from the first rounds of the RCCS.  
 
Differences in the prevalence of clinic treatment seeking by gender 
Our data showed no difference in the prevalence of clinic treatment seeking by 
gender. This was unexpected, as other research in Uganda and the region 
suggest gendered patterns of treatment seeking in low-resource settings,85,92,94–
100 with women more likely to delay, and less likely to seek, STI treatment than 
men.36,41,42,91,101 While the 2016 Uganda DHS estimates show a higher 
prevalence of clinic treatment seeking among women than men,4 as 
aforementioned, we are hesitant to compare our findings to DHS estimates 
because of urban/rural differences. We recommend that future researchers 
continue to assess gender-specific treatment seeking behavior across a range of 
settings. 
 
Differences in the prevalence of clinic treatment seeking by community type  
Our analysis found that men in the fishing community are significantly less likely 
to seek clinic treatment, as compared to men in the inland community.  The 
epidemiologic differences between fishing and inland communities in Rakai are 
well-established: fishing communities show a disproportionate burden of HIV, 
high prevalence of sexual risk behaviors and historically showed a lower use of 
combination HIV prevention services (though this has been increasing in recent 
years with significant new service provision).21,69,102,103 Furthermore, data show 
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that overall, men in Rakai are less likely to be enrolled in HIV care104,105 as are in-
migrants.104 Rakai fishing communities, or ‘landing sites’, generally have a high 
proportion of men, the majority of whom migrate from other communities in order 
to work as fishermen on Lake Victoria. Assuming that the barriers to HIV care for 
Rakai residents –  including stigma, demanding work schedules, transport costs, 
belief in spiritual healing, long wait times and inadequate staff respect for 
patients106 – also apply to STI treatment seeking, our observations indicating a 
lower prevalence of clinic treatment seeking among men in the fishing community 
is not unexpected. What is surprising, however, is the fact that this difference 
was not observed among women. We recommend future researchers explore the 
intersection of gender and community type, as well as try to better understand 
the barriers to treatment seeking in fishing communities among men.  
 
Differences in the prevalence of clinic treatment seeking by STI symptomatology 
We found the presence of some, but not all, symptom to be associated with clinic 
treatment seeking for each gender. For instance, lower abdominal pain, pain or 
bleeding during intercourse, and genital ulcers showed no association with 
treatment seeking among men in our study. The same goes for genital warts and 
thick/colored discharge among women. Not recognizing STI-related symptoms, 
not perceiving them as severe, or not attributing/misattributing them to STI-
related causes can prevent treatment seeking.5,86,90,107 A similar phenomenon 
may have occurred in our sample: participants may not have attributed lower 
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abdominal pain, warts or discharge to an STI, thereby explaining why the 
presence of some symptoms were associated with clinic treatment over others.  
 
Private versus public clinics 
The frequency of private clinic use was notable. The Ugandan healthcare system 
suffered losses during the decades of civil unrest in the 1980s.108 
Consequentially, Ugandans have come to perceive health centers as expensive 
and lacking medication, and many turn to self-medication first and use health 
centers as a last recourse if all else fails.108–112 Also as a result of the political 
turmoil, the number of public health services in the Uganda decreased and the 
number of private clinics increased.112,113 While we did not include a treatment 
location mapping exercise in our study, we did find a 2010 study that mapped the 
availability of private and public facilities in rural areas of Uganda.114 Based on 
their work, the authors reported that public facilities made up 4.3% of all the 
health care units that were mapped as compared to private facilities which made 
up 95.7%. Private-for-profit clinics and drug shops made up 17.1% of all mapped 
facilities and private-not-for-profit facilities made up 1.6% of all mapped 
facilities.114 While still considered rural, the districts included in their study are 
more central and developed than Rakai district. Nevertheless, we expect that 
their finding of more private than public clinics may still apply to Rakai. As such, 
the high prevalence of private clinic treatment that we observed may be partially 
explained by the high availability of private clinics in the area.  
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We also found a difference in private versus government clinic treatment seeking 
by gender, with women more likely to attend government clinics than men. 
Previous research has seen this to be the case in other settings, too.115–117 A lack 
of finances, unfriendly reception and long wait times have been identified as 
reasons for why women do not seek care at formal sector clinics.118 These 
factors may help explain why women in our study did not go to private clinics as 
often as men. More in-depth research into why women attended government 
clinics more than men would be useful to further contextualize our observation. 
 
Factors associated with clinic treatment seeking 
Our research identified community type (for men) and the number of STI-related 
symptoms (for both men and women) to influence clinic treatment seeking. As 
aforementioned, fishing communities are uniquely different from inland 
communities in a variety of ways, and so we are not surprised that being from the 
fishing community reduced the likelihood of seeking clinic treatment; once again, 
however, we are not able to explain why community type affected treatment 
seeking for men and not women, as we expected treatment seeking to be lower 
in fishing communities for both genders. It also makes sense that those who are 
experiencing a combination of symptoms (likely an indication of disease severity) 
would be more likely to seek treatment at a clinic than those who experienced 
just one, as was observed elsewhere.91  
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In contrast to our findings, other studies have found additional sociodemographic 
factors – such as increasing age (among women), higher education/literacy and 
a positive HIV status – to be associated with treatment seeking.89,119–122 For age, 
one study in India suggested that older females may have better treatment 
seeking behavior than younger females due to their decision making and/or 
spending power;89 Ugandan cultural norms may be different – age may not affect 
decision-making power – thereby explaining why age showed no association with 
treatment seeking in our study. For education, it is likely that we saw no 
association because of the limited nature of our data: we only asked participants 
whether or not they ever went to school (yes or no). It is possible that we may 
see an association between education and clinic treatment seeking if we broke 
down the level of educational attainment to more specific groups (i.e. 
none/illiterate, primary school, secondary school, post-secondary school).  
 
Finally, the lack of association between clinic treatment seeking and HIV status 
surprised us; we expected that individuals who were HIV-positive to be more 
likely to seek clinic treatment for their symptoms than those who were HIV-
negative. This was observed among Rwandan women.122 Eighty-six percent of 
HIV-positive individuals in our study reported being on antiretroviral treatment 
(ART) at the time of interview; we would have expected that their routine 
interaction with the health system due to ART would make them more likely to 
attend a clinic for treatment than those without HIV, all other things being equal. 
HIV-positive individuals may also be more conscious of their sexual risk behavior 
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and sexual health than those who are negative,123–125 furthering their likelihood of 
seeking clinic treatment. We speculate that the availability and affordability of 
services or stigma may have affected treatment seeking behavior among HIV-
positive individuals. We recommend researchers continue to explore treatment 
seeking among HIV-positive individuals in order to better understand barriers to 
clinic care seeking. 
 
Previous treatment seeking and current STI prevalence 
We found that approximately one-third of men and women who previously sought 
clinic treatment for their symptoms were diagnosed with at least one curable STI 
(CT, NG, TV or active syphilis) at the time of the survey. Furthermore, our 
analysis showed no difference in the current prevalence of curable STIs 
comparing those who previously sought clinic treatment versus those who did 
not, for either gender. Assuming that seeking clinic treatment meant receiving 
treatment, these data could indicate that reinfection rates were high, treatment 
was inadequate, or both. Further studies exploring the temporal association 
between past treatment seeking, including receiving and adhering to treatment, 
and current STI prevalence are recommended in order to assess for treatment 
effectiveness.  
 
Strengths and Limitations 
A strength of our study lies in its population-based sample, which is rare in other 
studies focused on treatment seeking behavior. Calls have been made for a 
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broader research perspective in order to understand sexual healthcare seeking 
behavior.43 This perspective includes a focus on non-attendance at healthcare 
services as well as research that uses non-patient samples recruited from non-
medical settings in order to accurately capture the gamut of behaviors, beliefs 
and health issues occurring within the population and ensure appropriate and 
effective service provision.43 We addressed these items in our study by 
interviewing all eligible individuals in our study communities and including both 
persons who did, and did not, seek treatment. Taken together, this information 
can provide program managers and decisionmakers with a better understanding 
of treatment seeking patterns within the community.  
 
Despite this, our research is not without limitations. First, we did not further 
define treatment sources or ask participants to name specific treatment locations. 
As a result, it is possible that some treatment locations were misclassified in our 
analysis (e.g. drug shops being reported as private clinics, etc.), resulting in a 
biased estimate of prevalence and treatment seeking. In addition, inclusion of 
study participants was based on self-reported symptom history in the past six 
months and seven days. It is possible that eligible participants may have been 
not included because they were too shy, or embarrassed, to share their symptom 
history (social desirability bias), did not remember their symptoms (recall bias) or 
did not understand the terms we used for the symptoms. Given that the survey 
was administered by RHSP staff, it is also possible that participants over-
reported seeking clinical care or under-reported seeking care in informal sectors 
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(or not seeking any care at all) in order to please the interviewer. Given the lower 
than expected rates of treatment seeking, however, we doubt this to be the case. 
In addition, our study did not assess environmental, social, psychosocial, 
economic, geographic or service-related factors, as well as symptom severity, 
which have been shown to be associated with treatment seeking behavior in low-
resource settings.5 The omission of such factors may have biased our results. 
We also did not measure the availability of each type of treatment location in our 
study communities – this information would be useful to contextualize our results. 
We also note that, while our study was sufficiently powered to assess for 
differences between men and women, we may have been underpowered to 
detect differences by both gender and community type. This sub-analysis may be 
of programmatic interest; we recommend that researchers consider this when 
designing future studies. 
 
Finally, our analysis grouped together private and government clinics, and 
compared them to other treatment locations/no treatment. In doing so, we made 
the assumption that these clinics provided appropriate and effective care, of 
equal/sufficient quality, and that anything but clinical care was ineffective. This 
may be an unfair assumption: in low-resource settings, formal sector facilities 
tend to show poor quality of care in general.126,127 It is likely, too, that, given the 
use of the syndromic approach and the low priority of STIs for health systems, 
STI care is especially poor in such settings. In fact, a study specifically on the 
quality of STI case management in Ugandan private clinics and drug shops 
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concluded that the quality of management was poor.109 We recommend studying 
quality of care and barriers to providing quality care in local facilities, as well as 
urge leadership to strengthen care and enforce quality standards across health 
service sectors and facilities. 
4.6 Conclusion 
Timely and appropriate diagnosis is critical to STI control. We found that half of 
adults with STI symptoms in two rural Ugandan communities are not seeking 
appropriate clinical care under the syndromic management strategy. These 
individuals are a priority for public health intervention. We recommend 
researchers continue to focus on treatment-seeking behavior in low-resource 
settings and explore barriers to seeking care; we urge decision-makers to target 
their efforts in order to increase appropriate care seeking for STIs in this and 
similar contexts.    
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Chapter 5. The Acceptability of Self-Collected 
Samples for STI Testing: A Qualitative Study Among 
Adults in Rakai, Uganda  
5.1 Abstract 
Background: Timely and accurate diagnosis is critical to reduce the spread of 
sexually transmitted infections (STIs). Self-collected samples (SCS) for STI 
testing have been shown to be feasible and acceptable in high-income settings, 
where they have been shown to be an effective approach to expand STI 
diagnosis. However, few studies have assessed the acceptability of SCS for STI 
testing in a general population in low-resource settings. The objective of our 
study was to explore the acceptability of SCS among adults in south-central 
Uganda. 
Methods: Our study was nested within the Rakai Community Cohort Study, a 
population-based study among adults in Rakai district, Uganda. We conducted 
semi-structured interviews among 36 adults aged 18-49 years, both with and 
without STI-related symptoms, after they self-collected samples for STI testing, 
as well as nine key informants, in order to assess the acceptability of SCS. We 
analyzed the data using an adapted version of the Framework Method, 
comparing prominent themes between genders as well as those with and without 
symptoms. 
Results: We found that the acceptability of SCS did not differ by gender or 
symptom status. Overall, participants found no problem with SCS and did not find 
SCS physically uncomfortable. Perceived advantages to SCS included increased 
privacy and confidentiality and gentleness, as well as the perception that SCS 
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were best if resources are limited. Disadvantages included the lack of HCW 
involvement, fear of self-harm and the perception that SCS was unhygienic. 
Given this, most participants preferred healthcare worker (HCW)-collected 
samples to SCS (18/36 [50%] for HCW versus 13/36 [36%] for SCS; 5/36 [15%] 
with no preference). Nevertheless, almost all participants said they would 
recommend SCS to others and would do it again in the future. 
Conclusion: Despite a preference for HCW-collection, SCS are still acceptable 
among adults in this population; SCS are a possible means to expand STI 
diagnosis and can be one additional tool to reduce disease spread. To promote 
SCS uptake and acceptability, proper education and messaging are needed to 
increase user’s knowledge as well as allay their concerns. 
5.2 Introduction 
Countries in sub-Saharan Africa (SSA) currently use the syndromic approach to 
manage non-HIV sexually transmitted infections (STIs).7 This involves a clinic-
based examination and subsequent antibiotic administration for individuals who 
report symptoms common to prevalent STIs in the region. While practical and 
cost-effective, syndromic management can result in inappropriate- and/or over- 
treatment of STIs and the development of antimicrobial resistance.10,28,128,129 
Syndromic management of STIs also lacks the specificity of a diagnostic test and 
cannot detect asymptomatic cases, which comprise the majority of STI cases. 
Even among those with symptoms, the syndromic approach relies upon the 
patient to: a) recognize their symptoms, b) perceive those symptoms to be 
health-related and treatable and c) seek appropriate care.8 Given these 
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limitations, the World Health Organization (WHO) has recommended a global 
shift away from syndromic case management in favor of etiologic testing where 
feasible and cost-effective.9  
 
Self-collected samples (SCS) may be a way to make etiologic testing more 
accessible in low-resource settings. SCS for STI testing (SCS/STI testing) occurs 
when individuals obtain a swab or fluid sample themselves, either within or 
outside the clinic, and send the specimen to a laboratory for testing.44 Research 
in high-resource settings show that SCS are as accurate as clinician-based 
tests,45 and that SCS/STI testing interventions are feasible and acceptable in a 
variety of populations.46–55 While not a replacement for clinic-based examination 
and clinician counseling, SCS may be a way to expand STI case management 
beyond the clinician- and clinic-dependent, syndromic approach.60–62 By allowing 
the patient to collect a sample themselves, studies suggest that SCS can 
circumvent barriers to clinic- and/or clinician-based STI case management, like 
stigma and privacy concerns.10–12 In particular, community- or home-based SCS 
interventions can provide direct services to those who would otherwise not seek 
care and treatment at the clinic or other formal establishments, perhaps due to 
access issues. For instance, SCS/STI testing can provide opportunities for 
testing outside of the clinic, such as within schools or homes.60 A recent meta-
analysis assessing the programmatic value of SCS/STI testing found that SCS 
increased overall uptake of STI testing services and case finding, suggesting that 
SCS could be an effective additional strategy to increase STI case 
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management.62 For these reasons, the WHO recently recommended SCS as an 
additional approach to deliver STI testing services.130 
 
Despite their potential, SCS/STI testing interventions are not common in SSA. 
This is due to a historic lack of cheap and accurate diagnostic tests,63 as well as 
proper laboratory facilities. However, intensive scale-up of HIV care and 
treatment over the past 15 years has resulted in strengthened supply chains, 
infrastructure and laboratory capacity in the region. As such, the potential for 
using cheaper technologies to facilitate STI etiologic testing is now becoming a 
viable reality,61 especially in countries like Uganda. In order to develop effective 
interventions, however, context-specific data are required, yet little data exist on 
the acceptability of SCS in a general population in low-resource settings. In a 
review of the literature, only a few studies explored the acceptability of self-
collected swabs in the African context;61,131,132 of these, only vaginal swabs were 
assessed and the experiences of men were not evaluated. While comparisons 
can be made to the acceptability of self-collection for human papillomavirus 
(HPV) testing – which has been more widely studied in the region133–136 – here, 
once again, the perspectives of men are not represented. Studies assessing the 
acceptability of HIV self-testing (HIVST) in SSA include both men and 
women;137,138 however, since HIVST involves a blood or oral fluid specimen, we 
lack data on the acceptability of self-collection using a genital swab in men. This 
qualitative study aimed to fill the existing research gaps and provide data on user 
acceptability of self-collected genital swabs for STI testing in both women and 
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men in a low-resource setting. Our study sought to answer the following research 
questions: 
1. What motivates adults to provide a self-collected sample for STI testing? 
2. What is their overall experience during the self-collection process? 





Uganda Demographic and Health Survey data show a steady increase in self-
reported STIs and STI symptoms in both men and women since the mid-1990s. 
In 2016, the self-reported prevalence of previous STIs and/or STI symptoms for 
those ages 15-49 years was 24.4% among women and 13.6% among men.4 
Similar to other low-resource settings in the region, Uganda currently mandates 
the syndromic management of STIs in all health care delivery levels in the 
country: in primary health care settings, syndromic management is 
recommended; in referral centers and hospitals where laboratories are available, 
it is recommended that the syndromic approach be “supplemented” by lab-based 
case management, “if necessary.”7 As such, STI testing does not occur on a 
routine basis; the clinical management of disease is only initiated in the general 
population if a patient presents for care, and is based on health care provider 




This study was based in the Rakai region of South-central Uganda. The majority 
of Rakai’s population resides in small agrarian villages; however, the district also 
contains several mid-sized trading towns along the trans-African highway and 
fishing communities along Lake Victoria. Data from a community randomized 
controlled trial of mass STI treatment for HIV control from 1994-1998 showed 
that the STI burden in Rakai communities was high: prevalence of active syphilis 
was ~10%, Trichomonas vaginalis (TV) prevalence was 20%, and Neisseria 
gonorrhoeae (NG), Chlamydia trachomatis (CT) prevalence were ~4% and ~2%, 
respectively.75  
 
Implemented by the Rakai Health Sciences Program (RHSP), the Rakai 
Community Cohort Study (RCCS) is an ongoing, open community-based cohort 
of residents aged 15-49 years in agrarian communities, semi-urban trading 
centers and Lake Victoria fishing communities in Rakai district. RCCS includes 
the administration of a demographic and health questionnaire, as well as HIV 
testing for all consenting participants. Nested within the RCCS, the STI 
Prevalence Study (STIPS) aimed to estimate STI prevalence among 1,825 
sexually active HIV+ and HIV- men and women aged 18-49 years in two 
communities (one inland and one fishing), from May to October 2019. In addition 
to the standard RCCS questionnaire, STIPS included an STI module that 
assessed current and previous symptoms and treatment seeking behavior. 
STIPS participants were also tested for TV (in the field), syphilis (screening in the 
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field; samples tested in the lab), NG, CT, and herpes simplex virus type 2 (HSV-
2) (samples tested in the lab). To this end, three HCW-collected penile-meatal 
swabs were obtained for all male STIPS participants who consented to STI 
testing. Because we were interested in men’s experience with SCS, a fourth, 
self-collected swab was obtained from a sub-sample of men (n=40); it is from this 
sub-sample that we recruited the male study participants for our qualitative 
interviews (n=15). Three self-collected vaginal swabs were obtained for all 
female STIPS participants who consented to STI testing (HCW-collected 
samples were not obtained for females); it is from this sample that we recruited 
the female study participants for our qualitative interviews (n=21). All participants 
who self-collected samples received instructions from a same-gender HCW 
before sample collection and were then given privacy to self-collect. Interviews 
were conducted after participants received their HIV, TV and syphilis screening 
results but before their NG, CT and HSV-2 results. All individuals who tested 
positive for any STIs were provided treatment by RHSP according to the 
Ugandan National Clinical Treatment Guidelines for Sexually Transmitted 
Infections.   
 
Methodology 
This qualitative study was conducted among 36 adults – 15 men and 21 women 
– from the STIPS inland community who self-collected a sample in the STIPS. 
We selected participants based on their gender as well as their self-reported 
symptom status, with 9/15 men and 15/21 women reporting at least one STI-
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related symptom in the last six months. We conducted semi-structured interviews 
with all participants that explored their experience and preferences related to 
self-collecting a sample for STI testing. We also conducted nine key informant 
interviews that covered similar topics, in order to contextualize participant data. 
Key informants (KIs) from various levels of the local health system were selected, 
including: a community mobilizer, a village health worker, a community health 
worker, a traditional healer, a STIPS team leader, a STIPS clinical officer, two 
local hospital-based clinicians and a district health officer.  
 
RHSP social and behavioral scientists, experienced in qualitative research 
methods, conducted all interviews, which were in Luganda and lasted 
approximately a half an hour. After each interview, the interviewers and YPO 
discussed relevant and/or novel findings, reviewed reflexive notes and planned 
for the next interview. The average time between a participant’s STIPS 
participation and their qualitative interview was approximately five days, with the 
majority of interviews occurring either immediately after or within a few days of 
STIPS participation. Because NG, CT and HSV-2 tests and syphilis titers were 
done in the RHSP central lab and not in the field, participants only had their final 
HIV and TV test results at the time of their qualitative interview. After all 
interviews were complete, interviewers transcribed and translated them to 
English. We then imported the data into MAXQDA 2018 (VERBI Software, 
2018)78 for review and initial analysis.  
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Our data analysis methods were adapted from the Framework Method.79 First, 
we reviewed the interviews in MAXQDA to familiarize ourselves with the data. 
Second, similar to the Framework Method, we developed an analytic framework 
comprised of categories that were informed by our interview guide and research 
questions. We used this framework to index the interviews. Third, after all 
interviews were indexed, we charted the data into a framework matrix in Excel. 
We created one Excel spreadsheet for the 36 adults and another for KIs. Fourth, 
we used open-ended coding, followed by focused coding,80 to identify prominent 
themes within each category. Prominent themes were defined by the depth of 
discussion any one participant provided on the topic, prevalence across 
participants and ‘keyness’ in relation to our research questions.81 Fifth, we then 
compared the themes by gender and symptom-status in order to assess for any 
meaningful differences. Finally, we discussed our findings among the research 
team, comprised of interviewers and Principal Investigators, to assess for clarity 
and cohesion.   
5.4 Results 
Below, we present participants’ values, preferences and experiences related to 
SCS/STI testing. Participants are identified by a pseudonym, and further 
described by their gender (M: male; F: female) and symptom status (S+: self-
reported symptoms; S-: no self-reported symptoms). A description of the study 
sample is provided in Table 6. 
 
Table 6. Characteristics of the 36 IDI participants  
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Characteristics 





Average age (range) -  31 years (19-49 years) 
Any STI-related symptoms 
in past 6 months 
No 12 
Yes 24 










HIV status*  
Negative 31 
Positive 5 
*Based on latest RCCS HIV test result. 
 
Reason for Participation 
The process of STI testing using SCS was novel to participants. When asked 
why they agreed to participate in the STIPS/STI testing, as well as why they 
agreed to SCS, most participants discussed valuing their health, often worded as 
their “condition.” Participants indicated that ascertaining their disease status – 
and receiving treatment if they tested positive – was a major motive for 
participation. As described by one participant:  
 
Most people; we are living, you are alive and yet sometimes you may have 
diseases that affect your health. So, when I heard about that service, I 
was so touched, and I wanted to know the condition of my body. If I am 
sick, I can come for treatment and be cured. (Donozio, M, S-) 
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We also found that participants without symptoms referred to STIs as a ‘hidden’ 
condition, alluding to the fact that STIs can present with or without symptoms. As 
one man explained:  
 
Because sometime diseases are there inside when you don’t know they’re 
there, so when you decide to test, you will be able to know them and treat 
them. (Ponsiano, M, S+) 
 
A few participants indicated also that they felt at heightened risk for STI infection, 
and that motivated them to participate. A few participants did not trust their 
partner or suspected him/her to be infected. This was expressed by both men 
and women:  
 
Why I decided [to participate] is because you don’t know how you stand, 
you may also not know how even the person you’re having sex with is 
standing… (Ponsiano, M, S+);  
 
Now…the way we are with our partners, he may sometimes decide to get 
another woman and sometimes that woman may have an infection and he 
infects you without you knowing because it will not be written all over him 
that ‘I got someone else’... And so it was a must for me to test myself. 
(Juliet, F, S+) 
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Finally, we found that a few participants chose to participate because SCS was 
new to them; they were curious and wanted to learn how to do it. 
 
Overall Experience 
In terms of their experience self-collecting a sample, almost all of the participants 
reported ‘never [feeling] bad’ during the collection process and that they had ‘no 
problems’ with it. As one participant stated:  
 
To be honest, me, I didn’t find any problem with it...It was easy to me and I 
was very happy about it. (Bernard, M, S-)  
 
We found that the SCS instructions that were provided by the HCW before 
participants self-collected samples, helped participants: 
 
This time, we were given a chance to do it by ourselves without any 
difficulty.… I felt so good I was not scared at all; I did everything as 
instructed by the musawo <doctor> and I was able to collect the sample 
myself. (Rose Mary, F, S+) 
 
Overall, participants found the SCS process to be physically comfortable. The 
majority stated that they ‘never felt any pain’ during sample collection. A few men 
did indicate a minor discomfort when taking the swab but described it as “some 
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little pain” that was ultimately “bearable” (Richard, M, S+). In the words of one 
man:  
 
Just like you feel anything getting in your body, you feel [the swab]. You 
find that maybe the way I removed it would have been painful, but I was 
not affected. (Eugenio, M, S-) 
 
While participant responses were generally positive, two symptomatic women did 
not appreciate the SCS experience. The first woman did not feel comfortable with 
SCS because it was a new method, while the second simply did not find the 
method acceptable:  
 
[I] am satisfied [with] being checked by a musawo, I don’t like self-testing. 
(Rose Mary, F, S+) 
 
SCS Advantages  
Advantages of SCS included the perception that SCS are private/confidential and 
gentle, as well as the thought that they work best when resources are limited.  
 
Regarding privacy and confidentiality, some participants felt that SCS removed 
feelings of shyness and embarrassment associated with undressing in front of a 
HCW. This sentiment was expressed by both men and women:  
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I prefer doing it [collecting a sample] myself...If a musawo collected from 
me and touches my penis, somehow, I will feel shy. (Robert, M, S+);  
 
The good thing is that if I self-collect there is nothing like obuswavu 
<showing your nakedness> compared to when the health worker collects 
it….when the musawo is collecting the sample I must squat and then the 
musawo will see my private parts when removing the swab...Musawo, I 
prefer collecting it myself. (Phionah, F, S-) 
 
Some participants also liked SCS because it avoided embarrassment caused by 
being ‘dirty’. ‘Dirtiness’ related to being ungroomed or unkempt in the genital 
area. In the words of one participant: 
 
Personally the issue I have noticed there with the musawo collecting the 
sample is…[because] you were not given proper notice, so probably you 
came when you have not groomed or prepared yourself well. That is the 
problem I see.... [laughs] the musawo may find when you are somehow 
dirty [laughs].... You might come when you have not cleaned up and she 
says, get ready am collecting the sample and you get embarrassed 
because you came not well prepared. (Fausta, F, S+) 
 
A few men wanted to avoid this embarrassment as a professional courtesy to the 
HCW. As one man described, a patient may come when they are “munda oyo 
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tasawayo <not shaven>;” this could “for sure…scare the health care worker.” He 
later stated that self-collecting a sample was best as it would avoid disturbing the 
HCW in such a way (Robert, M, S+). 
 
‘Dirtiness’ was also mentioned in the literal sense; participants felt that SCS was 
better because it avoided embarrassment and discomfort due to bad hygiene: 
 
The other advantage [to self-collection] is that you may come when you’re 
not very clean and sometimes it may cause shame between you and the 
health worker...Someone might not have showered in a while so it may be 
shaming to undress before the health worker. (Patrick, M, S-) 
 
Confidentiality was another perceived advantage to SCS. Some participants, 
including both men and women, felt that SCS was more confidential than HCW-
collection. Participants described a local environment of mistrust and rumor 
mongering: “community people [i.e. people in the community/neighbors] are 
rumor mongers,” explained one woman, “they tell everyone.” (Martha, F, S-) 
Participants therefore valued confidentiality and the ‘keeping of secrets.’ 
Participants felt that SCS allowed them to maintain the secret that they 
participated in STI testing:  
 
[Self-collecting] is good, and [secrets don’t] spread because it is you that 
takes it off and give it to the health worker and it stops at you two.…[Self-
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collection] will also continue to keep secrets because it remains with just 
you.  (Patrick, M, S-) 
 
SCS was also perceived as advantageous for those who feared to discuss their 
private matters with a HCW. As one woman described it:  
 
For those people who are afraid of approaching a health worker to tell 
him/her the truth; it will be good because they will be self-testing and doing 
everything by themselves...everyone has their own secrets that they are 
hiding. (Rose Mary, F, S+) 
 
Some participants felt that SCS was gentler than HCW-collection. This was 
especially true among participants who reported symptoms. Both men and 
women feared that the HCW would inflict pain when taking a sample. As this 
participant described:  
 
You may find someone [a HCW] who presses [the swab] so hard…but if it 
is you…[and] you get it yourself very well and find that you do not feel the 
pain like [when] the musawo does [it]. (Eugenio, M, S-)  
 
Some participants felt that SCS would be less painful because the patient ‘knows 
their own body,’ as opposed to the HCW, who does not. As two participants 
described it:  
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Musawo, I know my body; the musawo may insert it far. [laughs]...I would 
be thinking that what if she pierces me. (Angela, F, S+); 
 
[Long laughter] It’s me [who is] supposed to insert it there...it’s you who 
knows where you want it to stop in order to get the sample because if the 
health worker inserts, she might think that she is hurting you but if you 
insert yourself you are able to know where to stop it. (Esther, F, S+) 
 
Finally, some participants felt that SCS would save resources if used at home, 
such as time and money. As one man explained:  
 
[Because] you can test yourself, it helps you to save money, time say that 
you would have used from here for example to Kalisizo [the neighboring 
hospital]. (Ponsiano, M, S+)  
 
Key informants agreed, and added that SCS would benefit areas with poor clinic 
access:  
 
[Self-collection] can work in villages where there are no hospitals, where 
there is no transport, [self-collection] can work for people who want 
secrecy and fear stigma, it can have a breakthrough. (Julius, Assistant 
District Health Officer)  
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Some participants also perceived SCS to be a faster method in comparison to 
HCW-collection, where clinic waiting times could cause delays. 
 
SCS Disadvantages 
Disadvantages of SCS included the lack of HCW involvement (and thus their 
training and expertise) in the collection process, fear of self-harm and the 
perception that SCS was unhygienic.  
 
Regarding HCW involvement, some participants worried that, if they were to 
collect a sample in the absence of a HCW, they may collect it poorly. Participants 
felt that the HCW was better trained and more experienced than them, and as 
such, would carry out the process correctly. As one participant explained it:  
 
The health worker is more experienced in carrying out these tests and 
gets to know the results very fast, as for me I will be there debating 
whether I carried out the test in the right way. (Richard, F, S-) 
 
Another participant had a similar response:  
 
I might [use the swab] wrongly or insert it wrongly, I might not know 
exactly how best to insert it and how far it should go, however a musawo 
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knows how best to insert and how far it should go and how best to remove 
it. (Godfrey, M, S+); 
 
Key informants also felt that low-literacy levels in the area would inhibit proper 
sample collection, because users may not read the instructions correctly:  
 
You will find different categories of people in the community; however, the 
biggest number are illiterate – they cannot read – so [they] may not 
understand exactly what to do. (Ivan, Community Mobilizer) 
 
A perceived risk of self-harm was another disadvantage of SCS. Some 
participants were afraid of hurting themselves if they took the sample. In the 
words of these participants: 
 
My worry is that [I] may insert it wrongly and hurt the uterus which may not 
be the case when the musawo does it because she knows how everything 
is. (Rose Mary, F, S+); 
 
Personally, I would prefer the health worker to collect…she is a health 
worker, she can’t insert it as if she is going to kill you. (Annet, F, S+) 
 
Finally, some participants were concerned that SCS was unhygienic: they stated 
that users do not wear gloves when they self-collect, whereas HCW do. Because 
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of this, participants were afraid of spreading germs in their genital area with SCS. 
As one participant described:  
 
What causes me to fear is [that the doctor] puts on gloves, [inaudible] and 
yet he has told me to do it with bare hands. Which means I can come 
when I have cleaned up myself, but someone else may come from the 
garden, has been digging and then starts from there. Now don’t you see 
his hands, if they have germs and then he touches his genital areas...And 
it is not good for them. (Eugenio, M, S-) 
 
Preference and Future Use 
When asked for their ultimate preference, the majority of participants preferred 
HCW-collection over SCS (18/36 [50%] for HCW versus 13/36 [36%] for SCS; 
5/36 [14%] with no preference). This was true regardless of symptom status or 
gender, though it should be noted that women – especially those reporting 
symptoms – were more amenable to SCS than men (9/21 [43%] of women 
preferred SCS versus 4/15 [27%] of men).  
 
Nevertheless, we found that almost all participants would recommend SCS to 
others, whether it be their friends, family or peers. We also found that almost all 
of the participants were willing to use SCS again in the future, citing once again a 
concern for their health. Many recognized the utility of SCS as a means to 
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receive an STI diagnosis and valued the opportunity to ascertain their disease 
status again in the future. As one man stated:  
 
I would use [SCS in the future] because sexually transmitted infections 
don’t just come in a particular time and stop – they come any time – so I 
would like to keep using this method so that I can know where I stand. 
(Patrick, M, S-)  
 
While almost all participants were willing to use SCS again, we did find one 
woman who stated that she would not use SCS again in the future because she 
was afraid that community members would spread rumors about her if they found 
out she participated. 
5.5 Discussion 
In this qualitative study in south-central Uganda, we found that SCS was 
acceptable to both male and female participants; this was the case regardless of 
whether or not they reported STI symptoms. Overall, participants reported a 
positive experience with self-collection. Advantages of SCS included 
confidentiality, privacy and comfort, as well as the perception that SCS were best 
if resources were limited. Disadvantages included a lack of HCW involvement, as 
well as the fear of self-harm and the perception that SCS was unhygienic. Given 
this, most participants said they preferred a HCW-collection for STI testing. 
Nevertheless, we found the findings on future use to be encouraging: regardless 
of participants’ preference for who takes the sample, with one exception, all 
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participants stated that they would recommend SCS to others and would use 
SCS again in the future. 
 
Data on the acceptability of self-collected genital swabs for STI testing in a 
general population in low-resource settings, particularly in SSA, are rare. Our 
findings corroborate previous studies in Rakai, which demonstrated that self-
administered vaginal swabs were valid and acceptable methods to screen for 
STIs among women, and urine samples were acceptable to both women and 
men.56–59 Our findings also agree with those of a systematic review by Paudyal et 
al. on patient experiences obtaining self-samples to diagnose STIs.52 While the 
review included a variety of self-collection methods (not just genital swabs) and 
only two studies from low-resource settings, it evaluated the same STIs as our 
study, and found that the majority of adults accepted SCS and found it to be an 
‘easy’ procedure. The review also found that privacy and safety were the most 
common concerns adults had about SCS, with 30% of adults reporting concern 
about privacy and 17% about safety.  
 
While more specific to women, we can draw comparisons between our data and 
data on the acceptability of self-collected swabs for HPV testing in SSA. Also 
recently recommended by the WHO in the fight against STIs alongside SCS for 
NG, CT, TV and syphilis testing, self-sampling for HPV involves the collection of 
a sample that can be conducted in the absence of a clinician using a vaginal or 
cervico-vaginal swab. Similar to our findings, a study accessing the acceptability 
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of SCS for HPV testing among women in Cameroon found SCS to be 
acceptable, with women finding it easy to perform, less painful, less 
embarrassing, less anxiety-inducing and more comfortable than clinician-
collected samples.133 A feasibility and acceptability study in Malawi also found 
SCS to be easy to perform and easy to understand by study participants, with the 
majority of women expressing confidence that they did it correctly.134 While 75% 
of participants reported no concerns with the method, some percentage of 
women did worry about pain, inaccurate results or that they may not test 
correctly. We also found two studies located in Uganda: a quantitative study by 
Mitchell et al. focused on women in a low-resource community in Kampala, and 
found that more than 80% of participants were willing to collect their own HPV 
samples.135 However, we note that, in that study, SCS was delivered by a HCW 
to the participant’s home (and SCS was conducted there, too); therefore it 
possible that the high acceptability that the authors observed could have been 
due to either: the location of sample collection (i.e. at home), the mode of 
delivery (i.e. by a HCW), the collection method (i.e. SCS), or some combination 
of the three. Despite this, the study did identify some barriers to self-collection, 
including: embarrassment due to a lack of privacy (in the home/community), 
worry of collecting incorrectly and older age. Likewise, a mixed methods study by 
Bansil et al. conducted across three sites – India, Nicaragua and Uganda – found 
that 75% of all women felt SCS was easy, though initial concerns included 
hurting themselves (52%) and getting a bad sample (24%).136 Women also 
reported concern over the inability to see their own genital area and an 
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unwillingness to touch the genital region; similar to our study, participants also 
valued sanitation, privacy and cleanliness in the collection process. 
 
To our knowledge, this was the first study to explore the acceptability of self-
collected penile-meatal swabs among men in a low-resource setting. We were 
surprised that SCS acceptance among men in our population was not higher. We 
expected the majority of men to accept SCS because of privacy and their 
masculinity: we expected that men would rather self-collect in order to avoid 
undressing and exposing themselves in front of a clinician. This was observed 
among men in their acceptance of HIV self-testing (HIVST) in SSA.138 We also 
expected men to prefer SCS, as it would give men the flexibility to test during 
non-clinic hours, as was observed in men’s HIVST acceptance.137 This was the 
case for some, but not all men. We recommend researchers continue to explore 
SCS acceptability among men in diverse settings.  
 
Finally, we were initially surprised by our finding that both men and women 
preferred a HCW-collected sample over SCS, despite indicating that SCS was 
acceptable. The aforementioned review by Paudyal et al. found that SCS was 
preferred to HCW-collection.52 A study assessing the acceptability of self-
collected penile swabs among men in the U.S. also found that 77% of 
participants preferred a self-collection over attending a clinic.139 Data on HPV 
self-sampling preferences, however, present a mixed picture: one systematic 
review amongst women in mostly high-resource settings found that the majority 
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of participants preferred self-sampling over clinician-based sampling.140 Another 
review found that about half of the included studies showed that participants 
preferred SCS, while the other half showed that women preferred clinician-
collection because they lacked confidence in their ability to self-collect a sample 
correctly.141 The authors also reported that, in ten of the 23 included studies, 
women felt that clinician sampling was more reliable than SCS. Results from the 
aforementioned HPV studies based in SSA also show that our findings are, in 
fact, not unexpected: the study in Cameroon found women’s ‘uncertainties’ about 
the reliability of SCS to be a barrier to acceptance; despite high acceptance of 
HPV self-sampling, the majority of participants preferred physician sampling 
because they were unsure if they sampled correctly and/or felt that clinician-
sampling was more trustworthy.133 In the study by Bansil et al., too, the authors 
reported that the acceptance and uptake of SCS for HPV testing was highest in 
Uganda at 100% (versus 99.5% in rural Uttar Pradesh, 82.8% in Nicaragua and 
78.6% in Hyderabad), but this acceptance dropped when SCS was compared to 
clinician collection: only 64% of women in Uganda preferred SCS over clinician-
collection (versus 50% in Nicaragua, 93.1% in Uttar Pradesh and 95.5% in 
Hyderabad).136 The authors reported that while women in Hyderabad and 
Nicaragua were mainly concerned about hurting themselves when self-collecting, 
women in Uganda were most concerned about not getting a good sample.  
 
The disconnect that we observed – between participants’ acceptance of SCS but 
preference for HCW-collection – could be explained by the legacy of health 
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services provided in the Rakai region. Established in 1987, RHSP has been 
delivering health services to the community for decades; the majority of Rakai 
community members are either current or past RCCS participants and are 
familiar with RHSP and its services. With some of the highest rates of HIV in the 
country, the region is also no stranger to other public health interventions and 
services, including PEPFAR-funded activities. As such, it is possible that 
community members have come to perceive (RHSP) clinicians and HCWs as 
powerful authorities. Our data suggest this to be true: some participants felt that 
HCWs were ‘experts,’ and that their [the participants’] ‘lives were in their [the 
HCW’s] hands.’ This would have us believe that, while participants may have 
accepted SCS, they did not feel as confident in their abilities to collect a sample 
when they were being compared to a HCW, because the HCW was ‘better 
trained,’ ‘more knowledgeable’ and ‘better able to complete the task’ than them.  
 
Strengths and Limitations 
This study was novel in that it explored the acceptability of SCS among a general 
population of women and men in a low-resource setting, and provided 
participants the opportunity to self-collect. Because they were able to use the 
swabs themselves, we were able to gather detailed and practical feedback on the 
ease of use and their experience. Men experienced both SCS and a HCW-
collected sample, which allowed them to draw direct comparisons between the 
two. On the other hand, women only self-collected a sample and did not 
experience HCW-collection, but were still asked to compare the two. We feel that 
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women can fairly easily imagine what a HCW-collected would be like, particularly 
if they have experienced antenatal care before, and so we do not believe that the 
credibility of their responses was affected. However, it is possible that their 
opinions could change after they experienced HCW-collection, in other words, 
that their stated preferences may differ from their revealed preferences.142,143 
 
Another strength of our study included the qualitative nature of data collection. By 
using semi-structured interviews, we were able to gather rich descriptions and a 
breadth of responses, which would not have been possible in a quantitative 
survey. Nevertheless, it is possible that social desirability bias may have affected 
our results: because our interviewers were RHSP staff members, it is possible 
that participants responded more favorably to SCS than they would have 
otherwise; additionally, they may have reported a preference for HCW-collection 
out of respect for the RCCS HCWs, even though confidentiality of responses was 
assured and reviewed during the informed consent process. We doubt these 
possibilities strongly biased our results, given the fact that participants provided 
both advantages and disadvantages for both collection methods. 
 
Lastly, another strength of our study was the fact that we selected adult 
participants from within the community, and purposefully selected them based on 
both their gender and symptom status. This allowed us to assess if acceptability 
varied between users across these strata, which could help guide the 
development of future SCS/STI testing interventions. However, this qualitative 
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study focused only on men and women in the inland community and we did not 
specifically recruit any high risk groups, such as truck drivers, sex workers or 
fisherfolk. Given their mobility and sexual risk behaviors, such groups are key 
targets for a SCS/STI testing service. Understanding their acceptance of SCS is 
critical for future program development. Age135 and awareness144 have also been 
shown to affect SCS acceptability. Level of education and/or socioeconomic 
status may also influence participant preferences.144–146 We did not sample 
based on these criteria; we recommend future studies use mixed methods to 
explore how such contexts could influence SCS acceptability. 
5.6 Conclusion 
Our study found that SCS were acceptable, but concerns over taking a sample 
without a HCW, self-harm and poor hygiene made the majority of men and 
women in our population prefer HCW-collection. Nevertheless, users said they 
would still use SCS in the future. Taken together, these findings suggest that 
SCS is an acceptable, additional approach to current STI diagnostic methods. To 
promote SCS uptake and acceptability, we recommend decision-makers use 
these data to design health communication messages that allay user concerns – 
such as pictures showing how to sample safely and correctly – as well as 
messages that emphasize the perceived advantages – such as increased 
confidentiality and privacy. SSA needs a diversity of strategies to address the STI 
burden and prevent the spread of infection. SCS/STI testing is one tool in the 
toolbox; we encourage researchers to continue to provide data that explore the 
acceptability, viability and feasibility of SCS/STI testing in low-resource settings.    
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Chapter 6. STI Testing Using Self-Collected Samples: 
A Qualitative Investigation on Service Delivery 
Preferences Among Adults in Rakai, Uganda  
6.1 Abstract 
Background: Self-collected samples (SCS) for sexually transmitted infections 
(STI) testing (SCS/STI testing) is a promising approach to expand STI diagnosis 
in low-resource settings. For the user, SCS/STI testing involves multiple activities 
besides the self-collection of a sample, including requesting sampling materials, 
receiving those materials, returning the sample to the laboratory and receiving 
results and treatment, if necessary. With the potential to sample outside of the 
clinic, many questions exist around SCS/STI testing service delivery, including 
where and how these activities can be completed and what users most prefer. 
This study explores user acceptability of and preferences for various approaches 
for SCS/STI testing service delivery in Rakai, Uganda.  
Methods: This qualitative study sampled 36 adults both with and without STI-
related symptoms, who resided in an inland community and self-collected 
samples for STI testing as part of the Rakai Community Cohort Study. We 
conducted semi-structured interviews to assess the acceptability of and 
preferences for various approaches for service delivery for the different SCS/STI 
testing activities. Approaches of interest included: facility-based (e.g. at  a clinic 
or community location), home-based (the participant’s home), mobile phone 
communication, postal mail or the internet. We analyzed our data using an 
adapted version of the Framework Method, comparing themes between genders, 
activities and approaches. 
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Results: Among our sample of 36 men and women, almost all approaches for 
service delivery were acceptable, though some had greater support than others. 
Participants found it equally acceptable to complete SCS/STI testing activities 
on-site at a facility or at home, but for different reasons. There were concerns 
around mobile phone communication, and postal mail and online approaches 
were not very acceptable. Participants’ preferences were explained by a variety 
of themes – including privacy and confidentiality; HCW consultation and 
counseling (HCW interaction); certainty; access and resources; time; and 
personal responsibility and professional courtesy to the HCW. While we did not 
find one, most preferred approach, we found that men and women most 
preferred approaches that they perceived to be more confidential and private 
and/or allowed for HCW interaction (e.g. facility- and home-based approaches).  
Conclusions: To our knowledge, this is first study to comprehensively explore 
user acceptability of and preferences for the delivery of a SCS/STI testing service 
in a low-resource setting. Our data suggest that, in our population, individual 
choice is critical for SCS/STI testing service delivery, though common themes of 
confidentiality and HCW interaction exist. We recommend public health guidance 
allow for different approaches for SCS/STI testing service delivery in order to 
make the service acceptable to the larger population.   
6.2 Introduction 
Sexually transmitted infections (STIs) are a global issue of growing concern; 
more than one million STIs occur every day.147 STI infection has deleterious 
effects on both reproductive health and quality of life and can increase the risk of 
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HIV acquisition three-fold.13–15 Sub-Saharan Africa (SSA) – where over two-thirds 
of new HIV cases and AIDS-related deaths occur – accounts for approximately 
40% of the global STI burden16 and the largest per-capita rates of syphilis, 
Neisseria gonorrhoeae (NG), Trichomonas vaginalis (TV), and herpes simplex 
virus-2 (HSV-2) globally.17,18  
 
Accurate and timely diagnosis is critical for STI control. Similar to other low-
resource settings, countries in SSA currently use the syndromic approach to 
manage non-HIV STIs.7 While practical and cost-effective, the syndromic 
approach can result in inappropriate- and/or over-treatment of STIs and the 
development of antimicrobial resistance.128 Given these limitations, the World 
Health Organization (WHO) has recommended a global shift away from 
syndromic case management in favor of etiologic testing where feasible and 
cost-effective.9 Despite their successful implementation in high-income settings, 
STI testing programs are not commonplace in SSA because of a lack of cheap 
and accurate diagnostic tests;63 and a historic lack of well-equipped laboratory 
facilities. However, intensive scale-up of HIV care and treatment activities in the 
region over the past 15 years have resulted in strengthened supply chains, 
infrastructure and laboratory capacity. This scale-up in the context of HIV has 




One approach to etiologic STI testing involves the use of self-collected samples 
(SCS). SCS involves an individual to take a swab of fluid sample themselves, 
either within or outside a clinic, which is then sent to a lab for testing.44 SCS for 
STI testing (SCS/STI testing) is currently implemented in high-resource settings, 
where data show that the method is as accurate as clinician-based tests.45 
Research also shows that SCS/STI testing is acceptable in a variety of 
populations and they are feasible to implement.46–55 Given these benefits, the 
WHO recently recommended SCS/STI testing as an additional approach to 
deliver STI testing services.130 
 
Because an individual can take the sample themselves, SCS/STI testing can 
expand the availability and reach of etiologic testing services: since services are 
neither clinician-dependent nor tied to a clinic, they can be made available in a 
variety of other venues, including pharmacies, schools and even at the users’ 
home.60–62,148–150  However, because there is no precedent for SCS/STI testing 
services in SSA, questions exist around where and how services can be 
delivered and what approach for service delivery is most preferred by users.  
 
This study uses qualitative methods to explore user service delivery preferences 
for a SCS/STI testing service. We sought to answer the following research 
questions:  
1. How acceptable are various SCS/STI testing service delivery approaches? 




This study was based in the Rakai region of South-central Uganda. The majority 
of Rakai’s population resides in small agrarian villages; however, the district also 
contains several mid-sized trading towns along international highways and 
fishing communities along Lake Victoria. Data from a community randomized 
controlled trial of mass STI treatment for HIV control from 1994-1998 showed 
that the STI burden in Rakai communities was high: prevalence of active syphilis 
was ~10%, TV prevalence was 20%, and NG and C. trachomatis (CT) 
prevalence estimates were ~4% and ~2%, respectively.75  
 
The Rakai Community Cohort Study (RCCS) is an ongoing, open community-
based cohort of residents aged 15-49 years in agrarian communities, semi-urban 
trading centers and Lake Victoria fishing communities. RCCS includes the 
administration of a demographic and health questionnaire, as well as HIV testing 
for all consenting participants. Nested within the RCCS, a STI study entitled the 
STI Prevalence Study (STIPS) was conducted to estimate STI prevalence among 
1,825 sexually active HIV+ and HIV- men and women aged 18-49 years in two 
communities (one inland and one fishing), from May-October 2019. In addition to 
the standard RCCS questionnaire, STIPS included an STI module that assesses 
current/previous symptoms and treatment seeking behavior and evaluated 
participants for syphilis, NG, CT, TV, and HSV-2. To this end, three clinician-
collected penile urethral meatus swabs were obtained for all consenting men 
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(n=860), with a small sub-sample of men (n=40) asked to also self-collect a 
sample using a fourth swab; all consenting women (n=964) were asked to 
provide three self-collected vaginal swabs. 
 
Study Sample 
This qualitative study was conducted among 36 adults – 15 men and 21 women 
– from the STIPS inland community who self-collected a sample in the STIPS. 
Participants were selected based on their gender and variation in self-reported 
symptom status, with 24 participants (9/15 men, 15/21 women) reporting any 
STI-related symptoms in the last six months and 12 participants (6/15 men, 6/21 
women) reporting no STI-related symptoms. Once identified, participants were 
asked to participate in a semi-structured interview that explored their service 
delivery preferences. 
 
Defining a SCS/STI Testing Service 
Prior to data collection, to understand the delivery requirements for a SCS/STI 
testing service, we first reviewed the literature for data describing the structure 
and implementation of past and present SCS/STI testing services.139,151–155 From 
these data we found that there were more user-dependent activities involved in 
SCS/STI testing than just the act of self-collection. From our review, we identified 
five common user-dependent activities: (1) requesting SCS materials, (2) 
physically receiving those materials (and self-collecting a sample), (3) returning 
self-collected samples to the lab for testing, (4) receiving test results and (5) 
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receiving treatment. We concluded that, together, these five activities – hereafter 
referred to as ‘testing activities’ – represented the basics of a SCS/STI testing 
service. As such, in this study, we defined a SCS/STI testing ‘service’ as 
comprised of these five activities. We used this definition to design our interview 
guide and inform the structure our qualitative interviews, which are further 
described below.  
 
Because a SCS/STI testing service allows for sampling outside of a clinic, we 
also reviewed the data for various approaches for service delivery. To this end, 
we found that an array of different SCS/STI testing service delivery approaches 
can be considered, depending on the context, target population and resources of 
the testing program. We found that SCS/STI testing services were largely facility-
based (where the user completes activities on-site at a clinic, pharmacy or some 
other predesignated location) or home-based. In addition, various channels were 
used to facilitate the completion of some testing activities. These included: text 
messages or phone calls (mobile phone communication), postal mail or the 
internet (online). This information was also used to structure our interview guide.  
 
To illustrate how the testing activities and approaches for service delivery relate 
to one another, we can look at a SCS/STI testing service that is currently 
implemented in the US. ‘iwantthekit.org,’ is a SCS/STI testing service that is 
available to men and women 14 years and older in the Baltimore, Maryland and 
Washington D.C. areas in the US.139,151,152,156 As a part of this service, users can 
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request self-test kits online (Activity 1; approaches: home-based and internet). 
Users receive the kits via postal mail, and collect a sample at home (Activity 2; 
approaches: home-based and postal mail). Users then send their samples to the 
lab for testing via postal mail (Activity 3; approaches: home-based and postal 
mail) and results are returned to users online (Activity 4; approaches: home-
based and internet). Users are then required to receive their treatment by picking 
it up in-person at a clinic or pharmacy (Activity 5; approach: facility-based).  
 
Data Collection 
We used semi-structured qualitative interviews to assess user preferences for 
the various approaches for service delivery. As aforementioned, we defined a 
SCS/STI testing service as comprised of five testing activities, which can be 
completed in one of two locations and/or via various channels. We chose to 
collect data for each activity, rather than for the service as a whole, in order to 
capture any differences in preference that may exist between the activities.  
 
At the start of  each interview, interviewers first described the goal of a SCS/STI 
testing service to the participant. Then, the interviewer described the one of the 
five testing activities to the participant as well as each of the service delivery 
approaches. Then, the interviewer asked the participant what they felt were 
advantages and disadvantages of each of the approaches in relation to that 
activity. Finally, interviewers asked the participant to select their preferred 
approach for service delivery for that activity and explain why. This exercise was 
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repeated for all five of the testing activities. As an example, for the first activity 
(requesting sampling materials), interviewers asked participants to describe the 
advantages and disadvantages of: (a) requesting materials at a facility, (b) 
requesting materials from their home (via a home visit from a health worker or 
some other representative), (c) requesting materials via mobile phone (by text or 
phone call), (d) requesting materials via postal mail and (e) requesting materials 
via the internet. Then, participants were asked which of the aforementioned 
approaches they would ultimately prefer in order to request sampling materials, 
and why.  
 
All interviews were conducted and recorded in the local language – Luganda – by 
one of three behavioral scientists trained in qualitative research methods, and 
lasted approximately a half an hour. Interviewers were trained on the research 
objectives and participated in numerous roleplay exercises to make sure that 
they understood the purpose and structure of a SCS/STI testing service, 
including the five testing activities and approaches for service delivery. 
Interviewers were also trained to redirect participants back to the research 
questions in the event that they suspected that the participant did not understand 
what they were being asked. Throughout data collection, the study team 
engaged in-depth debriefs after each interview to discuss relevant and/or novel 




After all data were collected, interviewers transcribed and translated the 
interviews to English. Then, we imported the data into MAXQDA 2018 (VERBI 
Software, 2018)78 for review, initial coding and analysis. First, we noted each 
participant’s most preferred approach for service delivery for each of the testing 
activities. Second, we used an adapted version of the Framework Method79 to 
identify prominent themes around participant preferences. To this end, we used 
our interview guide to develop an analytic framework. Similar to the Framework 
Method, we indexed our transcripts using the framework and charted the data 
into an Excel spreadsheet. We then used open-ended, followed by focused 
coding,80 to identify prominent themes for each testing activity. Prominent themes 
were defined by the depth of discussion any one participant provided on the 
topic, prevalence across participants and ‘keyness’ in relation to study  research 
questions.81 We also assessed for prominent themes within each approach for 
service delivery. We then compared the data by gender and symptom-status in 
order to assess for any meaningful differences between the groups. We 
discussed our findings with the larger research team, comprised of interviewers 
and Principal Investigators, and present them here.  
6.4 Results 
The Acceptability of Various Approaches for Service Delivery 
Participants were most accepting of facility-based and home-based service 
delivery, to a similar degree. Mobile phone communication was sometimes 
acceptable and postal mail and the internet were least acceptable. We identified 
a number of themes that explained participants’ acceptance of the different 
 110 
approaches for service delivery, which are further elaborated below and of which 
included: privacy and confidentiality; HCW consultation and counseling (HCW 
interaction); certainty; access and resources; time; and personal responsibility 
and courtesy for the health worker (responsibility and courtesy) (Table 7).  
 
Table 7. Description of prominent themes 





Testing as a 
‘secret’ 
process and a 
personal issue 
• “It’s a private issue…[I] want to 
take [it] as a private issue such 
that people will not know.” 
(Justina, F, S+) 
 
• A2. Receiving SCS 
materials/collecting 
a sample 
• A4. Receiving test 
results 







• “If one knows the problem you 
have, they cannot keep a 
secret, they spread it.” (Juliet, 
F, S+) 
• “People are gossipers…You 
can do something, and find 
that everyone knows about it.” 






• “The clinics, we have basawo 
<doctors> who are our peers 
here; they may do some rumor 
mongering...It results into 
ashaming you.” (Sophia, F, S-) 
HIV-related 
stigma 
• “You see how you [the 
interviewer] have come here 
[to my community], people are 
thinking something totally 
different…As we are seated 
here, they think you are talking 
to me about HIV/AIDS...It 
hinders [us] because people 
stigmatize you about 
something you are not.” 




collect and use 
SCS materials 
• “There may be some things 
especially about how to use 
the kit you may want to inquire 
from the musawo <doctor>, so 
that you leave the place after 
understanding.” (Prossy, F, 
S+) 
• A2. Receiving SCS 
materials/collecting 
a sample 
• A5. Receiving 
treatment Language 
barriers and 
ability to read 
instructions 
• “I may not know how to read 
the direction on the kit…not 
everyone can read English and 
translate it so…where you 
can’t read, the health worker 
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reads for you…and [you will] 
know how to use it.”(Maria, F, 
S+) 
HCW as a 
health expert 
• “[HCWs have] more 
experience and better 
knowledge.” (Rose Mary, F, 
S+) 
• ‘[If services were facilitated by 
a HCW, then I] am sure you 




• “If you don’t see the musawo, 
you cannot heal. You have to 
see the musawo and explain 
what you are suffering from 
and he gets you the 
medication.” (Gerald, M, S+) 
• “It is always good to… see a 
musawo; you share views and 
decides for you what he/she 
feels is right for you…the 
musawo is the one who will 
give you medicine to cure your 
illness, so basically our life is in 





• “The health worker is the 
service provider, you can call 
him…and [he] gives it to you 
as this service is...It shows you 
have a connection with the 
health worker, he knows 
something about you, you call 
him, and he knows what is 
going on.” (Hassan, M, S+) 
• “[Seeing the doctor] can ease 
the communication between 
the patient and the doctor….it 
can build the ‘relationship’ – 
the relationship between me 
and the doctor. There is a 
strong relationship built 
because you are face-to-face. 
It gives one time to explain to 
the doctor and receive advise.” 
(Bosco, M, S+) 
HCW 
counseling 
• The truth is that there is a way 
[the HCW] will counsel me and 
I do not worry so much about 
the disease I have. I get 





• “[I] can make a mistake [taking 
a sample]…[whereas the 
HCW] might take it off as he 
wants.” (Hassan, M, S+) 
• A3. Returning 
samples to the lab 
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• “I may not be responsible 
enough to [return the sample], 
it may become difficult for me.” 
(Stella, F, S+) 
• “[I] may keep it for a long time 
and sometimes it gets lost…I 
may get [a sample] and I 
misplace it.” (Sophia, F, S-) 





• “[The HCW] cannot mix or 
disorganize the samples to end 
up elsewhere.” (Annet, F, S+) 
• “I would prefer the musawo 
delivering [my results] at home 
or personally picking 
them...Because my results will 
be safe no one will have to 
know...It’s something taken 
under tight security.” (Joyce, F, 
S+)  
• “[The HCW will be] sure that 
this box I have got it from this 
lady, if it has a number or 
names it can be packed and 
he gets where to place it that is 
safe and he puts the other 
persons box safely also and for 
another one like that...He won’t 
mix them up.” (Maria, F, S+) 
• “[If the HCW handles the 
sample,] I am sure that it has 
been delivered to the right 





• “The issue is transport...okay it 
is money, sometimes it may be 
difficult because you don’t 
have money to transport you.” 
(Prossy, F, S+) 
• A1. Requesting SCS 
materials 
• A2. Receiving SCS 
materials/collecting a 
sample 




• “I can’t move for long 
distances. So you may tell me 
that where I am supposed to 
pick them there is a distance 
which I will not be able to 
manage.” (Jane, F, S-) 
Service hours 
• “Here in the community it may 
be easy because here you can 
go there whenever you want 
even if it is in the night you can 
go and get it; which isn’t the 
same with a hospital because 
for them they have hours they 
open and hours on which they 
close.” (Ponsiano, M, S+) 
Partner 
dynamics 
• “Here are some men who don’t 
allow their wives to leave 




and ease of 
use 
• “The phone is easy to 




• “[A phone call] is faster, I can 
get the things very fast and 
then leave fast.” (Ronald, M, 
S+) 
• “[A phone call] is convenient...it 
gives you quick information.” 
(Sophia, F, S+). 
• A1. Requesting SCS 
materials 
• A3. Returning 
samples to the lab 
• A4. Receiving test 
results 
HCW delays 
• “Sometimes the prespecified 
location may have a health 
worker who might be busy on 
that day that you may want 
treatment that way he may not 
be able to come to you.” 
(Patrick, M, S-) 
• “You might go to see a health 
worker when he has his own 
programs…sometimes it could 
be that he doesn’t have the 
time so he will opt to give you 
another appointment.” 
(Godfrey, M, S+) 
Bureaucracy  
• “[Using my phone,] I am able 
to call [the HCW] to bring those 
materials faster; basically in 
time. If I go there myself, they 
may make me go through 
processes and steps, yet there 




Health as a 
personal 
responsibility 
• “As a person who wants to 
self-test it’s my responsibility 
to go there rather than sending 
someone to bring for me.” 
(Rose Mary, F, S+) 
• “It is not good to 
inconvenience someone every 
time you look  for medicine.” 
(Immaculate, F, S+) 
• A2. Receiving SCS 
materials/collecting 
a sample 
• A4. Receiving test 
results 




for the HCW 
• “I would prefer picking [the 
sampling materials] myself 
because sometimes you also 
give musawo a hard time...by 
making him/her personally 
coming to your home all the 
time.” (Prossy, F, S+) 
• “Personally I would go and 
receive the results…[if the 
HCW comes to my home] that 
means she will pick the 
samples and also come back 
to deliver the results; it will be 
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tiresome for her that’s why I 
will go and receive it myself.” 
(Milly, F, S+) 
HCW= Healthcare worker; SCS= self-collected sample; musawo= doctor; basawo= doctors 
*Participants are identified by a pseudonym, their gender (M: male; F: female) and symptom 
status (S+: self-reported symptoms; S-: no self-reported symptoms)  
† This theme was more commonly discussed by women. 
‡ This theme was exclusively described by women. 
 
Below, we summarize the acceptability of each of the approaches for service 
delivery in relation to the aforementioned themes; participants are identified by a 
pseudonym, their gender (M: male; F: female) and symptom status (S+: self-
reported symptoms; S-: no self-reported symptoms).  
 
Facility-based Service Delivery 
Going to a facility to complete testing activities was acceptable to participants. A 
variety of factors influenced the acceptability of facility-based service delivery. 
Some participants felt that completing testing activities on-site, at a facility would 
maintain confidentiality. As one man explained:  
 
When you pick [the testing materials] yourself, there is confidentiality, no 
one knows what you’re up to. (Patrick, M, S-)  
 
Completing activities at a facility could also circumvent community gossip, as this 
woman explained:  
 
You see, our fellow community members/neighbors – when they notice 
that there is a health worker coming so often at your home they will start 
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asking what problem you may be having. For example, they will start 
gossiping how the other time the health worker came and took you; but if I 
go myself, I don’t have to explain to anyone... (Esther, F, S+) 
 
Some participants also felt that it was important to see the HCW, in person. As 
one woman described it: 
 
Talking to a person face-to-face is different from sending a message or 
phone call. (Angela, F, S+)  
 
Going to a facility was also the only way participants felt that they could be 
certain that testing activities were completed correctly; this was especially true 
when it came to returning their samples for testing:  
 
I would…prefer personally taking them...Because it’s the only way I could 
know that the samples are safe. (Joyce, F, S+)  
 
A few participants felt that facility-based treatment prevented others from 
consuming their medicine:  
 
I can’t send someone to pick for me the medicine. The health worker may 
have prepared for me a full dose but because the person I sent may be 
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having the same infection as mine she might decide to take some. (Joyce, 
F, S+) 
 
Facility-based service delivery was also perceived to be more time-efficient by 
some, as it eliminated the middleman (i.e. the HCW or other program 
representative). As one woman explained: 
 
I see as if we are wasting time…Imagine delivering the kit, taking it back 
for screening, and then [the HCW] calls to find out how I would prefer 
receiving treatment – according to me the difference is zero, that’s why I 
will personally go there. (Anna Maria, F, S+); 
 
Also, some participants felt that going on-site to complete testing activities would 
mean that they would finish faster. Finally, some found facility-based service 
delivery acceptable out of personal responsibility, and as courtesy to the HCW. 
As one woman stated:  
 
It will be quite tiresome for the health worker [to deliver the service]; 
imagine coming home every now and then…If she doesn’t get tired, she 
can bring it, but I can also go and pick the treatment myself. (Phionah, F, 
S-) 
 
Home-based Service Delivery 
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Home-based service delivery was also acceptable to participants. Some 
participants found home-based service delivery acceptable because they feared 
gossip if they visited publicly known STI testing sites. As one woman told us:  
 
I would prefer having [the materials/results/treatment] delivered at home 
by the health worker...those are private issues... [it is important to make] 
sure that no one gets to know about it...[Others] may go on spreading 
rumors telling whoever they come across that so and so has infections 
and when you hear about [it], you feel bad. (Justina, F, S+) 
 
Some participants who found it acceptable to complete testing activities at home 
appreciated the ability to consult with the HCW. If the HCW met them at home, 
participants felt that the HCW would give them “enough time to explain…about 
how [the SCS materials] are used.” (Harriet, F, S-) This included repeating 
instructions if participants did not understand them, as one woman described:  
 
If it is the health worker that has come [to your home]…he can explain [the 
process] to you or if you have not understood, can even repeat three times 
or five times and he remains not tired…if the health worker has come in 




Also, some participants felt that home-based service delivery could “ease 
communication between the patient and the doctor” and build a “relationship” 
between them (Bosco, M, S+); home-based service delivery showed that the 
HCW cared for their patients, in a unique way:  
 
[Home-based service] shows you have a connection with the health 
worker, he knows something about you, you call him, and he knows what 
is going on and he brings it…it shows [that] your health worker cares 
about you…he is responsible to you and cares about you. (Hassan, M, 
S+)  
 
Delivering a SCS/STI testing service at home also provided an opportunity for 
counseling that was unique to other approaches. As this man explained:  
 
When [a HCW] comes home, he asks you how you feel, what your status 
is...even if he has not brought me medication, just checking on me is good 
enough to give me hope and courage. (Denis, M, S+) 
 
Completing testing activities at home gave some participants certainty that they 
were completed correctly and sent to the right place. This was a particular 
concern when it came to returning samples to the lab: some participants felt that 
at-home pick-up of samples by the HCW would avoid the risk that someone 
(either the participant themselves or a courier) would misplace or damage the 
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samples. Others felt that at-home pick-up of samples by a HCW would help 
prevent inevitable delays that were the result of the participant being confused 
about where samples should be taken. In addition, some participants felt that 
home-based completion of activities was more accessible and resource-friendly, 
as they did not require any additional travel time or cost on behalf of the 
participant. Home-based service delivery was perceived as easier for women 
whose husbands would not let them leave the house. As one woman explained:  
 
When I tell him [my husband] that the musawo will always deliver my 
treatment [at home], he will not be suspicious because he is aware that 
you deliver it here. (Fausta, F, S-) 
 
Lastly, some participants found home-based service delivery to be acceptable 
felt that it was time-efficient; as one participant explained: with the HCW 
delivering the service at home, “you are sure that the health worker takes it to the 
right place and will also deliver it in time.” (Ponsiano, M, S+) 
 
Service Delivery via Mobile Phone Communication 
To complete testing activities, mobile phone communication was sometimes 
acceptable to participants. With respect to confidentiality/privacy and mobile 
phone communication, participants were of mixed opinion. Some found it 
acceptable to complete some of the testing activities via a phone call because it 
made them feel ‘free to talk,’ as this man explained:  
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When I come physically to your center, I might find there other people and 
I get shy....but if you are [on] a call, you don’t physically see me so I am 
free to talk. (Denis, M, S+)  
 
Others, however, did not agree with phone calls because they felt that it did not 
protect their secrets. To this end, participants were concerned about receiving a 
call in the ‘wrong place’:  
 
The phone, the way voices move, where the person you’re calling is, the 
place he/she is in, maybe a wrong place yet the matters are private or 
where one is calling from may be wrong. (Bernard, M, S-)  
 
Partner dynamics also played a role; one woman explained that she would rather 
receive her testing information first, in private, and disclose to her partner later. 
Phone calls, she said, could make this difficult:  
 
Sometimes it’s better to know first and then disclose to your partner 
later…[if notified by phone] the health worker may call you when you don’t 
have a safe place to speak from. (Teopista, F, S+)  
 
A few participants were concerned about having messages read or received by 
the “wrong person” (Patrick, M, S-).  
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Access and resources also affected the acceptability of mobile phone 
communication. Some participants felt that mobile phone communication was 
easier in the event that they did not have transportation to access the SCS/STI 
testing service, on-site. Mobile phone communication was also cheaper than 
other approaches for service delivery, since it meant that participants did not 
have to pay for transport:  
 
When I just place a telephone call, I will just use 700 shillings; however, if I 
travel to your office, I will need 10,000 shillings. (Denis, M, S+)  
 
Some participants found it acceptable to complete some testing activities via 
mobile phone communication rather than at home because, that way, they could 
complete them when they are not home. As one woman phrased it:  
 
If you just came without calling me, you wouldn’t find me around, see how 
you waste your fuel? (Maria, F, S+)  
 
In addition, mobile phone communication was perceived to be more accessible 
than postal mail or online approaches in terms of technological literacy: because 
participants interacted with phones more often, they were more open to using 
phones over postal mail or the internet. As one woman told us: phones were 
“eas[ier] to understand” (Sophia, F, S-). Lastly, participants who found mobile 
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phone communication acceptable felt that it was more time-efficient. They stated 
that mobile phone communication was more direct and resulted in faster service 
delivery, as this participant explained:  
 
I can make a phone call at that moment directly to the responsible 
receiver; then it becomes much easier for me to receive [what I need]…It 
is faster, I can get the things very fast and then leave. (Ronald, M, S+)  
 
Service Delivery via Postal Mail 
The delivery of services via postal mail was not very acceptable. Most 
participants questioned the confidentiality and privacy of postal mail. If the courier 
did not know what was being delivered, then participants felt more comfortable 
with the approach. If that was the case, then a few appreciated the fact that 
packages could be delivered surreptitiously. As one woman explained it:  
 
[Postal mail is okay] because [the courier] delivers and hand it to you 
without the people getting to know. Ekili muttu kimanyibwa nyinikyo 
<whatever is in the package is only known by the owner>. (Sophia, F, S-)  
 
Nevertheless, most all participants felt that the other approaches were more 
confidential and private than postal mail. Postal mail also omitted interaction with 
the HCW; this omission was not favored by participants. Participants also did not 
trust the postal mail system. They felt that it was disorganized and were not 
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certain that testing activities would be completed safely, correctly or in time. As 
one man explained to us:  
 
Mailing is not very trusted, they over-delay things most of the time, the 
quality of mailing is not good, taking it yourself is better. (Hassan, M, S+)  
 
Lastly, most participants perceived postal mail to be inaccessible, because the 
approach did not reach everyone and many people do not understand how to 
use it. 
 
Service Delivery via the Internet 
The internet was also not acceptable in our population. The internet was 
perceived to be neither confidential nor private. As one woman stated:  
 
I would prefer to go where [the diseases] were screened from or the health 
worker to bring them at home…[this is] very good compared to the online, 
for [the testing process] is secret... (Deborah, F, S-)  
 
Some participants did not readily accept using the internet because it lacked 
HCW interaction. Some perceived the internet as inaccessible: only a few 
community members could afford smartphones to access the internet. The 
internet was neither well understood nor perceived as user-friendly among many 
participants, making it even more inaccessible.  
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Participant Preferences for Service Delivery 
Table 8 summarizes participant’s ultimate service delivery preferences. First, we 
did not find one approach that was most preferred; rather, we found that users’ 
preferences changed in response to the activity that was being discussed. 
Despite this, we found that facility- and home-based approaches were most 
preferred, suggesting that a desire for confidentiality/privacy, as well as HCW 
interaction, most strongly influenced preference: the approaches that participants 
perceived to be either confidential/private and/or allowed for increased interaction 
with the HCW (e.g. home- and facility-based approaches) were preferred over 
those that did not allow for such circumstances (e.g. mobile phone 
communication, postal mail, internet). Finally, we found that women most often 
preferred a home-based approach, while men preferred home- or facility-based 
approaches equally as often. We found no meaningful differences when we 
compared the preferences of participants with and without STI-related symptoms 
(data not shown).  
 
Table 8. Service delivery preferences among participants (n=36) 
by testing activity, with the most popular preference 
highlighted 
 
























A1 5 16 21 2 1 3 7 4 11 0 0 0 0 0 0 1 0 1 
A2 7 7 14 3 14 17 4 0 4 0 0 0 0 0 0 1 0 1 
A3 5 6 11 8 15 23 2 0 2 0 0 0 0 0 0 0 0 0 
A4 2 5 7 10 13 23 3 3 6 0 0 0 0 0 0 0 0 0 
 125 
A5 8 9 17 4 12 16 2 0 2 0 0 0 0 0 0 1 0 1 
M= Men, W=Women, B=Both men and women 
*Facility-based: on-site request/pick-up/drop-off of SCS materials by the user at a 
predesignated facility such as clinic, hospital, pharmacy, medical camp, school or some other 
location; Home-based: request/pick-up/delivery of SCS materials to the user’s home via a 
HCW or some other representative; Mobile phone: phone call or text message communication 
to facilitate the request/pick-up/drop-off of SCS materials; Postal mail: using the postal mail 
system to facilitate the request/pick-up/drop-off of SCS materials; Internet: using the internet to 
facilitate the request/pick-up/drop-off of SCS materials; No Preference/Preference unclear: 
user indicated either no preference or the user’s preference was not clear 
**A1: Requesting SCS materials; A2: Receiving SCS materials/collecting a sample; A3: 




With the exception of postal mail and the internet, we found that all approaches 
for SCS/STI service delivery were acceptable to different degrees, for different 
reasons: facility- and home-based service delivery were the most acceptable, 
while postal mail and the internet were the least acceptable. Though we did not 
find one, most preferred approach for service delivery, we found that both men 
and women’s desire for confidentiality/privacy during the testing process, as well 
as the ability to interact with a provider, most strongly affected their preference. 
The prominence of these two themes helps to explain our overall finding that 
home- and facility-based approaches (which more readily allow for confidentiality 
and HCW interaction, in different ways) were more acceptable and preferable 
over mobile phone communication, postal mail and the internet.  
 
To our knowledge, this is the first study to comprehensively explore user 
acceptability of and preferences for the delivery of a SCS/STI testing service in a 
low-resource setting. In a systematic review of patient experiences with SCS in 
middle- and high-income settings, Paudyal et al. found that across studies, 65% 
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of participants preferred to self-sample at home, versus 44% in the clinic.52 One 
of the included studies assessed the validity, feasibility and acceptability of SCS 
versus HCW-collection in a low-resource setting in South Africa. The authors 
found that, among women who self-collected, most thought that women should 
be able to self-collect at home and then take the sample to the clinic.157 The most 
frequently mentioned reasons for choosing SCS at home were that it can be 
done “in full privacy in one’s own time” and circumvents clinic waiting times. 
Another study in the United Kingdom asked sex workers to provide tampon 
samples for STI testing.158 The authors found that women preferred being tested 
away from clinics because of ‘embarrassment,’ ‘convenience,’ ‘clinic wait times,’ 
and other logistical reasons. These themes are similar to those found in our data.  
 
We can also draw upon lessons learned from other self-testing methods in SSA, 
such as HIV self-testing (HIVST). While users can conduct HIVST independently 
(i.e. they do not have to send samples to a lab for testing) and collect the sample 
differently (i.e. they collect an oral or fluid sample rather than a genital swab), the 
delivery of an HIVST service still requires a distribution model to provide test kits 
to users. An HIVST service also needs to link users to care and treatment, if 
necessary. In this way, some service delivery considerations (like where, when 




In Malawi and Zambia, a series of discrete choice experiments were conducted 
to inform HIVST service delivery.159,160 When asked about their distribution 
preferences, adults preferred to receive HIVST at home or at a distributor’s 
home, rather than at mobile clinics (and drugstores in Zambia only). HIVST price 
also had a strong negative influence on acceptance. The study also found that 
for linkage to care, participants preferred a phone call over text message, a 
personal visit or no follow-up. These findings are similar to ours, in the sense that 
preferences changed response to the task to be completed (i.e. preference for 
home- or facility-based approaches to receive test kits and mobile phone 
communication or home-based approaches to be linked to care) as well as the 
desire for in-person communication. In both studies, too, access to financial 
resources affected user service delivery preferences. Another discrete choice 
experiment conducted in rural Zimbabwe aimed to asses user preferences of 
HIVST distribution models in order to optimize HIVST uptake.161 The authors 
found that the strongest preferences were for (1) free kits, (2) (at home) door-to-
door delivery of kits versus collection from a public/outreach clinic, (3) a 
telephone helpline for pretest support relative to in-person or no support, and (4) 
distributors from their own/local village versus those from external areas. The 
study also found that the strongest preferences for linkage to confirmatory testing 
– an activity analogous to receiving results and treatment in a SCS/STI testing 
service – were for immediate treatment, free services and proximity to the 
clinic.160 Once again, we see that users preferred a mix of service delivery 
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approaches. We also see similar themes to our data, including the importance of 
direct and indirect costs (i.e., resources), time, stigma and the need for privacy. 
 
Finally, in a review exploring the evidence for scale-up of HIVST in SSA, 
Indravudh et al. reported varied service delivery preferences by population group: 
a general population in Kenya valued enhanced accessibility and preferred a fee-
based, pharmacy model for service delivery; individuals in Uganda and South 
Africa valued professionalized care and preferred to obtain HIVST kits from 
health facilities; young people in Malawi and Zambia valued confidentiality and 
cost and preferred at-home service; men in Uganda valued convenience and 
flexible hours of operation considering their work demands, and preferred picking 
up HIVST kits on-site at lodges and bars.162 These data further corroborate our 
finding that individuals are different: they have different preferences and different 
considerations that are important to them, though common themes may exist. 
 
This study had several strengths. By using qualitative, semi-structured 
interviews, we gave the participants time and space to provide rich descriptions 
on the advantages and disadvantages of each approach, as well as detailed 
rationales for their preferences. Despite this strength, using a qualitative 
approach also had limitations. In our study, we did not systematically compare 
the approaches against one another, and so we are not able to provide a 
measurement of their relative importance in the way that a quantitative survey 
could. We also did not evaluate the acceptability of service delivery approach 
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combinations. We recommend future researchers use quantitative methods, such 
as discrete choice experiments, to further explore user preference.  
 
We also acknowledge that a SCS/STI testing service has never been 
implemented in our population. While participants did self-collect a sample in our 
study, they did not complete any of the other SCS/STI testing activities. As such, 
it is possible that the preferences participants’ reported to us may change after 
they actually use a SCS/STI testing service; in other words, that revealed 
preferences may differ from stated preferences.142,143  
 
Lastly, while the selection criteria for our participants was a strength, it was 
limited. Given the social and economic differences between men and women in 
SSA, we suspected a priori that men and women may have different service 
delivery preferences; as such, we specifically sampled both males and females 
from the general population in order to capture any differences in preferences or 
themes between the two. We also included participants with and without STI 
symptoms in the event that a future testing service may want to prioritize one 
group over the other. While we gathered a rich body of data from participants 
selected on these criteria, our study results do not necessarily represent the 
interests of other specific groups. For instance, we did not sample based on 
socioeconomic status. It is possible that, due to a lack of resources, persons of 
lower income may have service delivery preferences that are unique to other 
income groups. It is also possible that persons with more high-risk or transitory 
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occupations (e.g. sex workers, truck drivers, fisherfolk), or those who are HIV-
positive, may have different service delivery preferences than the general 
population. We recommend future studies explore the perspectives of users from 
a variety of social and economic backgrounds. 
6.6 Conclusion  
SCS/STI testing is a promising additional method for STI diagnosis in low-
resource settings and many possible approaches to service delivery exist. In our 
study, we found that there is no one-size-fits-all approach for SCS/STI testing 
service delivery. Much like any other service, individual choice for service 
delivery is critical, yet common themes – such as confidentiality and HCW 
interaction – are present. We recommend public health guidance provide for 
different approaches for SCS/STI testing service delivery, in order to make the 
service acceptable to the larger population.  
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Chapter 7. Conclusions  
7.1 Summary of findings 
7.1.1 Treatment seeking (Aim 1) 
Aim 1 focused on treatment seeking behavior and SCS as a means to improve 
STI diagnosis in Uganda and other low-resource settings. Results from Aim 1 
described current treatment seeking behavior among adults with STI-related 
symptoms and identified factors associated with seeking clinic treatment. Fifty-
three percent (962/1825) of participants in the STIPS study reported that they 
experienced STI-related symptoms in the past six months. Of these, 57% 
(545/962) reported seeking any treatment for their symptoms. Among men and 
women, the likelihood of seeking any treatment was similar between genders and 
did not differ by community type. The majority of participants who sought 
treatment reported seeking treatment at only one location; private clinics were 
the most common location visited among both men and women. Women were 
less likely to seek treatment at a private clinic (versus a government clinic) than 
men (PRR: 0.75, p=0.00, 95% CI: 0.66-0.85). For both men and women, those in 
fishing communities were more likely to seek treatment at a private clinic (versus 
a government clinic) than those in inland communities (men: PRR: 1.25, 95% CI: 
1.03-1.52; women: PRR: 1.68, 95% CI: 1.37-2.06). Forty-eight percent (457/962) 
of participants who reported STI-related symptoms in the past six months 
reported seeking treatment at a government or private clinic for their symptoms. 
For men and women, we found no difference in the prevalence of clinic treatment 
by gender (47% males; 48% females; PRR: 1.02, 95% CI: 0.88-1.18) or by 
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community type (48% inland communities; 47% fishing communities; PRR: 0.98, 
95%CI: 0.78-0.86). Though only marginally significant, we found that men in 
fishing communities were less likely to seek clinic treatment than men in inland 
communities (PRR: 0.78, 95% CI: 0.61-1.00). Factors independently associated 
with clinic treatment seeking for men included being from the inland community 
and having multiple STI-related symptoms. For women, the only significant factor 
was having multiple STI-related symptoms. We also found that, approximately 
one-third of men and women who previously reported seeking clinic treatment for 
their symptoms were diagnosed with at least one curable STI (CT, NG, TV or 
active syphilis) at the time of the STIPS survey. When we analyzed the 
association between previous clinic treatment and current prevalence for any 
curable STI, we found no significant association, for either gender. 
 
Our estimates differed from those gathered in the DHS as well as those from the 
first rounds of the RCCS in the mid-1990s. This can be partially explained by the 
types of communities that we selected for our study: as aforementioned, STIPS 
communities were selected to represent the diversity of communities in the area. 
However, our included communities are rural and so our estimates of treatment 
seeking cannot be compared to DHS estimates, which are aggerated for both 
urban and rural communities. We also cannot directly compare our findings to 
those from the first rounds of the RCCS due to the differences in study 
communities and time. Regardless, our findings suggest that approximately half 
of adults with STI-related symptoms in our study communities are not seeking 
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appropriate treatment. These persons may be spreading infection in the 
population and are a public health priority. We recommend researchers 
investigate barriers to treatment seeking and urge decision-makers to focus 
efforts on increasing appropriate care seeking in this, and similar, settings.  
 
To our surprise, we did not observe a difference in clinic treatment seeking 
between men and women. Research in low-resource settings has described a 
gender difference in STI treatment seeking, with women less likely to seek any 
and/or prompt treatment as compared to men; 38,39,84–86 factors associated with 
this included prevailing gender norms, lack of time or money, lack of access to 
facilities, as well as the misattribution of symptoms or symptoms being perceived 
as normal or mild by women. Besides cultural differences, we have no reason to 
believe that such factors would not also apply to our study population to some 
degree. We recommend researchers continue to assess for a gender difference 
in treatment seeking and generate data in similar contexts to which we can 
compare our findings. 
 
We were also surprised not to find any difference in treatment seeking between 
the two communities overall, though we did observe a difference in clinic 
treatment seeking among men of different communities. Fishing communities are 
epidemiologically different than inland communities in a variety of ways;21,69,102,103 
compared to inland communities, fishing communities exhibit distinguished 
social, behavioral, demographic and structural characteristics – including high 
 134 
levels of HIV, mobility, risky sexual behavior (e.g. transactional sex, multiple 
partnerships), alcohol use and a high population of men.69,163–165 Despite the 
efforts of numerous PEPFAR-funded HIV prevention activities, uptake of HIV 
services in fishing communities has historically been low (though this has been 
increasing in recent years with significant new service provision),103 suggesting 
that there may be socio-ecologic factors beyond the availability of services that 
affect the uptake of care and treatment services. While we cannot say for sure, 
we can speculate that some of the socio-ecologic factors that prevent HIV 
service uptake in Rakai – transport costs, stigma, no available time to seek care, 
poor quality services105,106,166 – could also affect clinic treatment seeking for STIs. 
Furthermore, studies have shown that fisherfolk engage in lifestyles of high risk-
taking and hyper-masculinity;165 we thus might expect fisherfolk (especially 
fishermen) to be less likely to admit that they are sick and vulnerable (even if 
they experienced symptoms), and also less likely to seek care for their symptoms 
than non-fisherfolk. Given this data, we expected that the prevalence of clinic 
treatment seeking among men in the fishing community would be lower than that 
among men in the inland community, and so, we were not surprised by our 
results. What did surprise us, however, was that community type did not affect 
clinic treatment seeking among women. We recommend researchers further 
explore the intersection of gender and community type, as well as try to better 
understand the barriers to treatment seeking among men in fishing communities. 
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We also observed that a significant majority of participants sought treatment at 
private clinics as opposed to government clinics, particularly in the fishing 
community. Given the rise in the number of private clinics in the country since the 
1980s, this observation was not surprising.  
 
We were also not surprised by the factors that we found to be independently 
associated with clinic treatment for men and women. We did, however, wonder 
why other factors that have been associated with clinic treatment seeking – such 
as higher education, increasing age (among women), and being HIV-positive – 
showed no significant association in our population. Data limitations, as well as 
culture, the availability and affordability of services and/or stigma may explain 
why these factors showed no association in our study. We recommend 
researchers continue to explore and characterize factors associated with clinic 
care seeking in low-resource settings. 
 
Finally, we expected that previous clinic treatment seeking would be associated 
with significantly lower rates of current STI infection, for curable STIs. However, 
our analysis showed no difference in the current prevalence of any curable STI 
when we compared those who previously sought clinic treatment versus those 
who did not, for either gender. Assuming that seeking treatment meant receiving 
and completing appropriate treatment, these data could indicate that reinfection 
rates were high, treatment was inadequate, or both. We recommend that future 
studies explore the temporal association between previous STI treatment 
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seeking and current STI prevalence in order to assess for treatment 
effectiveness. 
 
7.1.2 Acceptability of SCS (Aim 2)  
Aim 2 explored the acceptability of SCS for STI testing. We interviewed 36 
STIPS participants from the inland community, both with and without STI 
symptoms, about their experience self-collecting a sample. We supplemented 
user data with KI interviews for added context. We found that adults valued their 
health and the condition of their lives and they participated in STIPS STI testing 
because they wanted to ascertain their disease status and ‘know how they stand’ 
for the betterment of their health. Overall, we found that participants did not have 
a problem with SCS and they did not perceive the process to be physically 
uncomfortable. Perceived advantages of SCS included increased privacy and 
confidentiality and gentleness, as well as the idea that SCS were best if 
resources were limited. Perceived disadvantages included the lack of HCW 
involvement, fear of self-harm and the idea that SCS was unhygienic. We found 
that most participants preferred HCW-collected samples to SCS (18/36 [50%] for 
HCW versus 13/36 [36%] for SCS; 5/36 [15%] with no preference). Regardless of 
their preference, however, we found that participants would still recommend self-
collection to others and would do it again in the future.  
 
Because SCS for STI testing is not commonly implemented in low-resource 
settings, comparative data on its acceptability in a general population in such 
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settings is limited. Studies from high-resource settings indicate that SCS are 
highly acceptable.46–55 In low-resource settings, trials on the acceptability of HPV 
self-sampling among women or HIVST among both men and women indicate 
similar advantages to those that we observed. Our study findings differ from the 
findings of studies conducted in high-resource settings, which indicate that 
participants prefer SCS to HCW-collection. However, when we compare our 
findings to similar self-care movements in low-resource settings (e.g. HPV self-
sampling, HIVST in SSA), we see similar trends: adults prefer HCW-collection 
out of concern that they may take a bad sample or will do it incorrectly if they do 
it themselves. Our finding indicating that participants would recommend the 
method to others and do it again was reassuring, and has been observed in other 
study settings, too. 
7.1.3 Service delivery (Aim 3) 
Findings from Aim 3 of this dissertation identified user SCS/STI testing service 
delivery preferences. We conducted interviews with 36 adults from the inland 
community who self-collected a sample for STI testing in the STIPS, and found 
that the acceptability of various approaches for service delivery varied. To 
complete testing activities, facility- and home-based approaches were most 
acceptable, mobile phone communication was sometimes acceptable, and postal 
mail and the internet were not acceptable.  While we found that a number of 
factors informed participants’ acceptance of the various approaches – including 
privacy and confidentiality; HCW consultation and counseling (HCW interaction); 
certainty; access and resources; time; and personal responsibility and 
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professional courtesy to the HCW – we observed that confidentiality/privacy and 
HCW interaction most strongly influenced participant choice. Though we did not 
find one, most preferred approach for service delivery, we found that both men 
and women most often preferred home- and facility-based approaches, which 
they perceived to be more confidential/private and interpersonal than other 
approaches (e.g. mobile phone communication, postal mail, the internet).  
 
To our knowledge, this was the first study to comprehensively explore service 
delivery preferences for a SCS/STI testing program in a low-resource setting. 
Our findings are similar to those of studies conducted in high-resource settings, 
which found that users prefer home-based services for reasons of increased 
privacy and convenience. We can also compare our results to those from studies 
focused on HIVST service delivery, which found that service delivery preferences 
differed for different activities, as well as differed for different populations. Similar 
to our results, findings from HIVST studies highlight the importance of direct and 
indirect costs, time, and stigma, as well as the desire for privacy and provider 
interaction.   
 
7.2 Strengths and limitations 
An overall strength of this dissertation was its novel focus on treatment seeking 
behavior and SCS as means to improve and expand STI diagnosis in a low-
resource setting. Moreover, to our knowledge, this was the first population-level 
assessment of STI treatment seeking behavior in Uganda, beyond the DHS, 
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conducted since the 1990s. This was also the first study to assess the 
acceptability of SCS using penile-meatal swabs among men in a low-resource 
setting, as well as the first study to comprehensively explore user service delivery 
preferences for a SCS/STI testing service in a low-resource setting. 
 
With regard to treatment seeking (Aim 1), calls have been made to broaden the 
research perspective in order to understand sexual healthcare seeking 
behavior.43 Our study answered these calls through its population-based 
sampling approach: by sampling all eligible individuals within each community, 
we included both those who previously sought care at a clinic as well as those 
who did not. This allowed us to estimate clinic attendance as well as non-
attendance, which is not common in other studies. Despite this, our findings may 
still be subject to measurement bias: inclusion criteria for our study relied on 
participant self-report of their symptoms and we classified participants based on 
their self-reported treatment seeking behavior. These self-reported data may 
have been affected by recall or social desirability bias. We also did not include 
psychologic or structural factors, such as the perception of symptoms, perception 
of health services, availability of health services, service quality or socioeconomic 
status, in our analysis; the inclusion of such variables could help explain our 
findings further. Finally, while we were sufficiently powered to address our main 
research questions, we may have been underpowered to assess for any 
differences in treatment seeking by both gender and community type. 
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With respect to SCS (Aims 2 and 3), studies that assess SCS acceptability in 
low-resource settings, especially among men, are rare. Our study was unique in 
that we included both men and women in our sample. By providing participants 
the opportunity to self-collect a sample, we were able to gather detailed and 
practical feedback on ease of use and their experience. Using qualitative 
methods, rather than quantitative methods, also allowed us to explore the 
nuances of participant acceptability and search for emerging themes. From a 
programmatic perspective, sampling based on gender and symptom status was 
an additional strength: gathering the perspectives of these different groups 
allowed us to assess for any meaningful differences between them. This 
information can help decision-makers prioritize resources and focus future 
interventions. Nevertheless, our study was not without limitations. Regarding the 
acceptability of SCS, it is possible that social desirability bias affected our results. 
We also did not sample participants based on socioeconomic status or age – 
these factors could influence SCS acceptability and sampling on these strata 
could inform our findings further. Regarding service delivery, our study relied on 
stated preferences; because participants operated within a hypothetical 
understanding of SCS/STI testing activities, it is possible that revealed 
preferences will differ from stated preferences once individuals actually 
experience the activities. Again, we did not sample high-risk groups or those of 
different socio-economic statuses. These groups may have preferences that 
differ from those we observed. Finally, because we did not assess preferences 
systematically, we are not able to present a ranking order of participant 
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preferences, and rather, can only present data on which approach for service 
delivery could work and potential reasons why. 
 
7.3 Implications for practice 
With STI cases rising in settings that have successfully implemented HIV 
combination prevention programs (particularly PrEP),1–3 countries like Uganda 
need to be prepared to combat a similar trend. Accurate and timely STI diagnosis 
is critical to STI control. Improving and expanding STI diagnostic services will be 
essential in the event that STIs rise in Uganda and similar low-resource settings. 
 
Prompt and appropriate STI diagnosis and treatment can lower the duration of 
infectiousness and limit the spread of disease.5 In this context, it is important for 
STI control programs to understand a population’s treatment seeking behavior. In 
Aim 1, we found that nearly half of adults with STI-related symptoms were not 
seeking appropriate treatment. This is a cause of concern, as untreated cases 
risk spreading infection to others in the population. Given the fact that they 
present with symptoms (and are thus easier to detect than asymptomatic cases), 
individuals reporting STI-related symptoms are ‘low-hanging’ fruit in terms of STI 
control; in a resource-limited setting, these individuals can be prioritized: 
resources can be focused to target such individuals first, getting them diagnosed 
and on treatment in order to avoid infection spread. We recommend researchers 
explore barriers to treatment seeking in this, and similar populations.  
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We also found that there is still a high proportion of STIs among those who have 
reported previously seeking clinic care, suggesting poor management of STI 
disease, high reinfection rates, or both, in this population. We urge decision-
makers to quickly focus their attention on methods to increase appropriate STI 
diagnosis and treatment in this setting now, before STI burdens increase.  
 
SCS/STI testing can also facilitate accurate and timely STI diagnosis, particularly 
in settings where syndromic management is the standard of care and there may 
be barriers to clinic-based diagnosis.128 With an improved infrastructure and 
increased laboratory capacity thanks to HIV prevention efforts, Uganda and 
similar low-resource settings stand ready to shift toward etiologic testing for STI 
diagnosis. Using findings from this dissertation, program-planners and decision-
makers can assess the potential of SCS as a means to expand STI diagnosis 
and control efforts. In Aim 2, we found that SCS is acceptable among users, but 
there is hesitancy to use SCS over HCW-collection. We recommend that our 
findings from Aim 2 be used to support the design of health education and 
communication campaigns to increase SCS uptake. For instance, program-
planners can design SCS-promoting messages that emphasize individual health 
and life, confidentiality and privacy, as well as assure users of the low risks 
associated with SCS. Successful uptake of a SCS/STI testing service also 
requires a service delivery model that is acceptable to users. In Aim 3, we found 
that some approaches for service delivery are more acceptable than others for 
different reasons and individuals vary in their service delivery preferences. 
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Nevertheless, we observed a common desire for confidentiality and HCW 
interaction, making home- and facility-based approaches more appealing than 
other approaches, to all participants. We recommend program-planners take this 
data to mean that, like most services, individual choice is critical for SCS/STI 
testing service delivery; nevertheless, some common themes exist. We 
recommend public health guidance provide a variety of strategies for SCS/STI 
testing service delivery in order to make the service acceptable to the larger 
population.   
7.4 Recommendations for future research 
Concerning treatment seeking behavior for STI-related symptoms in low-
resource settings, a number of questions still remain. First, we recommend 
researchers explore barriers to treatment seeking so that we can understand why 
treatment seeking behavior was so low in our population. Second, we 
recommend researchers to assess the influence of psychosocial and socio-
contextual factors on treatment seeking behavior in SSA. We especially 
recommend an investigation of the health system and its organization in order to 
assess how the availability, accessibility and perception of various health 
services affect treatment seeking behavior in different low-resource populations 
and communities. Third, we also recommend future researchers collect data on 
the timing/order of treatment seeking and develop pathways models5 to further 
differentiate treatment seeking behavior; such information can further guide the 
allocation of resources and future intervention development. Finally, we 
recommend researchers explore the temporal association between past 
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treatment seeking and current STI prevalence in order to assess for treatment 
effectiveness and/or possible reinfection rates in this population. 
 
Our work regarding the acceptability of SCS/STI testing in a low-resource setting 
was exploratory; a number of other research questions exist. Results from our 
study suggest that SCS are acceptable and can be a potential means to expand 
STI testing in this setting. Further research should be conducted to better 
quantify this acceptability and measure its strength in different contexts and 
among specific target populations. With regard to service delivery, we 
recommend a series of discrete choice experiments to systematically assess 
user values and preferences for a SCS/STI testing service. We also recommend 
that researchers supplement our findings with studies assessing the capacity of 
health systems to rollout SCS/STI testing interventions. Pilot studies of SCS/STI 
testing interventions will also be critical to identify revealed preferences and 
optimal models of service delivery. 
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Chapter 8. Appendices 
8.1 STIPS STI module (for females) 
 
18-49 YEARS FEMALE STIPS QUESTIONNAIRE RCCS R19 
Q.1 In the past 6 months, have you had any of the following health problems? PROMPTED:  
(Code in past 6 months  column)          
Do you have these symptoms now or have you had them over the past 7 days 
 (Code in current Column)                         Past 6 months       Current   
                                                   Yes  No  DK        Yes  No  DK  
                           Genital ulcer          1    2   7  {SXM1}  1   2    7  {CUR1}  
                       Genital discharge          1    2   7  {SXM2}  1   2    7  {CUR2}  
   Thick and/or colored vaginal discharge     1    2   7  {SXM3}  1   2    7  {CUR3}  
                   Itching of the vagina          1    2   7  {SXM4}  1   2    7  {CUR4}  
                Unpleasant vaginal odour          1    2   7  {SXM5}  1   2    7  {CUR5}  
                      Frequent urination          1    2   7  {SXM6}  1   2    7  {CUR6}  
                       Painful urination          1    2   7  {SXM7}  1   2    7  {CUR7}  
                 pain during intercourse          1    2   7  {SXM8}  1   2    7  {CUR8}  
             bleeding during intercourse          1    2   7  {SXM9}  1   2    7  {CUR9}  
                    lower abdominal pain          1    2   7  {SXM10} 1   2    7  {CUR10}  
                           genital warts          1    2   7  {SXM11} 1   2    7  {CUR11}  
       If no to all the above, END                                                                                            
                                                           
Q.2 Did you do anything to help cure these symptoms or to prevent passing on           
       infection to your spouse/partner(s)?        
                                        Yes  1            |_| {TMT}  
                                         No  2    -------->END 
                                         NR  9    -------->END  
 
Q.3 If Yes to Q 2. ask: What actions did you take?    
      PROBE and RECORD all RESPONSES    
                                                    Yes    No    NR  
  Used condoms           1      2      9   {CON}  
  Abstinence   1    2    9   {ABS} 
   Sought treatment for self       1     2      9   {SLF}  
 Sought treatment for partner          1      2      9   {TMTSPS}  
  Other action       1      2      9   {OTHERACT}  
                    Specify)_____________________  {OTHACT Memo}  
                                                   
  IF RESPONDENT DID NOT SEEK TREATMENT FOR SELF,   END                                 
                                                  
Q.4 Where did you go for treatment?             
      (PROBE and RECORD up to 3 RESPONSES)        
                          Pharmacy/Drug store  01       |_|_| {TRTSTD1}  
                           Market/shop         02    
                         Rakai Project Clinic  03       |_|_| {TRTSTD2}  
                    Govt. doctor/nurse/clinic  04    
                    Prvt. doctor/nurse/clinic  05       |_|_| {TRTSTD3}  
                           Traditional healer  06   
         Other (specify _____________________) 07        {OTHTRTSTD}  
                                   Don't know  97   
                      No additional responses  88    
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8.2 User interview guide 
 
Note: This guide is intended to be comprehensive of all questions that may be asked in these 
interviews, to provide a sense of the topics covered. We anticipate that not all questions will be 
asked of each participant, per the nature of in-depth qualitative interviews. 
 
NOTE TO INTERVIEWER:  





NOTE TO INTERVIEWER: 
State your name. Repeat. 
State your ID number. Repeat. 
State participant RCCS ID number. Repeat. 
State interview start time and date. Repeat.  
 
INTERVIEW START 
Our study would like to learn more about your health and treatment seeking behavior.  
Mukunonyereza kuno twagala okumanya ku byobulamu bwo nengeri gyononya obujajabi. 
 
Module 1 – General Health Seeking. 
 
Okunonya Obujajabi obwa wamu. 
Let’s start by discussing the types of health care services available in the community. 
 
Katutandiike nokubaganya ebilowoozo ku bika byo bujajabi ebiri mu kitundu. 
1. Can you please list for me the health care and treatment services that are available in the 
community? PROBE: PROBE: relief of symptoms, barriers to care. 
 
Kusaba omenyele ebika byempereza byo bujajabi ebiri mu kitundu kino?  
PROBE:  relief of symptoms, barriers to care. 
 
2. Can you describe each one to me in terms of access and service quality?  
PROBE: accessibility, distance, appeal (opinions/attitudes of each service), acceptability, 
quality, communication, cost, confidentiality, trust. 
Kusaba onyinyole ku buli mpereeza engeri gyozifunamu awamu no mutindo? 
PROBE: accessibility, distance, appeal (opinions/attitudes of each service), acceptability, 
quality, communication, cost, confidentiality, trust. 
 
Now let’s talk about the last time you were sick. 
Katwogele ku mulundu gwe wasebayo okuba omulwadde. 
3. Can you tell me more about your symptoms and what you did to feel better? PROBE: 
treatment seeking, source of care, social support. 
STI-Related 
Symptoms? 
Sought Treatment? Self-Collected 
Sample? 
Administer Modules: 
Yes No No 1, 2, 4 
Yes No Yes 1, 2, 4, 5 
Yes Yes No Do not interview 
Yes  Yes Yes 1, 2, 3, 5 
No -  No Do not interview 
No -  Yes 1, 5 
 147 
kusaba obulileko obubonero bwo bulwadde lwe wasebayo okuba omulwadde ne 
kyi kyewakolawo okuwulira obulungi? 
PROBE: treatment seeking, source of care, social support. 
 
a) IF TREATMENT WAS SOUGHT: Can you tell me more about your experience 
with that source of treatment? What happened when you got there and how were 
you treated? PROBE: service quality, satisfaction with service, confidentiality. 
OBA OBUJAJABI BWA FUNIBWA: 
bulilako bye wayitamu ne jewafunira obujajabi? 
Kyi ekyabawo  bwe watukawo era wayisibwa otya? 
PROBE: service quality, satisfaction with service, confidentiality 
 
b) IF NO TREATMENT WAS SOUGHT: What were some reasons why you chose 
not to seek treatment? PROBE: relief of symptoms, barriers to care 
OBA OBUJAJABI TWE BWAFUNIBWA: 
Songa kyi ezakuletela okusalawo obutagenda kufuna bujajabi? 
 PROBE: relief of symptoms, barriers to care 
 
[IF THE PARTICIPANT REPORTED STI-RELATED SYMPTOMS, ELSE SKIP TO MODULE 5] 
 
Module 2 – STI Symptoms 
 
Now we are going to talk more about your personal health. 
Kati tugenda kwogera ku bikwatagana n’ebyobulamu bwo. 
 
Sometimes, people experience uncomfortable symptoms like [FOR FEMALES: genital  
discharge, genital sores, itching of the vagina, unpleasant vaginal odor, frequent or painful 
urination, or pain during intercourse; FOR MALES: genital discharge, genital sores, frequent or 
painful urination, or pain during intercourse]. In the previous RCCS, you mentioned that you 
experienced one or more of these symptoms. 
 
Ebiseera ebimu abantu bafuna obubonero bw’endwadde ne butabayisa bulungi, okugeza 
[FOR FEMALES: okubundula amazzi amabi okuva mu bifo by’ekyama, obubwa mu bifo 
by’ekyama, okusiiyibwa mu bifo by’ekyama, olusu olubi okuva mu bifo by’ekyama, 
okufuuyisa omusulo oguluma oba okufuuyisafuuyisa  buli kadde, oba okulumwa nga 
weegatta,  FOR MALES: okufulumya amazzi amabi okuva mu bifo by’ekyama, obubwa mu 
bifo by’ekyama, okusiiyibwa mu bifo by’ekyama, okufuuyisa omusulo oguluma oba 
okufuuyisafuuyisa  buli kadde, oba okulumwa nga weegatta ]. Mu kubuuzibwa ebibuuzo 
bya RCCS ebiwedde  ku nkambi, wagamba nti wafunako obumu ku bubonero 
bw’endawadde buno. 
 
4. Can you tell me more about the symptoms you experienced? PROBE: symptom 
recognition, symptom duration, symptom severity 
Mbuulira ku bubonero bw’endwadde bwe wafunako. PROBE: symptom recognition, 
symptom duration, symptom severity. 
 
a. At the time, what did you think caused those symptoms? 
Mu kaseera ako, kiki kye walowooza nti kye kyaleeta obubonero 
bw’endwadde buno? 
b. At the time, what did you think would happen to those symptoms? 
Mu kaseera ako, kiki kye walowooza ekyaali kiyinza okubeerawo ku 
bubonero bw’endwadde obwo? 
5. After you noticed your symptoms, what did you do? PROBE: changes in sexual behavior 
Oluvannyuma lw’okulaba obubonero bw’endwadde buno, wakolawooki? PROBE: 
Wakyusa mu nneeyisa yo mu by’okwegatta? 
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6. Did you tell anyone about your symptoms? If so, who did you tell and what was their 
reaction? PROBE: family, friends, partner 
Olina gwe wabuulirako nga ofunye obubonero bw’endwadde buno? 
 If so,  
Wabuulirako ani era yakuddamu ki?  
PROBE: family, friends, partner. 
 
7. How are such symptoms viewed in the community? PROBE: partners, peers, community  
leaders, elders, religious organizations, any differences by gender.  
Ani gwe wabulirako kububonero? 
PROBE: partners, pers, community leaders, elders, religious organizations, any 
differences by gender  
 
Our study would like to learn more about your health and treatment seeking behavior. 
Mukunonyereza kuno twagala okumanya ku byobulamu bwo nengeri gyononya obujajabi. 
 
Module 3 – STI Treatment, Sought Treatment 
 
In the RCCS, you also mentioned that you sought treatment for these symptoms.  
Mukubuuzibwa ebibuuzo ebiwedde kunkambi, (RCCS), era wagamba nti  wanoonya  
obujjanjabi kububonero buno. 
 
1. Can you tell me more about that decision? What was happening at that time; was there 
anything      that helped you seek treatment? PROBE: facilitators to seeking treatment, 
services available but not chosen, services available and chosen, rationale for choosing 
service, previous treatment seeking experience 
 
Nsaba okunnyinyonyoramu kuku salawoko? 
Biki ebwaaliwo mukaseera ako?  
Waliwo  ebya kuyamba mukunoonya obujanjjabi?  
PROBE: abakuyambako okunonya obujanjjabi, empeereza eziriwo nayenga 
tezaakozesebwa, empeereza eziriwo era nga zakozesebwa, ensonga lwaki 
wasalawo okukozesa empeereza eyo, byewayitamu nga onoonya obujanjjabi.  
 
2. Other people have mentioned that certain factors like community and/or social stigma, 
confidentiality and/or privacy issues, poor access to the clinic, cost, etc. were barriers to 
seeking treatment for such symptoms. Do you think these issues affected you when you 
experienced those symptoms? Why or why not?   
 
Abantu abalala batugambyeeko nti ensonga nga  abantu b’omukitundu ne/oba 
okutya okusongebwamu olunwe, okukuuma ebyama ne/oba esonga ezekuusa 
kubyaama, obuzibu bw’okutuuka ewajanjjabirwa, ebisale, etc. Byali bilemesa  
okunoonya obujanjjabi bw’obubonero buno.  
Olowooza bino byakutuukako bwewafuna obubonero buno? 
Lwaki oba lwaki nedda? 
 
3.  Other people have mentioned that certain factors like community and/or family support, 
peer groups, religious groups, access to the clinic, quality of services and patient care 
were facilitators to seeking treatment for such symptoms. Do you think these issues 
affected you when you experienced those symptoms? Why or why not?   
 
Abantu abalala batugambyeeko nti ensonga nga  abantu b’omukitundu  ne/oba 
okuyambibwaako ab’omumakaago, abekikoosi bo, ebenzzikiriza ezenjawulo, 
okutuuka ewajanjjabirwa, omutindo gwenpereeza n’abalwadde okufibwaako byaali 
biyambako okunoonya obujanjjabi bw’obubonero obwo.  Olowooza bino 
byakutuukako bwewafuna obubonero buno? Lwaki oba lwaki nedda? 
 149 
 
[IF THE PARTICIPANT REPORTED NOT SEEKING TREATMENT FOR STI-RELATED 
SYMPTOMS, ELSE SKIP TO MODULE 5] 
 
Module 4 – STI Treatment, Did Not Seek Treatment 
 
In the RCCS, you also mentioned that you did not seek treatment for these symptoms.  
Mukubuuzibwa ebibuuzo ebiwedde kunkambi, (RCCS), era wagamba nti   tewanoonya 
obujjanjabi kububonero obwo.   
 
4. Can you tell me more about that decision? What was happening at that time; was there 
anything that prevented you from seeking treatment? PROBE: barriers to seeking 
treatment, services available but not chosen, previous treatment seeking experience 
 
Nsaba okunnyinyonyoramu kuku salawoko? Biki ebwaaliwo mukaseera ako? 
Waliwo  ebya kulemesa okunoonya obujanjjabi?  PROBE:  ebyakulemesa  
okunonya obujanjjabi, empeereza eziriwo nayenga tezikozesebwa, empeereza 
eziriwo era nga zikozesebwa, ensonga eyokusalawo okukozesa empeereza, 
byewayitamu nga onoonya obujanjjabi. 
 
5. Other people have mentioned that certain factors like community and/or social stigma, 
confidentiality and/or privacy issues, poor access to the clinic, cost, etc. were barriers to 
seeking treatment for such symptoms. Do you think these issues affected you when you 
experienced those symptoms? Why or why not?   
 
Abantu abalala batugambyeeko nti ensonga nga  abantu b’omukitundu ne/oba 
okutya okusongebwamu olunwe, okukuuma ebyama ne/oba esonga ezekuusa 
kubyaama, obuzibu bw’okutuuka ewajanjjabirwa, ebisale, etc. Byali bilemesa  
okunoonya obujanjjabi bw’obubonero buno. Olowooza bino byakutuukako 
bwewafuna obubonero buno? Lwaki oba lwaki nedda? 
 
6. Other people have mentioned that certain factors like community and/or family support, 
peer groups, religious groups, access to the clinic, quality of services and patient care 
were facilitators to seeking treatment for such symptoms. Do you think these issues 
affected you when you experienced those symptoms? Why or why not?   
 
Abantu abalala batugambyeeko nti ensonga nga  abantu b’omukitundu  ne/oba 
okuyambibwaako ab’omumakaago, abekikoosi bo, ebenzzikiriza ezenjawulo, 
okutuuka ewajanjjabirwa, omutindo gwenpereeza n’abalwadde okufibwaako byaali 
biyambako okunoonya obujanjjabi bw’obubonero obwo.   
Olowooza bino byakutuukako bwewafuna  obubonero buno?  
Lwaki?  
Oba lwaki nedda? 
 
[IF THE PARTICIPANT SELF-COLLECTED A SAMPLE, ELSE END] 
Module 5 – Self-collected Sample 
 
Now, we are going to talk more about your recent experience in the RCCS. As part of the 
study, you were asked to provide a sample using a [vaginal/penile] swab for STI testing.  
Kati, tugenda kwongera okwogera ku biki bye waakayitamu nga obuuzibwa ebibuuzo bya  
RCCS ku nkambi.  Ekimu ku byaliwo kwolwo, wasabibwa okwejjako ka ppamba okusobola 
okukeberamu endwadde eziva mu kwegatta.  
7. Can you tell me more about why you decided to participate in the study and provide a 
sample for STI testing? 
Mbuulira lwaki wasazeewo okwetaba mu kunoonyereza kuno era noosalawo 
okwejjako  ka ppamba n’okawaayo kakeberwemu endwadde eziyitira mu kwegatta? 
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8. [IF THE PARTICIPANT REPORTED NO STI-RELATED SYMPTOMS] 
Can you tell me more about what you know about STIs? PROBE: transmission, risk 
factors, symptoms, treatment 
Yongera ombuulire biki by’omanyi ku  ndwadde eziyitira mu by’okwegatta?  
PROBE: transmission, risk factors, symptoms, treatment. 
 
9. Please tell me more about your experience providing a sample. What were the positive 
aspects? What were the negative aspects? PROBE: ease of sample collection, 
comfort/discomfort, privacy, trust of results, any other concerns 
Mbuulira bwe wayisibwa ku ky’okwejjakoka ka ppamba  n’okukawaayo. Kyalimu 
birungi ki? Wakisangamu buzibu ki?  
PROBE: ease of sample collection, comfort/discomfort, privacy, trust of results, any other 
concerns 
a. Would you have preferred for a clinician to collect the sample? Why or why not? 
Owulira wandyagadde omusawo yaaba akujjako ka pamba?  
Lwaki/lwaki nedda? 
 
10. In your opinion, what do you think are the advantages and disadvantages of taking your 
own sample as compared to having a clinician take it? PROBE: time, cost, confidentiality, 
privacy, convenience, trust in results, stigma, patient-provider interaction 
Mu ndowoozayo, biki ebirungi awamu n’ebibi by’olaba ebiri mu gwe okwejjako ka 
ppamba bw’okigeraageranya n’omusawo okukakujjako?  
PROBE:  time, cost, confidentiality, privacy, convenience, trust in results, stigma, patient-
provider interaction 
a. If you were to provide a sample again in the future, would you prefer having a 
clinician collect it or collect it yourself? Can you explain your choice to me? 
Singa oli wakuwaayo ka ppamba omulundi omulala mu biseera ebijja, 
wandyagadde musawo y’aba akakujjako oba gwe okukejjako? 
Nyinnyonnyola lwaki ekyo kye wandyagadde. 
  
11. If you don’t mind, may I ask what were the results of your tests? 
Bwe kiba tekikuyisa bubi, nandyaagadde ombuulire ebyava mu kukebera ka 
ppamba kebakujjoko? 
a) Can you tell me more about the experience of getting your test results? How did 
you feel and what did you do? PROBE: personal reaction, social support, partner 
notification, treatment seeking and quality of services, any changes in sexual 
behavior.  
Nsaba ombuulire engeri gye wayisibwamu ng’ofunye ebyava mu kukebera 
ka ppamba.  
Muli wawulira otya, 
 Era wakolawooki?  
PROBE:  personal reaction, social support, partner notification, treatment 
seeking and quality of services, any changes in sexual behavior  
 
IF NEGATIVE: How would you have felt if you were positive for an STI? What 
would you     have done? PROBE: personal reaction, social support, partner 
notification, treatment seeking and quality of services, any changes in sexual 
behavior. 
IF NEGATIVE: Wandiwulidde otya singa wasangibwa nga olina endwadde 
eziva mu kwegatta?, 
Kiki kye wandikoze? 
 PROBE: personal reaction, social support, partner notification, treatment seeking 
and quality of services, any changes in sexual behavior 
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My last few questions relate to future STI testing programs. We are thinking about designing a 
program that provides STI testing services using self-collected sampling methods like the swab 
you took yourself. We would provide ‘self-test kits’ that have instructions and the tools to help you 
take a sample. Using a self-test kit could mean that you could test yourself for an STI without 
having to go to a clinic or be seen by a physician.  
Ebibuuzo byange ebitono ebisembayo byekuusa kunkola ey’okukebera endwadde eziyitira 
mu kwekagata gyetuteekateeka mu biseera eby’omumaaso. Tulowooza okuteekateeka 
enkola e’yokwekebeza endwadde eziyitira mukwegata ngatukozesa enkola eyokwekebera 
nga bu pamba bwemwejako. Tujja kugaba ebikozesebwa mu kwekebera okuli endagiriro 
n’ebikozesebwa ebirara okwejjako ka pamba. Okukozesa enkola ey’okwekebera kiyinza 
okutegeeza nti oyinza okwekebera gwe kenyini obulwadde obuyitira mu kwegata nga 
togenze mu dwaliro oba okulaba omusawo. 
 
To help us design a program that would best serve you, we need your honest feedback on what 
would and wouldn’t work for you. 
Okutuyambako okuteekateeka enkola enabayamba obulungi, twetaaga ebirowoozo 
byamwe eby’amazima ku kiki ekinabakolera oba ekitabakolere. 
 
12. There are various ways that you could request a self-testing kit, how do you prefer to 
request a self-testing kit? Can you help me understand your choice? What about this way 
makes it most appealing to you?  
a. PROBE: opinion on requesting the kit in-person at a prespecified location like a 
clinic, pharmacy or other community site 
b. PROBE: opinion on requesting a kit online 
c. PROBE: opinion on requesting via the phone by text or phone call, etc.  
 
13. There are also many ways to physically get the kit, how do you prefer to physically get a 
self-testing kit? Can you help me understand your choice? What about this way makes it 
most appealing to you?  
a. PROBE: opinion on picking up a kit at the clinic, a community location, school, 
religious organization or pharmacy 
b. PROBE: opinion on having a kit delivered to the home by mail or by a health care 
worker  
 
14. To get your result, the samples you collect will have to be sent back to the lab for 
processing. There are many ways to do this, how do you prefer to send your samples to 
the lab? Can you help me understand your choice? What about this way makes it most 
appealing to you?  
a. PROBE: opinion on personally dropping off the sample at a prespecified location 
like a clinic, pharmacy or other community site 
b. PROBE: opinion on personally mailing the samples to a lab 
c. PROBE: opinion on having the samples picked up by health worker at their home  
 
15. Now in terms of receiving your results, how do you prefer to receive your results? Can 
you help me understand your choice? What about that way makes it most appealing to 
you?  
a. PROBE: opinion on receiving the results by phone call, by text message, by mail, 
and/or online 
b. PROBE: opinion on receiving the results in-person at the clinic, pharmacy, lab or 
some other location  
c. PROBE: opinion on receiving the results at home by a health care worker  
 
16. There are also a few options for how you would like to receive treatment if you tested 
positive, how do you prefer to receive treatment? Can you help me understand your 
choice? What about that way makes it most appealing to you?  
a. PROBE: opinion on delivery of treatment at home via a health worker 
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17. Thank you, you have provided us with some very useful feedback. If we were to design a 
program that used self-collection of samples for STI testing, considering the preferences 
you mentioned, would you use such a service in the future? Why or why not? PROBE: 
advantages/disadvantages, barriers, concerns, willingness to pay, willingness to 
recommend to others 
Webale, otuwadde ebirowozo byo ebirungi era nga bya mugaso. Bwetuba nga tuli 
bakutekateka enkola e’yokwejjako bu pamba okukebera endwadde eziyitira mu 
kwegata, bwetutunurira ku nkola z’oyogeddeko ezisinga okukolera,  
wandikozeseza empereeza ezo gyebujja?  
Nyonyola .  
PROBE: advantages/disadvantages, barriers, concerns, willingness to pay, 
willingness to recommend to others 
 
a. Do you think such a program would meet your needs is there something else we 
could do to help you seek treatment for STI-related symptoms?  
Olowooza enkola eno enatukiriza eby’etaago byo?  
Waliwo ekintu ekirara kyona kyetuyinza okukola okuyamba okufuna 
obujanjabi bw’obubonero obw’endwadde eziyitira mu kwegatta? 
 
 
This concludes my questions. 
18. Is there anything else you would like to share or think is important for me to know? 
Waliwo ekintu ekirara kyona kyewandyagadde okumbuliramu oba kyolowooza nti 
kyamugaso gyendi okumanya? 
 
Thank you for participating. 
Webale okwetaba mukunonyereza kuno. 
 
INTERVIEW END 
NOTE TO INTERVIEWER: 





8.3 Key informant interview guide 
 
Note: This guide is intended to be comprehensive of all questions that may be asked in these 
interviews, to provide a sense of the topics covered. We anticipate that not all questions will be 




NOTE TO INTERVIEWER: 
State your name. Repeat. 
State your ID number. Repeat. 
Describe type of key informant (health officer, physician, community health worker, etc.). 




Thank you for participating in this study. Our goal is to better understand treatment seeking 
behavior among adults with STI-related symptoms, in order to design STI testing interventions 
that meet their needs. We invited you to participate in this study based on your experience with 
[patients with STIs OR STI control programs in the community]. 
Webale kukiriza kwetaba mukunonyereza kuno. Ekigendererwa kyaffe kwe kutegera 
obulungi engeri abantu abakulu gye banonyamu obujajabi bwo bubonero bw’ endwadde 
eziyitira mu kwegatta,kitusobozese okuteekateeka enkola e’yokwekebeza edwadde 
eziyitira mu kwegatta etukagana ne byetago byabwe. Walondedwa okwetaba mu 
kunoonyereza kuno okusizira kubumanyirivu bwolina ne [abalwaddwe abayina edwadde 
eziyitira mu kwegatta oba enkola eziziyiza edwadde z’obukaba mu kitundu]. 
 
Module 1 
To start, let’s focus on STIs and treatment seeking behavior among adults. 
Nga tutandiika ,tugenda kutunulira obulwadde obuyitira mu kwegatta ne ngeri abantu 
abakulu gye banonya obujajabi 
1. In general, what is the perception of STIs in the community? PROBE: knowledge of STI 
causes & transmission, perceived risk, stigma 
Okutwalira awamu ,edwadde eziyitira mu kwegatta abantu bo mu kitundu 
bazilowozako ki?  PROBE: knowledge of STI causes & transmission, perceived 
risk, stigma 
 
2. What care and treatment options are available for persons with STI-related symptoms? 
Bika bya bujajabi kyi ebiliwo eri abantu abalina obubonero bwe ndaddwe eziyitira 
mu kwegatta?  
a. Can you describe each in terms of quality, cost and accessibility?  PROBE: quality of 
services, availability of services, patient-provider interaction, trust, cost, access, distance 
Nkusaba onyonyole ku mutindo gwo bujajabi obwo ,ebisale  ne engeri 
 
 
gyobufuna   PROBE: quality of services, availability of services, patient-provider 
interaction, trust, cost, access, distance  
 
b.  What factors influence an adult’s decision to seek one treatment provider over another 
PROBE: quality, cost, accessibility 
Biki ebivirako omuntu omukulu okusalawo okunonya obujajabi okuva 
mubagabi bo bujajabi abenjawulo (i.e. obujajabi bwe kizungu oba obujajabi 
bwe kinansi)? PROBE: quality, cost, accessibility, (i.e. western medicine vs. 
traditional healer)?   
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3. In your experience, how do adults commonly react if they notice STI-related symptoms? 
PROBE: changes in sexual behavior, discussion with others/partner, average time to 
seek treatment, location and type of treatment    
Mu bumanyirivu bwo, abantu abakulu batela kweyisa batya oluvanyuma lw’okulaba 
obubonero bw’endwadde eziyitira mu kwegatta? PROBE: changes in sexual 
behavior, discussion with others/partner, average time to seek treatment, location 
and type of treatment    
 
a. Does this differ between males and females? Young and old persons? Persons 
of low or high Social economic status? Any other factor? How so? 
Kino kilina engeri gye kyawuka wakati wa basajja na bakazi? Abato na 
abakulu? Abantu ba embera yenfuna eri wansi oba eri wagulu? Waliwo 
ensonga endala yona? Kitya? 
4. In your opinion, how common is it for adults to  seek treatment if they have STI-related 
symptoms?  
Mu ndowooza yo, kyabuligyo abantu abakulu obutanonya bujajabi singa babeera 
no bubonero bw’eddwadde eziyitira mu kwegatta? 
a. Does this differ between males and females? Young and old persons? Persons 
of low or high social economic status? Any other factor? How so? 
Kino kilina engeri gye kyawuka wakati wa basajja na bakazi?Abato na 
abakulu? Abantu ba SES eri wansi oba eri wagulu? Waliwo ensonga endala 
yona? Kiri kitya? 
5. We conducted an analysis among adults living in Rakai to see which factors are 
associated with NOT seeking treatment for STI-related symptoms. Our preliminary results 
found that certain factors like community and/or social stigma, confidentiality and/or 
privacy issues, distance to the clinic and cost, increased the odds of a person to not seek 
treatment. Does this make sense to you? Why or why not?  
Twakola okunonyereza ku bantu ababela mu Rakai okulaba biki ebiletela abantu 
obutanonya bujajabi bwo bubonero bw’endaddwe eziyitira mu kwegatta.Ebyavamu 
bilaga nti ensonga nga abantu b’omukitundu ne /oba okutya okusongebwamu 
olunwe,okukuuma ebyama ne/oba ensonga ezekuusa kubyaama,obuzibu 
bw’okutuuka ewajanjjabirwa,ebisale,etc byalemesa abantu okunonya obujajabi. 
Kino kikola amakulu gy’oli?Lwaki oba lwaki nedda 
a. Are there any other factors that you think will increase the chance that a person 
with symptoms will not seek treatment? PROBE: individual factors, interpersonal 
factors, community factors, health system factors, contextual/social factors 
Waliwo ensonga eddala gy’olowooza eyinza okulinyisa emikisa gy’omuntu 
alina obubonero obutanonya bujajabi? PROBE: individual factors, 
interpersonal factors, community factors, health system factors, 
contextual/social factors 
 
b. We also found that men are more likely to seek treatment for their symptoms 
than women, can you help explain why this is the case? Era twakizude nti 
abami batera okunonya obujanjabi obw’obubonero bwabwe ekitali 
mubakyala, mbulirako lwaki kirikityo? 
 
 
6. From your experience, what are the major barriers to seeking treatment among adults 
with STI-related symptoms? PROBE: health care service quality, access and affordability, 
social networks, family dynamics, partner dynamics, social stigma  
 
Okusinzira ku bumanyirivu bwo, kiki ekisinga okulemesa abantu abakulu 
okunonya obujajabi bwo bubonero bw’endwadde eziyitira mu kwegatta?  PROBE: 
health care service quality, access and affordability, social networks, family 
dynamics, partner dynamics, social stigma  
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a. Do these barriers differ between males and females? Young and old persons? 
Persons of low or high social economic status? Any other factor? How so? 
Ebilemesa bino okunonya obujajabi byawuka wakati wa basajja na bakazi? 
Abato na abakulu? Abantu befuna entono oba abantu abalina ku nsente? 
Waliwo ensonga endala yona? Lwaki kili kityo 
7. Based on your experience, what do you think would help facilitate an individual to seek 
treatment for STI-related symptoms? PROBE: health care service quality, access and 
affordability, social networks, family dynamics, partner dynamics, social stigma  
Okusinzira ku bumanyirivu bwo ,kiki kyolowooza ekisobola okuyamba omuntu 
sekinomu okunonya obujajabi bw’endwadde eziyitira mu kwegatta  PROBE: health 
care service quality, access and affordability, social networks, family dynamics, 
partner dynamics, social stigma  
 
a. Do females need anything different than males? What about younger versus 
older persons? Persons of lower social economic status versus higher social 
economic status? How so? 
Abakazi balina ekyenjawulo kyebetaga okusinga ku basajja?Ate abato 
ng’obagerageranya kubantu abakulu? Abantu abembera yenfuna entono ku  
abembera yenfuna eriwagulu?   
 
8. In our study, we also found that both men and women had issues disclosing their 
symptoms and test results to others; for both men and women, persons did not often 
share this information with others. Can you help explain why this is the case? 
Mukunonyereza kwaffe, twazudde nti abami na abakyala ebisera ebisings 
tebabuliko muntu yena ku bubonero oba ebivudde mukeberebwa. Mburilako lwaki 
kino kiri bwekityo? 
a. Some men and women were also hesitant to disclose their symptoms and test 
results to their partners, specifically. Can you help explain why this is the case? 
Abami abamu nabakyala tebagala kubulira bubonero bwabwe ne ebivude 





Thank you, this information so far has been very informative. Another goal of the study is related 
to improving STI case management. To this end, I would appreciate your insights on current 
practice for STI case management. 
Webale,   ebirowozo bw’otuwadde bya mugaso.Ekigendererwa ekirala mu kunonyereza 
kuno kyekuusa ku kulongosa engeri  edwaddwe eziyitira mu kwegatta bwezigonjolwamu. 
Kakati,nyaniriza endowoozayo ku ngeri endwadde eziyitira mu kwegatta bwezigonjolwa 
ensagi zino 
9. Can you describe how STI are currently managed in thi community? PROBE: diagnosis, 
treatment, follow-up care 
Kusaba onyonyole engeri endwadde eziyitira mu kwegatta bwezikwatibwa mu 
kitundu kino/Uganda?  PROBE: diagnosis, treatment, follow-up care 
 
a. Does this differ by service provider? PROBE: western medicine, traditional 
healer, pharmacist, self-treatment 
Olowooza Kino kyawuka okusinzira obujajabi gy’bufunibwa?  PROBE: 
western medicine, traditional healer, pharmacist, self-treatment 
 
10. Please describe to me the syndromic management approach to STI case management.  
Kusaba onyinyonyole ku nkola yokujajaba nga basinzira  kububonero era enkola 
eno eyamba etya  mukungojola ebizibu by’endwadde eziyitira mu kwegatta. 
a. Do you think this is a good approach to STI case management in this 
community? What works/is good about it? What doesn’t work/is bad about it? 
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PROBE: asymptomatic patients, cost-effectiveness, misdiagnosis, antibiotic 
resistance, training of clinicians, patient access to services, linkage to care, loss 
to follow-up 
Olowooza eno enkola  nungi mukugonjola ebizibu by’endwadde eziyitira 
mu kwegatta mu kitundu kino ne Uganda yonna?ki ekikola/ oba ekilungi mu 
kola eno? Kiki ekitakole/oba ekibi mu nkola eno?  PROBE: asymptomatic 
patients, cost-effectiveness, misdiagnosis, antibiotic resistance, training of 
clinicians, patient access to services, linkage to care, loss to follow-up 
 
11. How common is laboratory testing for STI case management in this community?  
Kyabulijjo okukebelera mu lab okugonjola ebizibu by’endwadde eziyitira mu 
kwegatta mu kitundu kino? 
a. What do you think are the barriers to widespread, routine lab testing for STIs in 
this community? PROBE: cost, availability of equipment, lab capacity, 
transportation requirements, linkage to care 
Olowooza biki ebilemesa okubunya enkola yokukeberebwa mu lab buli 
endwadde eziyitira mu kwegatta buli kiseera mu kitundu kino n?  PROBE: 
cost, availability of equipment, lab capacity, transportation requirements, 
linkage to care 
 
 
Thank you. The next set of questions relate to future STI testing interventions.  
Webale.Ebibuzo byange ebilala byekuusa kunkola ey’okukebera endwadde eziyitira mu 
kwegatta gyetuteekateeka mu biseera eby’omumaaso. 
 
We are thinking about designing a program that provides STI testing services that use self-
collected sampling methods. This would require a patient to somehow obtain a self-test kit that 
will include a self-administered swab, which they can use to collect a specimen from the vagina or 
penis. The swab will then have to be sent to the lab for testing and the results returned to the 
patient. By self-collecting a specimen, patients could test themselves for an STI without having to 
go to a clinic or be seen by a physician.  
Tulowooza okuteekateeka enkola e’yokwekebeza endwadde eziyitira mukwegatta 
ngatukozesa enkola eyokwekwebera. kino kijja kwetagisa omulwadde okufuna 
ebikozesebwa mu kwekebera nga mulimu ka pamba ke banakozesa okwejjakko 
ebinakeberebwamu endwadde okuva mu bifo byabwe ebyekyama .Kapamba kebejjeko 
kajja kuwerezebwa mu lab okwekenenyezebwa era ebivudde mu kukeberebwa bijja 
kukomezebwayo eri omulwadde. Munkola  eno ey’okwejako kapamba , abalwadde  bajja 
kuba basobola okwekebera benyini obulwadde obuyitira mu kwegatta nga tebagenze mu 
dwaliro oba okulaba omusawo 
 
I would appreciate your help to identify some details of such a program: 
Twetaaga obuyambi bwo okusobola okulonda enkola enungi: 
 
12. What is your initial reaction to this idea? What do you like about it? What do you not like 
about it or think would not work?  
Ensonga eno ogyogerako kyi? Kiki kyojagalako? Kiki ekitakusanyusa ku nkola eyo 
oba kyolowooza ekitakole? 
13. What types of patients do you think would benefit from such a program? PROBE: sex, 
social economic status, age  
Balwadde  bakika ki bolowooza abanaganyulwa mu  ntekateeka eno? PROBE: sex, 
SES, age  
a. How do you recommend we engage with/reach such patients? 
Tukole tutya okulaba nga tutukirira abalwadde abo? 
14. What are some ways that self-test kits could be made available to patients? PROBE: 
passive approach initiated by individual request in-person at a prespecified location, 
individual request online, individual request via phone call or text; active approach 
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initiated by public health practitioners via community health workers during home visits or 
community outreach, clinic staff at health center visits, pharmacy staff 
 Nkola kyi zetwandikozeseza okusobola okutusa ebikozesebwa okwekebeza 
endwadde ezobukaba eri abalwadde?  PROBE: passive approach initiated by 
individual request in-person at a prespecified location, individual request online, 
individual request via phone call or text; active approach initiated by public health 
practitioners via community health workers during home visits or community 
outreach, clinic staff at health center visits, pharmacy staff 
a. Which do you recommend and why? 
Nkolaki gy’osazeewo era lwaki? 
b. We have found that community members generally prefer requesting a kit over 
the phone or via a healthcare worker because of privacy reasons or to save time 
and money. Can you help me understand why this is the case? 
Tukizudde nti abantu b’omukitundu abasinga bandyagade okusaba 
ebikozesebwa nga bayita mukukuba esimu oba oba okuyitira mu musawo 
olwensonga yo kukuma ebyama oba obutonona bisera ne sente. Nyonyola 
lwaki kino kiri bwekityo? 
 
15. What are some locations where self-test kits could be made available? PROBE: at the 
clinic, at a community location (specify), at school, at a religious organization, at the 
pharmacy, at home (specify how – by mail, health care worker drop-off) 
Bifo ki byolaba awasobola okutekebwa ebikozesebwa okwekebeza endwadde 
ezobukaba?  PROBE: at the clinic, at a community location (specify), at school, at 
a religious organization, at the pharmacy, at home (specify how – by mail, health 
care worker drop-off) 
a. Which do you recommend and why? 
Nkolaki gy’osazeewo era lwaki? 
b. We have found that community members generally prefer having a healthcare 
worker deliver the kit to their homes because it saves time and money. Can you 
help me understand why community members feel this way? 
Tukizudde nti abantu b’omukitundu abasinga badyagadde omusawo 
weby’obulamu okubaletela ebikozesebwa ewaka kubanga kitasa ebisera ne 
sente.Nyonyola lwaki abantu b’omukitundu balowooza bwatyo? 
 
16. How do you think individuals in this community who have STI symptoms would feel about 
doing a self- collected sample?  
Olowoozaa abantu mu kitundu kino abalina obubonero bw’endwadde eziyitira mu 
kwegatta banawulira baatya okwejako ka pamba 
a. How do you think self-collection will be accepted in this community as compared 
to attending a clinic for STI case management? 
Olowooza enkola eyo kwekebera enekirizibwa mu kitundu kino 
bw’okigeraageranya no genda mu dwaliro okusobola okugonjola ebizibu 
by’endwadde eziyitira mu kwegatta 
17. How do you think individuals in this community who do not have any STI symptoms 
would feel about doing a self- collected sample? 
Olowooza abantu mu kitundu kino abatalina bubonero bwona obw’endwadde 
eziyitira mu kwegata banawulira batya okwejako ka pamba? 
a. We have found that community members generally like self-collecting a sample 
but some would still prefer having a clinician collect the sample because they feel 
clinicians are better trained. Can you help me understand why community 
members feel this way? Tuzudde nti abantu b’mukitundu abasinga bagala 
okwejako bupampa naye abamu bandyagade omusawo yaba abakabajako 
kubanga omusawo mutendeke bulungi 
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18. After collection, patient samples would have be sent back to the lab for processing. What 
are some options for sending the sample to the lab? PROBE: pickup by health worker at 
home, drop off specimen at prespecified location (specify), mail in 
Oluvanyuma lw’okuganya ebijidwako ku mulwadde bilina okudizibwayo 
okwekenenyezebwa mu labu. Nkolaki ezandikozeseddwa okuzayo omulwadde 
byeyejeko okwekenenyezebwa mu labu? PROBE: pickup by health worker at 
home, drop off specimen at prespecified location (specify), mail in 
 
a. Which do you recommend and why? 
Nkolaki gy’osazeewo era lwaki? 
b. We have found that community members generally prefer having a healthcare 
worker pick up the kit from their homes because it ensures that the sample is 
taken safely and will reach the destination safely. Can you help me understand 
why community members feel this way? Tuzudde nti abantu bomukitundu 
abasinga bandyagade omusawo okukima bwewejjeko ewaka kubanga 
bupamba bwebejeko bujakutwalibwa bulungi era butusibye bulungi 
gyebulaga. Nyonyola lwaki abomukitundu bawulila bwebatyo? 
 
19. What are some ways that test results could be shared with the patient? PROBE: by 
phone, by mail, online, in-person at the clinic, in-person at pharmacy, in-person at the 
lab, in-person at some other location (specify) 
Nkolaki ezandikozeseddwa ebivudde mu kukeberebwa  okusobola okutusibwa eri 
omulwadde?  PROBE: by phone, by mail, online, in-person at the clinic, in-person 
at pharmacy, in-person at the lab, in-person at some other location (specify) 
 
a. Which do you recommend and why? 
Nkolaki gy’osazeewo era lwaki? 
b. We have found that some community members generally prefer having a 
healthcare worker deliver the results to their home or their go to the clinic for the 
results because of privacy reasons. Some preferred to have the results delivered 
by phone because it saves time and money. Can you help me understand why 
community members feel this way? Tuzude nti abantu b’omukitundu abasinga 
bandyagade omusawo okubatusako ebivude mukukeberebwa ewaka oba 
okubifunira mu clinic olwensonga yo kukuma ebyama. Abamu bandyagade 
okufuna ebivude mukukeberebwa okuyitira kusimu kubanga kitasa obisera 
ne sente . Nyinyonyola lwaki abantu b’mukitundu bawulira bwebatyo? 
c.  
20. What are some ways to connect the patient to treatment if their result is positive? 
PROBE: at home delivery via health worker, self pick-up in the clinic, pharmacy, 
community location 
Ngeri ki gy’etuyinza okukwataganya omulwadde awali obujajabi singa asangibwa 
n’endwadde eziva mu kwegatta?  PROBE: at home delivery via health worker, self 
pick-up in the clinic, pharmacy, community location 
 
a. Which do you recommend and why? 
Nkolaki gy’osazeewo era lwaki? 
b. We have found that community members generally prefer having a healthcare 
worker deliver the treatment to their home or at a central community hub 
because it saves time and money. Some also don’t mind to pick up the treatment 
at a local clinic or pharmacy. Can you help me understand why community 
members feel this way? Tuzude nti abantu b’omukitundu abasinga 
bandyagade omusawo okubatusako obujanjabi ewaka oba kukifo 
ekirondedwa mukitundu kubanga kitasa ebisera ne sente. Abamu tebayina 
buzibu kufuna bujanjabi okuva ku bu clinic oba obuduka obutunda edagala 




21. What are some ways to engage the sexual partners of those that are positive in STI 
testing services? 
Nkolaki zetuyinza okuyitamu okwogeraganya na bagalwa babasagiibwa 
n’endwadde eziyitira mu kwegatta?  
 
a. Which do you recommend and why?  
Nkolaki gy’osazeewo era lwaki? 
 
b.  We have found that partner mistrust is common, with some men and women not 
disclosing their test results to their partners or referring their partners to treatment 
because they fear being labeled as promiscuous. Can you help me understand 
why community members feel this way? Tuzude nti abagalana 
obutesigangana kyabuligyo abasaja abamu na abakyala tebabulirako 
abagalwa babwe ku bivude mukukeberebwa oba okugamba abagalwa 
babwe kubanga batya okubayita abenzi. Nyinyonyola lwaki abantu 




Thank you, you have provided us with some very useful insight. I have a few last questions:  
Webale ,otuwadde ebirowozo ebyomugaso. Ninayo ebibuzo bitono ebisembayo 
22. If implemented, a self-collection for STI testing program would be offered in addition to 
the current standard of care. What do you see as the advantages of this additional 
service as compared to only offering the current standard of care? What do you see as 
the disadvantages? PROBE: advantages/disadvantage of those with symptoms, 
advantages/disadvantages of those without symptoms 
Singa eletebwa,enkola yokwekebera endwadde eziyitira mu kwegatta  eja 
kutekebwawo  nga egattibwa ku mpereza eliwo kati.bilungi ki byolaba mu mpereza 
eno enaba eyogedwako bwokigeregeeranya ne mpereeza yobujajabi eliwo 
kati?Bibi kyi byokilabamu?  PROBE: those with symptoms, those without 
symptoms 
 
23. Do you have any concerns about such a program? Please describe. 
Olina okwekegera kwona ku ntekateeka eno? Nyonyola. 
24. How do you think the community would respond to such a program? PROBE: response 
of those with symptoms, response of those without symptoms.  Olowoza 
a’bomukitundu banajumbira entekateka nga eno? 
 
a. a. We have found that community members are accepting of such a service and 
would be open to using it. However, the main issue is cost. Can you help me 
understand why community members feel this way? Tuzude nti abantu 
b’omukitundu bakiriza empereza era betegefu okujikozesa naye ekikulu 
bisale. Nyinyonyola lwaki abantu b’omukitundu bawulira batyo? 
25. If the funding for STI testing and self-collection kits was available, do you think the health 
system is ready to implement an STI testing intervention that uses the self-collection of 
samples? Why or why not? 
Singa obusobozi bwokusasulira okwekebera endwadde eziyitira mu kwegatta ne 
bikozesebwa mu kwekebera webiri,olowooza abakwataganya eby’obulamu 
betegefu okuteka mu nkola empereeza yokwekebera endwadde eziyitira mu 
kwegatta ?lwaki/lwaki nedda? 
 
26. If the program was funded, what do you think would be the major barriers to successful 
implementation? PROBE: political will, health system capacity, trust, loss to follow-up, 
logistics issues, patient uptake of services 
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Singa etekateeka eno esasuliddwa,olowooza biki ebiyinza okusinga okugilemesa 
okutekwebwa mu nkola?  PROBE: political will, health system capacity, trust, loss 
to follow-up, logistics issues, patient uptake of services 
 
This concludes my questions. 
27. Is there anything else you would like to share or think is important for me to know? 
Waliwo ekintu ekirara kyonna kyewandyagadde okumbuliramu oba kyolowooza nti 
kyamugaso gyendi okumanya? 
 
Thank you for participating.  




NOTE TO INTERVIEWER: 
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